WO2005051170A2 - Integrated receiver for continuous analyte sensor - Google Patents
Integrated receiver for continuous analyte sensor Download PDFInfo
- Publication number
- WO2005051170A2 WO2005051170A2 PCT/US2004/038724 US2004038724W WO2005051170A2 WO 2005051170 A2 WO2005051170 A2 WO 2005051170A2 US 2004038724 W US2004038724 W US 2004038724W WO 2005051170 A2 WO2005051170 A2 WO 2005051170A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glucose
- single point
- sensor
- integrated receiver
- monitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/076—Permanent implantations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0456—Apparatus provided with a docking unit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/24—Hygienic packaging for medical sensors; Maintaining apparatus for sensor hygiene
- A61B2562/247—Hygienic covers, i.e. for covering the sensor or apparatus during use
Definitions
- the present invention relates generally to systems and methods for monitoring glucose in a host.
- a device for continuous glucose sensing is provided with an integrated receiver for single point glucose measurement and subsequent calibration of the continuous glucose sensor within the device.
- Background of the Invention [0002] A variety of continual and continuous glucose sensors have been developed for detecting and/or quantifying analytes in a biological fluid sample, for example, glucose sensors that continually or continuously measure glucose concentration in a host. Typically, these glucose sensors require a reference glucose measurement with which to calibrate the sensor-measured glucose values. Additionally, long-term implantable glucose sensors typically request regular updates of calibration, for example new reference glucose values every day, week, or month.
- a user has typically been required to keep track of and even stay close to (for example, carry) a device associated with the continuous glucose sensor that receives and processes data from the continuous glucose sensor. Additionally, a user has typically been required to carry a separate device that provides a reference glucose value for calibration of the continuous glucose sensor. Many times additional hardware, such as cables, test strips, and other auxiliary devices are necessary to connect, test, and otherwise use the devices. Therefore, the use of a continuous device can be cumbersome, particularly when the user is away from home. [0003] Furthermore, continuous sensors have conventionally been calibrated using a reference glucose monitor that uses different measurement technology than that of the continuous sensor, which can increase the error within the calibrated sensor values.
- an implantable glucose sensor that contains a membrane containing glucose oxidase is typically calibrated using self-monitoring blood glucose (SMBG) test strip-based measurement values.
- SMBG tests have an error of ⁇ 20% and additionally cannot be calibrated by the user.
- the reference measurement device for example, SMBG
- the possibility of accuracy in reporting time of SMGB can be prone to human error.
- a device for monitoring glucose concentration in a biological sample of a host comprising a continuous glucose sensor that produces a data stream indicative of a host's glucose concentration; an integrated receiver that receives the data stream from the continuous glucose sensor, wherein the integrated receiver comprises a microprocessor comprising programming to process the data stream received from glucose sensor; and a single point glucose monitor adapted to receive a biological sample from the host and measure the concentration of glucose in the sample; wherein the microprocessor further comprises programming to calibrate the data stream using the glucose concentration measured by the single point glucose monitor.
- the continuous glucose sensor comprises a sensing membrane comprising an enzyme; and an electrochemical cell that measures the glucose concentration.
- the single point glucose monitor comprises a sensing membrane comprising an enzyme; and an electrochemical cell that measures a concentration of glucose in the sample.
- the integrated receiver further comprises a user interface for displaying glucose concentration data from at least one of the continuous glucose sensor and the single point glucose monitor.
- a method for calibrating a continuous glucose sensor in an integrated receiver comprising continually receiving a data stream in the integrated receiver from a continuous glucose sensor; measuring a glucose concentration of a biological sample using a single point glucose monitor integral with the integrated receiver; and calibrating the data stream within the integrated receiver using the glucose concentration measured by the single point glucose monitor.
- the method further comprises the step of displaying the glucose concentration measured by the single point glucose monitor.
- the method further comprises the step of displaying a calibrated data stream.
- a device for calibrating continuous glucose sensor data comprising a single point glucose monitor adapted to measure a glucose concentration in a biological sample; a receiver for receiving a data stream from a continuous glucose sensor; a microprocessor comprising programming to calibrate the data stream from the continuous glucose sensor using the glucose concentration measured from the single point glucose monitor.
- the continuous glucose sensor comprises a sensing membrane comprising an enzyme; and an electrochemical cell that measures the glucose concentration.
- the single point glucose monitor comprises a sensing membrane comprising an enzyme; and an electrochemical cell that measures the glucose concentration in the biological sample.
- the device further comprises a user interface adapted to display glucose data from at least one of the continuous glucose sensor and the single point glucose monitor.
- the glucose monitor comprises a sensing region comprising a sensing membrane and at least two electrodes, wherein the sensing region is located within the integrated receiver.
- the integrated receiver comprises a removable cartridge, and wherein the sensing region is located within the removable cartridge.
- the integrated receiver comprises a housing, and wherein the glucose monitor comprises a sensing region movably mounted to the integrated receiver housing.
- the device further comprises a stylus movably mounted to the integrated receiver housing, and wherein the sensing region is located on the stylus.
- the device further comprises a receiving chamber located within the integrated receiver housing, and wherein the stylus is received within the receiving chamber for storage.
- the device further comprises a sterile solution chamber located at an end of the receiving chamber such that the sensing region is operably associated with the sterile solution chamber when the stylus is received within the receiving chamber for storage.
- the device further comprises a sterile solution port configured for refilling the sterile solution chamber with a sterile solution.
- the device further comprises a dispensing chamber located in the integrated receiver housing, the dispensing chamber adapted to dispense at least one disposable bioprotective film onto the sensing region.
- the device further comprises a storage chamber located in the integrated receiver housing, the storage chamber adapted to store the disposable bioprotective film.
- the device further comprises a shuttle mechanism located on the integrated receiver housing, the shuttle mechanism adapted to load the disposable bioprotective film into the dispensing chamber.
- the device further comprises at least one bioprotective film that is adapted to stretch or stick onto the sensing region to protect the sensing region from damage, clogging, or contamination from a biological fluid.
- the bioprotective film further comprises a sensing membrane comprising an enzyme.
- the sensing region comprises a sensing membrane and at least two electrodes, wherein the sensing membrane is disposed over the electrodes adapted for measuring a glucose concentration in a biological sample.
- the single point glucose monitor comprises a sensor port that houses a sensing region adapted for measuring a glucose concentration in the biological sample.
- the device further comprises a disposable capillary tube, wherein the capillary tube is configured to create a capillary action capable of drawing a liquid biological sample from a first end of the tube to a second end of the tube.
- the capillary tube comprises a filter configured to permit passage of glucose, but to filter or block passage of an undesired species or a contaminating species in the biological sample.
- the capillary tube further comprises a vent configured to allow displaced air within the capillary tube to escape therefrom.
- the sensor port comprises a cover adapted for protecting the sensing region.
- the disposable capillary tube comprises a sensing membrane, wherein the sensing membrane comprises a resistance domain, an enzyme domain, an interference domain, and an electrolyte domain.
- the single point glucose monitor and the receiver are detachably connected to each other.
- the single point glucose monitor and the receiver each comprise at least one contact adapted for operable connection when detachably connected to each other.
- the microprocessor is located within the receiver.
- the device further comprises a microprocessor located within the single point glucose monitor, wherein the microprocessor is adapted for communication between the single point glucose monitor and the receiver when the single point glucose monitor contact and the receiver contact are operably connected.
- a device for monitoring a glucose concentration in a biological sample in a host comprising a continuous glucose sensor configured to produce a data stream indicative of a glucose concentration in a biological sample of a host, wherein the glucose sensor comprises a sensing membrane comprising a catalyst, wherein the membrane is operably associated with at least two electrodes that are operably connected to an electrical circuit adapted for continuous glucose sensing; a single point glucose monitor configured to produce a glucose concentration measurement from a biological sample obtained from a host, wherein the glucose monitor comprises a sensing membrane comprising a catalyst, wherein the membrane is operably associated with at least two electrodes that are operably connected to an electrical circuit adapted for measuring the glucose concentration in the biological sample; a receiver integral with the single point glucose monitor adapted to receive a data stream from the continuous glucose sensor; and a microprocessor integral with the single point glucose monitor that comprises programming to calibrate the data stream from the continuous glucose sensor using the glucose concentration measurement from the single point glucose monitor.
- Fig. 1 is a block diagram that illustrates an integrated receiver in one embodiment in wireless communication with a continuous glucose sensor.
- Fig. 2A is an exploded perspective view of one exemplary embodiment of a continuous glucose sensor.
- Fig. 2B is an expanded view of an alternative exemplary embodiment of a continuous glucose sensor, illustrating the in vivo portion of the sensor.
- Fig. 3 is a block diagram that illustrates the continuous glucose sensor electronics in one embodiment.
- Fig. 4A is a perspective view of an integrated receiver in one embodiment showing a single point glucose monitor in its closed position.
- Fig. 4B is an exploded perspective view of the integrated receiver of Fig.
- FIG. 5A is a perspective view of an integrated receiver housing in another embodiment, showing a single point glucose monitor including a stylus movably mounted to the integrated receiver, wherein the stylus is shown in a storage position.
- Fig. 5B is a perspective view of the integrated housing of Fig. 5 A, showing the stylus in a testing position.
- Fig. 5C is a perspective view of a portion of the stylus of Fig. 5A, showing the sensing region.
- Fig. 5D is a perspective view of the integrated receiver housing of Fig. 5A, showing the stylus loaded with a disposable film, and in its testing position.
- Fig. 5A is a perspective view of an integrated receiver housing in another embodiment, showing a single point glucose monitor including a stylus movably mounted to the integrated receiver, wherein the stylus is shown in a storage position.
- Fig. 5B is a perspective view of the integrated housing of Fig. 5 A, showing the stylus in a testing position.
- Fig. 5C
- FIG. 5E is a perspective view of a portion of the stylus of Fig. 5 A, showing the sensing region with a disposable film stretched and/or disposed thereon for receiving a biological sample.
- Fig. 6A is a perspective view of an integrated receiver in yet another embodiment, including a single point glucose monitor and a disposable capillary tube for transferring a biological sample to a sensing region on the monitor.
- Fig. 6B is a perspective view of the integrated receiver of Fig. 6A, showing the disposable capillary tube inserted into the single point glucose monitor to transfer the biological sample to a sensing region on the single point glucose monitor.
- Fig. 6C is an expanded perspective view of a portion of the integrated receiver of Fig.
- Fig. 6A shows the capillary tube inserted into the single point glucose monitor.
- Fig. 6D is a schematic cross-sectional view of a capillary tube and a portion of the integrated receiver of Fig. 6A, illustrating the capillary tube in contact with the sensing membrane such that glucose from the biological sample can be measured by electrodes on the sensing region.
- Fig. 6E is a schematic cross-sectional view of the capillary tube of Fig. 6A, illustrating an embodiment wherein a filter is located on one end.
- Fig. 6F is a schematic cross-sectional view of the capillary tube of Fig. 6A, illustrating an embodiment wherein a filter is disposed within a wall of the capillary tube.
- Fig. 6G is a schematic cross-sectional view of the capillary tube of Fig. 6A, illustrating an embodiment wherein a vent extends from the capillary tube.
- Fig. 6H is a schematic illustration of one embodiment, wherein the capillary tube is round in shape with an inner capillary tube that is also round in shape.
- Fig. 61 is a schematic illustration of one embodiment, wherein the capillary tube is rectangular in shape with an inner capillary tube that is formed therein.
- Fig. 6J is a schematic illustration of one embodiment, wherein the capillary tube is rectangular in shape an inner capillary tube has a rounded structure.
- Fig. 6G is a schematic cross-sectional view of the capillary tube of Fig. 6A, illustrating an embodiment wherein a vent extends from the capillary tube.
- FIG. 7A is a perspective view of an integrated receiver in yet another embodiment, wherein the single point glucose monitor is detachably connected to the receiver to form a modular configuration, shown in its attached state.
- Fig. 7B is a perspective view of the integrated receiver of Fig. 7A, shown in its detached state.
- Fig. 8 is a block diagram that illustrates integrated receiver electronics in one embodiment.
- Fig. 9 is a flow chart that illustrates the process of initial calibration of the continuous glucose sensor and data output of the integrated receiver in one embodiment.
- Fig. 10 is a graph that illustrates one exemplary embodiment of a regression performed on a calibration set to create a conversion function.
- continuous glucose sensors can continually or continuously measure glucose concentration without requiring user initiation and/or interaction for each measurement, such as described with reference to U.S. Patent 6,001,067, for example.
- continuous glucose sensing is a broad term and is used in its ordinary sense, including, without limitation, the period in which monitoring of plasma glucose concentration is continuously or continually performed, for example, at time intervals ranging from fractions of a second up to, for example, 1, 2, or 5 minutes, or longer.
- single point glucose monitor is a broad term and is used in its ordinary sense, including, without limitation, a device that can be used to measure a glucose concentration within a host at a single point in time, for example, some embodiments utilize a small volume in vitro glucose monitor that includes an enzyme membrane such as described with reference to U.S. Patent 4,994,167 and U.S. Patent 4,757,022. It should be understood that single point glucose monitors can measure multiple samples (for example, blood or interstitial fluid); however only one sample is measured at a time and typically requires some user initiation and/or interaction.
- capillary action is a broad term and is used in its ordinary sense, including, without limitation, the phenomenon of a liquid, such as water or blood, spontaneously creeping up a thin tube or fiber due to adhesive or cohesive forces or surface tension.
- biological sample is a broad term and is used in its ordinary sense, including, without limitation, sample of a host body, for example blood, interstitial fluid, spinal fluid, saliva, urine, tears, sweat, or the like.
- host as used herein, is a broad term and is used in its ordinary sense, including, without limitation, mammals such as humans.
- biointerface membrane is a broad term and is used in its ordinary sense, including, without limitation, a permeable or semi-permeable membrane that can include two or more domains and is typically constructed of materials of a few microns thickness or more, which can be placed over the sensing region to keep host cells (for example, macrophages) from gaining proximity to, and thereby damaging the sensing membrane or forming a barrier cell layer and interfering with the transport of glucose across the tissue-device interface.
- host cells for example, macrophages
- sensing membrane is a broad term and is used in its ordinary sense, including, without limitation, a permeable or semi-permeable membrane that can be comprised of two or more domains and is typically constructed of materials of a few microns thickness or more, which are permeable to oxygen and are optionally permeable to glucose.
- the sensing membrane comprises an immobilized glucose oxidase enzyme, which enables an electrochemical reaction to occur to measure a concentration of glucose.
- domain is a broad term and is used in its ordinary sense, including, without limitation, regions of a membrane that can be layers, uniform or non- uniform gradients (for example, anisotropic), functional aspects of a material, or provided as portions of the membrane.
- copolymer is a broad term and is used in its ordinary sense, including, without limitation, polymers having two or more different repeat units and includes copolymers, terpolymers, tetrapolymers, etc.
- sensing region is a broad term and is used in its ordinary sense, including, without limitation, the region of a monitoring device responsible for the detection of glucose.
- the sensing region generally comprises a non-conductive body, a working electrode (anode), a reference electrode and a counter electrode (cathode) passing through and secured within the body forming an electrochemically reactive surface at one location on the body and an electronic connection at another location on the body, and a sensing membrane affixed to the body and covering the electrochemically reactive surface.
- a biological sample for example, blood or interstitial fluid
- an enzyme for example, glucose oxidase
- the reaction of the biological sample (or portion thereof) results in the formation of reaction products that allow a determination of the glucose level in the biological sample.
- electrochemically reactive surface is a broad term and is used in its ordinary sense, including, without limitation, the surface of an electrode where an electrochemical reaction takes place.
- an electrochemical glucose sensor hydrogen peroxide produced by an enzyme catalyzed reaction of the glucose being detected reacts at a working electrode creating a measurable electronic current (for example, detection of glucose utilizing glucose oxidase produces H 2 O 2 as a by product, H 2 O 2 reacts with the surface of the working electrode producing two protons (2H + ), two electrons (2e " ) and one molecule of oxygen (O 2 ) which produces the electronic current being detected), hi the case of the counter electrode, a reducible species (for example, O 2 ) is reduced at the electrode surface in order to balance the current being generated by the working electrode.
- a reducible species for example, O 2
- electrochemical cell is a broad term and is used in its ordinary sense, including, without limitation, a device in which chemical energy is converted to electrical energy.
- a cell typically consists of two or more electrodes held apart from each other and in contact with an electrolyte solution. Connection of the electrodes to a source of direct electric current renders one of them negatively charged and the other positively charged.
- proximal is a broad term and is used in its ordinary sense, including, without limitation, near to a point of reference such as an origin or a point of attachment.
- the electrolyte domain is located more proximal to the electrochemically reactive surface than the interference domain.
- distal is a broad term and is used in its ordinary sense, including, without limitation, spaced relatively far from a point of reference, such as an origin or a point of attachment.
- a resistance domain is located more distal to the electrochemically reactive surfaces than the enzyme domain.
- microprocessor and “processor,” as used herein, are broad terms and are used in their ordinary sense, including, without limitation, a computer system or state machine designed to perform arithmetic and logic operations using logic circuitry that responds to and processes the basic instructions that drive a computer.
- EEPROM electrically erasable programmable read-only memory, which is user-modifiable read-only memory (ROM) that can be erased and reprogrammed (for example, written to) repeatedly through the application of higher than normal electrical voltage.
- SRAM static random access memory
- A/D Converter is a broad term and is used in its ordinary sense, including, without limitation, hardware and/or software that converts analog electrical signals into corresponding digital signals.
- RF transceiver is a broad term and is used in its ordinary sense, including, without limitation, a radio frequency transmitter and/or receiver for transmitting and/or receiving signals.
- raw data stream and data stream are broad terms and are used in their ordinary sense, including, without limitation, an analog or digital signal directly related to the measured glucose from the glucose sensor, i one example, the raw data stream is digital data in "counts" converted by an A/D converter from an analog signal (for example, voltage or amps) representative of a glucose concentration.
- the terms broadly encompass a plurality of time spaced data points from a substantially continuous glucose sensor, which comprises individual measurements taken at time intervals ranging from fractions of a second up to, for example, 1, 2, or 5 minutes or longer.
- counts is a broad term and is used in its ordinary sense, including, without limitation, a unit of measurement of a digital signal, hi one example, a raw data stream measured in counts is directly related to a voltage (for example, converted by an A D converter), which is directly related to current from the working electrode. In another example, counter electrode voltage measured in counts is directly related to a voltage.
- electronic circuitry as used herein, is a broad term and is used in its ordinary sense, including, without limitation, the components (for example, hardware and/or software) of a device configured to process data.
- the data includes biological information obtained by a sensor regarding a particular glucose in a biological fluid, thereby providing data regarding the amount of that glucose in the fluid.
- U.S. Patent Nos. 4,757,022, 5,497,772 and 4,787,398, which are hereby incorporated by reference, describe suitable electronic circuits that can be utilized with devices of the preferred embodiments.
- the term "potentiostat,” as used herein, is a broad term and is used in its ordinary sense, including, but not limited to, an electrical system that applies a potential between the working and reference electrodes of a two- or three-electrode cell at a preset value and measures the current flow through the working electrode.
- the potentiostat forces whatever current is necessary to flow between the working and reference (2 electrode) or counter (3 electrode) electrodes to keep the desired potential, as long as the needed cell voltage and current do not exceed the compliance limits of the potentiostat.
- electrical potential is a broad term and is used in its ordinary sense, including, without limitation, the electrical potential difference between two points in a circuit which is the cause of the flow of a current.
- operably connected and operably linked are broad terms and are used in their ordinary sense, including, without limitation, one or more components being linked to another component(s) in a manner that allows transmission of signals between the components.
- one or more electrodes can be used to detect the amount of glucose in a sample and convert that information into a signal. The signal can then be transmitted to an electronic circuit. In this case, the electrode is "operably linked" to the electronic circuit.
- These terms are broad enough to include wireless connectivity.
- linear regression is a broad term and is used in its ordinary sense, including, without limitation, finding a line in which a set of data has a minimal measurement from that line. Byproducts of this algorithm include a slope, a y-intercept, and an R- Squared value that determine how well the measurement data fits the line.
- Fig. 1 is a perspective view of a device in one embodiment including a continuous glucose sensor and an integrated receiver that has a single point glucose monitor thereon.
- the continuous glucose sensor (10) continuously measures glucose concentration in a host to provide a data stream representative of the host's glucose concentration, such as described in more detail below with reference to Figs. 2 and 3.
- the integrated receiver (12) includes a single point glucose monitor (14), electronic circuitry that processes data from the continuous glucose sensor (10) and the single point glucose monitor (14), and a user interface (16) that displays glucose data to a user, all of which are described in more detail with reference to Figs. 4 to 10.
- Wireless transmissions (18) allow communication between the glucose sensor (10) and the integrated receiver (12), for example, so that the integrated receiver (12) can receive a data stream from the continuous glucose sensor (10).
- the preferred embodiments provide a continuous glucose sensor that measures a concentration of glucose or a substance indicative of the concentration or presence of the glucose
- the glucose sensor is an invasive, minimally-invasive, or non-invasive device, for example a subcutaneous, transdermal, or intravascular device.
- the device can analyze a plurality of intermittent biological samples.
- the glucose sensor can use any method of glucose-measurement, including enzymatic, chemical, physical, electrochemical, specfrophotometric, polarimetric, calorimetric, radiomefric, or the like.
- the senor can be any sensor capable of determining the level of an analyte in the body, for example oxygen, lactase, hormones, cholesterol, medicaments, viruses, or the like.
- the glucose sensor uses any known method to provide an output signal indicative of the concentration of the glucose.
- the output signal is typically a raw data stream that is used to provide a useful value of the measured glucose concentration to a patient or doctor, for example.
- One exemplary embodiment is described in detail below, which utilizes an implantable glucose sensor. However, it should be understood that the devices and methods described herein can be applied to any device capable of continually or continuously detecting a concentration of analyte of interest and providing an output signal that represents the concentration of that analyte.
- Fig. 2A is an exploded perspective view of one exemplary embodiment of a continuous glucose sensor (10a).
- the sensor is preferably wholly implanted into the subcutaneous tissue of a host, such as described in co-pending Patent Application No. 10/885,476 filed July 6, 2004 and entitled "SYSTEMS AND METHODS FOR MANUFACTURE OF AN ANALYTE-MEASURING DEVICE INCLUDING A MEMBRANE SYSTEM”; co- pending U.S. Patent Application No. 10/838,912 filed May 3, 2004 and entitled, "IMPLANTABLE ANALYTE SENSOR"; U.S. Patent Application No.
- a body (20) and a sensing region (21) house the electrodes (22) and sensor electronics (Fig. 3).
- the three electrodes (22) are operably connected to the sensor electronics (Fig. 3) and are covered by a sensing membrane (23) and a biointerface membrane (24), which are attached by a clip (25).
- the three electrodes (22) include a platinum working electrode, a platinum counter electrode, and a silver/silver chloride reference electrode.
- the top ends of the electrodes are in contact with an electrolyte phase (not shown), which is a free-flowing fluid phase disposed between the sensing membrane (23) and the electrodes (22).
- the sensing membrane (23) includes an enzyme, for example, glucose oxidase, and covers the electrolyte phase.
- the biointerface membrane (24) covers the sensing membrane (23) and serves, at least in part, to protect the sensor (10a) from external forces that can result in environmental stress cracking of the sensing membrane (23).
- Copending U.S. Patent Application 10/647,065, entitled, “POROUS MEMBRANES FOR USE WITH IMPLANTABLE DEVICES,” describes a biointerface membrane that can be used in conjunction with the preferred embodiments, and is incorporated herein by reference in its entirety.
- the biointerface membrane (24) generally includes a cell disruptive domain most distal from the electrochemically reactive surfaces and a cell impermeable domain less distal from the electrochemically reactive surfaces than the cell disruptive domain.
- the cell disruptive domain is preferably designed to support tissue ingrowth, disrupt contractile forces typically found in a foreign body response, encourage vascularity within the membrane, and disrupt the formation of a barrier cell layer.
- the cell impermeable domain is preferably resistant to cellular attachment, impermeable to cells, and composed of a biostable material.
- the sensing membrane (23) generally provides one or more of the following functions: 1) protection of the exposed electrode surface from the biological environment, 2) diffusion resistance (limitation) of the analyte, 3) a catalyst for enabling an enzymatic reaction, 4) limitation or blocking of interfering species, and 5) hydrophilicity at the electrochemically reactive surfaces of the sensor interface, such as described in co-pending U.S. Patent Application 10/838,912, filed May 3, 2004 and entitled "IMPLANTABLE ANALYTE SENSOR,” which is incorporated herein by reference in its entirety.
- the sensing membrane (23) preferably includes a plurality of domains or layers, for example, an electrolyte domain, an interference domain, an enzyme domain (for example, glucose oxidase), a resistance domain, and can additionally include an oxygen domain (not shown), and/or a bioprotective domain (not shown), such as described in more detail in the above-cited U.S. Patent Application No. 10/838,912.
- a sensing membrane modified for other devices for example, by including fewer or additional domains is within the scope of the preferred embodiments.
- the domains of the biointerface and sensing membranes are formed from materials such as silicone, polytefrafluoroethylene, polyethylene-co- tetrafluoroethylene, polyolefin, polyester, polycarbonate, biostable polytefrafluoroethylene, homopolymers, copolymers, terpolymers of polyurethanes, polypropylene (PP), polyvinylchloride (PVC), polyvinylidene fluoride (PVDF), polybutylene terephthalate (PBT), polymethylmethacrylate (PMMA), polyether ether ketone (PEEK), polyurethanes, cellulosic polymers, polysulfones and block copolymers thereof including, for example, di-block, fri-block, alternating, random and graft copolymers.
- materials such as silicone, polytefrafluoroethylene, polyethylene-co- tetrafluoroethylene, polyolefin, polyester,
- the counter electrode is provided to balance the current generated by the species being measured at the working electrode, hi the case of a glucose oxidase based glucose sensor, the species being measured at the working electrode is H 2 0 2 .
- Glucose oxidase catalyzes the conversion of oxygen and glucose to hydrogen peroxide and gluconate according to the following reaction: Glucose + O 2 - Gluconate + H 2 O 2 [0107]
- the change in H 2 0 2 can be monitored to determine glucose concentration because for each glucose molecule metabolized, there is a proportional change in the product H 2 0 2 .
- Oxidation of H 2 0 2 by the working electrode is balanced by reduction of ambient oxygen, enzyme generated H 2 0 2 , or other reducible species at the counter electrode.
- the H 2 0 2 produced from the glucose oxidase reaction further reacts at the surface of working electrode and produces two protons (2H + ), two electrons (2e " ), and one oxygen molecule (0 2 ).
- a potentiostat is employed to monitor the electrochemical reaction at the electrochemical cell.
- the potentiostat applies a constant potential to the working and reference electrodes to determine a current value.
- the current that is produced at the working electrode (and flows through the circuitry to the counter electrode) is substantially proportional to the amount of H 2 0 2 that diffuses to the working electrode.
- a raw signal can be produced that is representative of the concenfration of glucose in the user's body, and therefore can be utilized to estimate a meaningful glucose value, such as described herein.
- Fig. 2B is an expanded view of an alternative exemplary embodiment of a continuous glucose sensor, illustrating the in vivo portion of the sensor.
- Co-pending U.S. Provisional Application 60/587,787, filed July 13, 2004 and U.S. Provisional Application 60/614683, filed September 30, 2004, describe systems and methods suitable for the transcutaneous sensor of the illustrated embodiment; however, one skilled in the art appreciates a variety of transcutaneous sensors that can benefit from the integrated receiver of the preferred embodiments.
- the in vivo portion of the sensor (10b) is the portion adapted for insertion under the host's skin, while an ex vivo portion of the sensor (10b) is the portion that remains above the host's skin after sensor insertion and operably connects to an electronics unit (not shown).
- the sensor (10b) two or more electrodes: a working electrode (26) and at least one additional electrode (28), which can function as a counter and/or reference electrode, hereinafter referred to as the reference electrode.
- Each electrode is formed from a fine wire, with a diameter in the range of 0.001 to 0.010 inches, for example, and can be formed from plated wire or bulk material.
- the working electrode (26) comprises a wire formed from a conductive material, such as platinum, palladium, graphite, gold, carbon, conductive polymer, or the like.
- the working electrode (26) is configured and arranged to measure the concentration of an analyte.
- the working electrode (20) is covered with an insulating material, for example a non- conductive polymer.
- the insulating material comprises Parylene, which can be an advantageous conformal coating for its strength, lubricity, and electrical insulation properties, however, a variety of other insulating materials can be used, for example, fluorinated polymers, polyethyleneterephthalate, polyurethane, polyimide, or the like.
- the reference electrode (28), which can function as a reference electrode alone, or as a dual reference and counter electrode, is formed from silver, Silver/Silver chloride, or the like, hi one embodiment, the reference electrode (28) is formed from a flat wire with rounded edges in order to decrease sharp edges and increase host comfort. Preferably, the reference electrode (28) is juxtapositioned and/or twisted with or around the working electrode (26); however other configurations are also possible, hi some embodiments, the reference electrode (28) is helically wound around the working electrode (26) (see Fig. 2B). The assembly of wires is then optionally coated together with an insulating material, similar to that described above, in order to provide an insulating attachment.
- a window (28) is formed on the insulating material to expose an elecfroactive surface of the working elecfrode and at least some edges of the sensor are stripped to expose sections of elecfroactive surface on the reference elecfrode.
- Other methods and configurations for exposing elecfroactive surfaces are also possible, for example by exposing the surfaces of the working electrode (26) between the coils of the reference elecfrode (28).
- additional electrodes can be included within the assembly, for example, a three-electrode system (working, reference, and counter elecfrodes) and/or including an additional working electrode (which can be used to generate oxygen, configured as a baseline subtracting elecfrode, or configured for measuring additional analytes, for example).
- a sensing membrane (not shown) is deposited over the elecfroactive surfaces of the sensor (10b) (working electrode and optionally reference electrode) and includes a plurality of domains or layers, such as described above, with reference to Fig. 2A.
- the sensing membrane can be deposited on the exposed elecfroactive surfaces using known thin film techniques (for example, spraying, electro-depositing, dipping, or the like).
- each domain is deposited by dipping the sensor into a solution and drawing out the sensor at a speed that provides the appropriate domain thickness, i general, the membrane system can be disposed over (deposited on) the elecfroactive surfaces using methods appreciated by one skilled in the art.
- the sensor glucose oxidase electrochemical sensor wherein the working electrode (26) measures the hydrogen peroxide produced by an enzyme catalyzed reaction of the analyte being detected and creates a measurable electronic current (for example, detection of glucose utilizing glucose oxidase produces H 2 0 2 peroxide as a by product, H 2 0 2 reacts with the surface of the working elecfrode producing two protons (2 ⁇ t), two electrons (2e " ) and one molecule of oxygen (0 2 ) which produces the electronic current being detected), such as described in more detail above and as is appreciated by one skilled in the art.
- Fig. 3 is a block diagram that illustrates the continuous glucose sensor electronics in one embodiment.
- a potentiostat (30) is shown, which is operably connected to electrodes (24a) (Fig. 2) or (24b) (Fig. 3) to obtain a current value, and includes a resistor (not shown) that translates the current into voltage.
- An A/D converter (32) digitizes the analog signal into "counts" for processing. Accordingly, the resulting raw data stream in counts is directly related to the current measured by the potentiostat (30).
- a microprocessor (34) is the central control unit that houses EEPROM (36) and SRAM (38), and controls the processing of the sensor electronics.
- an application-specific integrated circuit can be used for some or all the sensor's central processing.
- the EEPROM (36) provides semi-permanent storage of data, for example, storing data such as sensor identifier (ID) and programming to process data streams (for example, programming for data smoothing and/or replacement of signal artifacts such as described in copending U.S. Patent Application entitled, "SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM,” filed August 22, 2003).
- the SRAM (38) can be used for the system's cache memory, for example for temporarily storing recent sensor data.
- memory storage components comparable to EEPROM and SRAM can be used instead of or in addition to the preferred hardware, such as dynamic RAM, non-static RAM, rewritable ROMs, flash memory, or the like.
- a battery 40 is operably connected to the microprocessor (34) and provides the necessary power for the sensor (10).
- the battery is a Lithium Manganese Dioxide battery, however any appropriately sized and powered battery can be used (for example, AAA, Nickel-cadmium, Zinc-carbon, Alkaline, Lithium, Nickel-metal hydride, Lithium-ion, Zinc- air, Zinc-mercury oxide, Silver-zinc, and/or hermetically-sealed).
- the battery is rechargeable, hi some embodiments, a plurality of batteries can be used to power the system.
- a Quartz Crystal (42) is operably connected to the microprocessor (34) and maintains system time for the computer system as a whole.
- An RF Transceiver (44) is operably connected to the microprocessor (34) and transmits the sensor data from the sensor (10) to a receiver (see Figs. 4 to 8) within a wireless transmission (46) via antenna (48).
- a RF fransceiver is shown here, some other embodiments can include a wired rather than wireless connection to the receiver.
- the receiver can be franscutaneously powered via an inductive coupling, for example.
- a second quartz crystal (50) provides the system time for synchronizing the data transmissions from the RF transceiver.
- the fransceiver (44) can be substituted with a transmitter in other embodiments.
- the continuous glucose sensor comprises a transcutaneous sensor such as described in U.S. Patent 6,565,509 to Say et al.
- the continuous glucose sensor comprises a subcutaneous sensor such as described with reference to U.S. Patent 6,579,690 to Bonnecaze et al. or U.S. Patent 6,484,046 to Say et al.
- the continuous glucose sensor comprises a refillable subcutaneous sensor such as described with reference to U.S. Patent 6,512,939 to Colvin et al.
- the continuous glucose sensor comprises an intravascular sensor such as described with reference to U.S. Patent 6,477,395 to Schulman et al.
- the continuous glucose sensor comprises an intravascular sensor such as described with reference to U.S. Patent 6,424,847 to Mastrototaro et al. All of the above patents are incorporated in their entirety herein by reference. [0120] Although a few exemplary embodiments of continuous glucose sensors are illustrated and described herein, it should be understood that the disclosed embodiments are applicable to a variety of continuous glucose sensor configurations.
- the integrated receiver provides an integrated housing that includes a single point glucose monitor, electronics (for example, hardware and software) useful to receive and process data from the continuous glucose sensor and the single point glucose monitor, and a user interface that displays processed data to a user (for example, patient or doctor).
- Figs. 4 to 7 illustrate preferred embodiments of the integrated receiver with a single point glucose monitor.
- Figs. 8 to 10 illustrate some preferred electronics and data processing within the integrated receiver that are applicable to all embodiments of the integrated receiver (for example, Figs. 4 to 7). Because the single point glucose monitor is integrated into the continuous sensor's receiver housing, there is no need for a separate glucose monitor to provide reference values for calibration or the like.
- the single point glucose monitor includes a meter for measuring glucose within a biological sample including a sensing region that has a sensing membrane impregnated with an enzyme, similar to the sensing membrane described with reference to Fig. 2, and such as described with reference to Figs. 4 to 7.
- the single point glucose monitor can use other measurement techniques such as optical, for example.
- Fig. 4A is a perspective view of an integrated receiver in one embodiment showing a single point glucose monitor in its closed position.
- Fig. 4B is an exploded perspective view of the integrated receiver, showing the single point glucose monitor with the cover removed to reveal the receptacle inside.
- the integrated receiver (12) provides a housing that integrates a single point glucose monitor (14) and electronics (Fig. 8) useful to receive, process and display data on the user interface (16).
- the single point glucose monitor permits rapid and accurate measurement of the amount of a particular substance (for example, glucose) in a biological fluid.
- the integrated receiver (12) includes a main housing (62) and a cartridge (64) that is removably mounted on the housing (62), which permits the cartridge (64) to be disposable and replaceable as needed.
- the housing (62) includes a case (66) having an upper portion (68) and a lower portion (70). The upper portion (68) and lower portion (70) are connected together by any particular fastening means such as several screws (not shown).
- the main housing (62) also includes electronic circuitry operably connected to at least two elecfrodes (not shown).
- the electrodes are preferably mounted within a sensing region (72) that supports the electrodes as they extend upwardly therein.
- a sensing membrane (not shown) overlays the elecfrodes on the sensing region (72) and is operably associated with the elecfrodes when the cartridge is removably mounted on the housing.
- the cartridge (64) also includes means for protecting the sensing membrane when not in use.
- the protection means is preferably a cover (74) that is movably mounted on a body portion (76) of the cartridge (64). Alternatively, the cover (74) can be mounted on the case (66).
- a hinge assembly (78) movably mounts the cover (74) on the body portion (76).
- the cover (74) has a first position such as shown in Fig. 4A in which it protects the membrane, and a second position. Access to the sensing membrane is preferable in order to conveniently place the biological fluid sample on the sensing membrane for analysis.
- the housing (62) preferably defines a well (80) having a bottom (82). In practice, the biological fluid sample is placed on the sensing region (72) in the well (80) for analysis.
- the well (80) defines an opening of less than 4 millimeters in diameter and less than 2 millimeters in depth.
- the protection means of the cartridge (64) preferably also includes means for sealing the well (80) and hence the sensing region including the sensing membrane, which is disposed at the bottom of the well (80), from the ambient surroundings.
- a retaining means is also provided for releasably retaining the cartridge (64) and its body portion (76) on the housing (62).
- the retaining means preferably includes a detent (84) on the cartridge (64), which is received in a recess defined by the upper portion (68) of the case (66).
- the retaining means also preferably includes at least one, preferably two wings (86) on the body portion (76) of the cartridge (64) which are received in one or more slots (88) on the case (66).
- the slots (88) are generally perpendicular to the cover (74) so that opening the cover will not disengage the wings (86) from the slots (88).
- the sensing region (72), in which the electrodes are disposed, is preferably generally annular in design with the interior portion thereof filled with an electrically nonconductive support material such as a hardened polyepoxide-containing resin.
- the elecfrically nonconductive support material and the top (electrochemically reactive) surfaces of the electrodes define a sensing membrane contact surface.
- the sensing membrane can be stretched over the contact surface to more effectively place the membrane in operative association with the elecfrodes (not shown), hi an alternative embodiment of the sensing region (72), the electrodes can be deposited onto a ceramic surface, and an elecfrically nonconductive material can be applied as a coating over the electrodes to form an insulating barrier. A portion of each electrode, however, is not coated to form a membrane contact surface so that a membrane can be applied over the electrodes in operative contact therewith.
- the sensing membrane can be constructed substantially similar to the sensing membrane described with reference to Fig.
- the sensing membrane includes a resistance domain most distal from the electrochemically reactive surfaces, an enzyme domain less distal from the electrochemically reactive surfaces than the resistance domain, an interference domain less distal from the electrochemically reactive surfaces than the enzyme domain, and an electrolyte domain adjacent to the electrochemically reactive surfaces.
- the sensing membrane can be modified for other devices, for example, by including . fewer or additional domains.
- design considerations for the sensing membrane of the single point glucose monitor can differ from that of the continuous glucose sensor due to oxygen availability, for example.
- the domains of the sensing membrane are formed from materials such as silicone, polytefrafluoroethylene, polyethylene-co-tefrafluoroethylene, polyolefin, polyester, polycarbonate, biostable polytefrafluoroethylene, homopolymers, copolymers, terpolymers of polyurethanes, polypropylene (PP), polyvinylchloride (PVC), polyvinylidene fluoride (PVDF), polybutylene terephthalate (PBT), polymethylmethacrylate (PMMA), polyether ether ketone (PEEK), polyurethanes, cellulosic polymers, polysulfones and block copolymers thereof including, for example, di-block, tri-block, alternating, random and graft copolymers.
- materials such as silicone, polytefrafluoroethylene, polyethylene-co-tefrafluoroethylene, polyolefin, polyester, polycarbonate
- the cover (74) is preferably provided with a closure means (not shown) such as one or more latches that engage the body portion (76). Generally, the force necessary to disengage the closure means from the body portion should be less than that necessary to disengage the wings (86) from the slots (88). In this manner, an operator can easily open the cover (74) without accidentally disengaging the cartridge (64) from the main housing (62).
- the sensing region (72) including the electrodes and sensing membrane, contacts the body fluid sample for analysis.
- the sensing region (72) is operably associated with the electronic circuitry (see Fig. 8) that analyzes the current from the reaction of the components in the body fluid with the elecfrodes.
- the electrode configuration includes a three-electrode electrochemical cell, which in combination with the chemical reactions occurring in the sensing membrane and on the electrochemically reactive surfaces, makes possible consistent electrode behavior and, in particular, performance of a reference electrode that is stable with time.
- the electrode configuration includes a two-electrode electrochemical cell with a reference cathodic, chloride ions will be lost from the reference electrode that eventually leads to unstable electrode behavior.
- permanent stable reference elecfrode behavior is achieved when the hydrogen peroxide produced in the membrane oxidizes the silver metal to silver oxide which is then converted to silver chloride by chloride ion.
- Advantages include ease of manufacturing of the electrode, self-forming and self-maintaining elecfrode behavior, and long-term reference electrode stability.
- the glucose measurement technique of the integrated receiver (12) is similar to that described with reference to Fig. 2 and 3, above, however the electronics are adapted for single point measurement. The electronics associated with the integrated receiver (12) are described in more detail below with reference to Fig. 8.
- glucose from a biological sample produces a current flow at a working electrode, with equal current provided by a counter electrode in a reference circuit.
- the current is converted in an analog section by a current to voltage converter to a voltage, which is inverted, level-shifted, and delivered to an A/D converter in the microprocessor (see Fig. 8).
- the microprocessor can set the analog gain via its control port.
- the A/D converter is preferably activated at one-second intervals.
- the microprocessor looks at the converter output with any number of pattern recognition algorithms known to those skilled in the art until a glucose peak is identified.
- a timer is then activated for about (30) seconds at the end of which time the difference between the first and last electrode current values is calculated. This difference is then divided by the value ⁇ tored in the memory during instrument calibration and is then multiplied by the calibration glucose concenfration.
- the result includes a calibrated glucose concenfration value that is meaningful to a user, and useful in calibrating the data stream from the continuous glucose sensor (10), for example.
- the single point glucose monitor described with reference to Figs. 4A and 4B can be calibrated by the user as described in more detail with reference to U.S. Patents 4,994,167 and 4,757,022, both of which are incorporated herein in their entirety.
- the ability to calibrate the glucose monitor is particularly advantageous, for example, as compared to a conventional test strip, which cannot be calibrated by the user.
- the similarity of the sensing membranes used for the continuous glucose sensor and the single point glucose sensor provides an internal control that creates increased reliability by nature of consistency and decreased error potential that can otherwise be increased due to combining dissimilar measurement techniques. Additionally, the disclosed membrane system is known to provide longevity, repeatability, and cost effectiveness, for example as compared to single use strips, or the like.
- prompts or messages can be displayed on the user interface (16) to guide the user through the calibration and sample measurement procedures. In addition, prompts can be displayed to inform the user about necessary maintenance procedures, such as "Replace Sensor" or "Replace Battery.”
- An on/off button (90) preferably initiates the operation and calibration sequences.
- Figs 5A to 5E illustrate another embodiment of an integrated receiver, wherein the single point glucose monitor includes a stylus movably mounted to the integrated receiver for measurement of glucose in a biological sample.
- Fig. 5A is a perspective view of the integrated receiver housing in another embodiment, showing a single point glucose monitor including a stylus movably mounted to the integrated receiver, wherein the stylus is shown in a storage position.
- Fig. 5A is a perspective view of the integrated receiver housing in another embodiment, showing a single point glucose monitor including a stylus movably mounted to the integrated receiver, wherein the stylus is shown in a storage position.
- FIG. 5B is a perspective view of the integrated housing of Fig. 5A, showing the stylus in a testing position.
- Fig. 5C is a perspective view of a portion of the stylus of Fig. 5A, showing the sensing region.
- Fig. 5D is a perspective view of the integrated receiver housing of Fig. 5A, showing the stylus loaded with a disposable film, and in its testing position.
- Fig. 5E is a perspective view of a portion of the stylus of Fig. 5 A, showing the sensing region with a disposable film sfretched and/or disposed thereon.
- the integrated receiver provides (92) a housing that integrates a single point glucose monitor (94) and electronics (see Fig.
- the single point glucose monitor (94) permits rapid and accurate measurement of the amount of a particular substance (for example, glucose) in a biological fluid.
- the integrated receiver electronics process single point glucose monitor data, receive and process continuous glucose sensor data, including calibration of the continuous sensor data using the single point monitor data for example, and output data via the user interface (96), such as is described below in more detail with reference to Fig. 8.
- the single point glucose monitor (94) includes a stylus (98) that is movably mounted to the integrated receiver housing (92) via a connector (93).
- the connector (93) can be a cord, bar, hinge, or any such connection means that allows the stylus to move from a first (storage) position (Fig.
- the stylus is not constrained to the first and second positions; rather the stylus can be configured to swing at various angles, about various pivots, or in any manner allowed by the connector for convenience to the user, i some alternative embodiments, the stylus (98) is removably mounted on the integrated receiver housing (92) and an operable connection can be established using a wireless connection, or alternatively using electrical contacts that operably connect the stylus (98) that is removably mounted onto the integrated receiver housing (92). [0144]
- the stylus (98) includes a sensing region (100) on one end that is operably connected to the integrated receiver's electronics (Fig. 8). As best illustrated in Fig.
- the sensing region (100) is provided with at least two, preferably three elecfrodes (102) and a sensing membrane (not shown) disposed over the electrodes (102) and/or the entire sensing region (100).
- the sensing region includes the elecfrodes (102) and the sensing membrane, which are configured to measure glucose in a manner such as described above with reference to the sensing region of Figs. 2 and 4.
- the sensing membrane is reusable and can be held on the sensing region (100) by a clip, such as described with reference to Fig. 2.
- the sensing membrane is reusable can be disposed onto the sensing region using depositing or bonding techniques known in the art of polymers.
- the integrated receiver housing (92) includes a sterile solution chamber (not shown) located at the end of the receiving chamber (100) that receives the stylus for storage, such that when the stylus is in its storage position (Fig. 5A), the sensing membrane is maintained in the sterile solution.
- a sterile solution port (106) is in communication with the sterile solution chamber and allows for refilling of the sterile solution chamber using a sterile refill solution (108).
- a single-use disposable bioprotective film (109) can be placed over the sensing region (100) to provide protection from contamination.
- the disposable film (109) can be any film with that allows the passage of glucose, but blocks the passage of undesired species in the blood that could damage or contaminate the sensing membrane and/or cause inaccurate measurements (for example, a thin film of very low molecular weight cutoff to prevent the transport of proteins, viruses, etc).
- the bioprotective film (109) further comprises a sensing membrane formed as a part of the film (for example, laminated to the film), instead of (or in addition to) a sensing membrane disposed on the sensing region.
- a sensing membrane formed as a part of the film (for example, laminated to the film), instead of (or in addition to) a sensing membrane disposed on the sensing region.
- This alternative embodiment is particularly advantageous in that it provides a disposable sensing membrane that requires no cleaning step, for example.
- the stylus (98) can be put into direct contact with the biological sample (106) (for example, on a finger or arm), no transfer mechanism is required, and therefore the sample size can be smaller than conventionally required. Additionally, sensing region (100) does not require a separate cleaning step, because the disposable film (109) fully protects the sensing region (100) from contamination, and should be disposed of after use.
- the integrated receiver (92) housing further allows for storage and dispensing of the disposable films (109).
- a shuttle mechanism (110) is provided that preferably feeds the films (109) into a spring-loaded storage chamber (not shown) beneath the shuttle mechanism (110), or the like.
- the shuttle mechanism (110) can be used to load the disposable films (109), one at a time, into a dispensing chamber (111) for dispensing onto the sensing region, hi alternative embodiments, other storage and dispensing mechanisms can be configured as a part of the integrated receiver housing (12) or separate therefrom.
- the stylus (98) is held in its storage position within the receiving chamber (104) where it is protected and maintained with a preferred wetness (Fig. 5 A).
- the sensing region (100) of the stylus (98) presses on the disposable film (109) within the dispensing chamber the film will be sfretched over and/or otherwise stick to the moist sensing membrane on the surface of the sensing region (100) (Fig. 5D).
- the stylus (98) is ready for a biological sample (for example, blood sample) (106).
- the stylus (98) can be brought into contact with the finger or arm of the user to directly receive the biological sample from the user without the need for a fransfer mechanism (Fig. 5E).
- Figs. 6A to 6J illustrate yet another embodiment of an integrated receiver, including a single point glucose monitor, electronics, and a disposable filtering capillary tube. Fig.
- FIG. 6A is a perspective view of the integrated receiver in yet another embodiment, including a single point glucose monitor and a disposable capillary tube for transferring a biological sample to a sensing region on the monitor.
- Fig. 6B is a perspective view of the integrated receiver of Fig. 6A, showing the disposable capillary tube inserted into the single point glucose monitor to transfer the biological sample to a sensing region on the single point glucose monitor.
- Fig. 6C is an expanded perspective view of a portion of the integrated receiver of Fig. 6A, showing the capillary tube inserted into the single point glucose monitor.
- Fig. 6D is a schematic cross-sectional view of a portion of the integrated receiver of Fig.
- FIG. 6A illustrating the capillary tube in contact with a sensing membrane such that glucose from the biological sample can be measured by electrodes on the sensing region.
- FIG. 6E is a schematic cross-sectional view of the capillary tube of Fig. 6A, illustrating an embodiment wherein a filter is located on one end.
- Fig. 6F is a schematic cross- sectional view of the capillary tube of Fig. 6A, illustrating an embodiment wherein a filter is disposed between two ends.
- Fig. 6G is a schematic cross-sectional view of the capillary tube of Fig. 6A, illustrating an embodiment wherein a vent extends from the capillary tube.
- Fig. 6E is a schematic cross-sectional view of the capillary tube of Fig. 6A, illustrating an embodiment wherein a filter is located on one end.
- Fig. 6F is a schematic cross- sectional view of the capillary tube of Fig. 6A, illustrating an embodiment wherein a
- FIG. 6H is a schematic illustration of one embodiment, wherein the capillary tube (132) is round in shape with an inner capillary tube that is also round in shape.
- Fig. 61 is a schematic illustration of one embodiment, wherein the capillary tube (132) is rectangular in shape with an inner capillary tube (144) that is formed therein.
- Fig. 6 is a schematic illustration of one embodiment, wherein the capillary tube (132) is rectangular in shape an inner capillary tube (144) has a rounded structure.
- the integrated receiver provides a housing (112) that integrates a single point glucose monitor (114) and electronics (see Fig. 8) useful to receive, process, and display data on a user interface (116).
- the single point glucose monitor (114) permits rapid and accurate measurement of the amount of a particular substance (for example, glucose) in a biological sample.
- a particular substance for example, glucose
- the electronics that process single point glucose monitor data, receive and process continuous glucose sensor data, including calibration of the continuous sensor data using the single point monitor data for example, and output data via the user interface (116), are described below in more detail with reference to Fig. 8.
- Buttons (118) can be provided on this or any of the preferred integrated receiver embodiments in order to facilitate user interaction with the integrated receiver.
- the single point glucose monitor (114) includes a sensor port (120) configured to receive a biological fluid and measure its glucose concentration therefrom. As best illustrated in Fig.
- a sensing region which includes a sensing membrane (124) (such as described in more detail elsewhere herein), is located within the sensor port (120).
- the sensing region includes electrodes (126), the top ends of which are in contact with an electrolyte phase (not shown), which is a free-flowing fluid phase disposed between the sensing membrane (124) and the electrodes (126).
- the sensing region (122) measures glucose in the biological sample in a manner such as described in more detail above, with reference to the sensing regions of Figs. 2, 4, and 5.
- the sensor port (120) includes a cover (not shown) configured to cover the sensing membrane (124) when the single glucose monitor is not in use in order to maintain a preferred wetness of the sensing region (122), and particularly of the sensing membrane.
- a single-use disposable capillary tube (132) can be provided to transport and filter the biological sample, for example from a blood sample of a finger or arm, to the sensing region (122).
- the disposable capillary tube (132) uses capillary action to draw the biological sample from a first end (134) to a second end (136) of the capillary tube (132).
- a filter (140) is provided within the capillary tube (132), which is designed to allow the passage of glucose, but filter or block the passage of undesired species in the biological sample that could damage or contaminate the sensing membrane and/or cause inaccurate measurements (for example, the filter can be formed from a membrane of very low molecular weight cutoff to prevent the transport of proteins, viruses, etc). Because the filter (140) protects the sensing region (122) from contamination, the sensing region does not require a separate cleaning step, and the filter should be disposed of after use. [0156] Referring now to Figs.
- Each capillary tube (132) has a capillary inlet (142) at a first end (134), an inner capillary tube (144), a filter (140), and an outlet (146) on the second end (136).
- the capillary tube (132) enables the transport of blood or other aqueous solutions from the capillary inlet (142) to the capillary outlet (146).
- the fluid transport is facilitated by capillary action and preferably enabled by a hydrophilic surface of the inner capillary tube (144).
- some portions of the inner capillary tube (144) can be made hydrophobic to control fluid flow.
- the inner capillary tube (144) has a volume between about 2 and 3 microliters; however a larger or smaller volume is possible.
- Fig. 6E is a schematic cross-sectional view of the capillary tube in one embodiment, wherein a filter (140) is disposed at the second end (136) within the inner capillary tube (144). This embodiment of the capillary tube is designed to filter the biological sample prior to its exit out of the capillary tube outlet (146).
- Fig. 6F is a schematic cross-sectional view of the capillary tube in another embodiment, wherein the filter (140) within the wall capillary tube (132) rather than within the inner capillary tube (144).
- the open inner capillary tube is designed to ensure accurate and repeatable fluid flow through the capillary tube by allowing displaced air to escape from the capillary tube outlet (146).
- the inner capillary tube (144) As the fluid passes through the inner capillary tube (144), at least a portion of the bodily fluid flows down through the filter (140) and exits the capillary tube (132) through a side exit (141).
- the surface of the inner capillary tube (144) near the second end of the capillary can be altered to be hydrophobic thereby preventing blood from escaping the second end.
- Fig. 6G is a schematic cross-sectional view of the capillary tube in yet another embodiment, wherein the capillary tube further comprises a vent (148).
- Fig. 6H is a schematic illustration of one embodiment, wherein the capillary tube (132) is round in shape with an inner capillary tube that is also round in shape. This is an embodiment similar to that shown in Fig.
- Fig. 61 is a schematic illustration of one embodiment, wherein the capillary tube (132) is rectangular in shape with an inner capillary tube (144) that is formed therein, hi one embodiment, the inner capillary tube (144) can be formed by methods, for example as known in the art of manufacturing test strips used for self-monitoring blood glucose meters.
- Fig. 6J is a schematic illustration of one embodiment; wherein the capillary tube (132) is rectangular in shape an inner capillary tube (144) has a rounded structure.
- the capillary tubes (132) can be manufactured using materials such as plastic, glass, silicon, or the like. In one embodiment, the preferred manufacturing material is plastic because of its low cost and the availability of numerous manufacturing processes.
- the inner capillary tube (144) can be molded or embossed to form the capillary structure, hi some alternative embodiments, such as shown Fig. 61, the inner capillary tube (144) can be formed by multi-layers including a top-capping layer that forms the capillary structure. Adhesive, ultrasonic bonding, solvents or other methods can be used to bond the layers.
- Holding tabs are not employed in certain embodiments of the capillary tube depending on their structure, for example the capillary tubes shown in Figs. 6H to 6J.
- a user obtains a biological sample from a source, such as a finger or forearm (in some alternative embodiments, the single point glucose monitor can by designed to measure biological fluids other than blood, such as urine, sweat, or the like).
- a source such as a finger or forearm
- the single point glucose monitor can by designed to measure biological fluids other than blood, such as urine, sweat, or the like.
- the user grasps a disposable capillary tube (132) (e.g., tab or outer surface) and contacts the source with the capillary inlet (142). Because of the design of the inner capillary tube (144), capillary action causes the biological sample to be drawn towards the capillary outlet (146).
- the biological sample is filtered as it passes through the filter (140), which is permeable to glucose but impermeable to large molecules and species in the blood that can clog, damage, or contaminate the sensing membrane (124), and/or cause inaccurate measurements. Therefore, the biological sample permeates the filter (140) and into the sensing membrane (124) (for example, fluid contact between the capillary tube and sensing membrane enables the transfer of the filtered biological sample), where it enyzmatically reacts with the catalyst (e.g., glucose oxidase) and produces hydrogen peroxide. Hydrogen peroxide is detected by the electrochemical sensor, wherein the elecfrical signal is converted into glucose value, such as described in more detail elsewhere herein.
- the catalyst e.g., glucose oxidase
- the sensing membrane (124) is a reusable component of the single point glucose monitor, which advantageously provides a low cost associated with each glucose measurement as compared to conventional glucose measuring test strips. Additionally, the disposable capillary tube (132) simplifies the cleanup of the device, as compared to conventional single point glucose monitors that utilize similar enzyme membrane technology. Furthermore, because the blood remains within the capillary tube (144), which can be disposed of without contaminating the integrated receiver housing (112) or the sensing membrane (124), the risk of human contact with blood is reduced.
- Figs. 7A and 7B are perspective views of yet another embodiment of an integrated receiver, wherein the single point glucose monitor is detachably connected to the receiver housing to provide a modular configuration. Fig.
- FIG. 7A is a perspective view of the integrated receiver in this embodiment, wherein the single point glucose monitor is detachably connected to the receiver to form a modular configuration, shown in its connected state.
- Fig. 7B is a perspective view of the integrated receiver of Fig. 7A, shown in its detached state.
- the integrated receiver (150) provides a receiver housing
- the receiver housing (152) includes electronics (hardware and software) useful to receive, process, and display data from the continuous glucose sensor and/or the single point glucose sensor on a user interface (156), such as described in more detail with reference to Fig. 8.
- some part of the electronics for example, the electronics specific to the single point glucose monitor (154)
- the single point glucose monitor (154) can be configured as described with reference to Fig. 6, for example, to permit rapid and accurate measurements of the amount of a particular substance (for example, glucose) in a biological sample.
- the single point glucose monitor of this modular embodiment can be configured as described with reference to any of the single point glucose monitors of the preferred embodiments, hi yet alternative embodiments, the single point glucose monitor can be configured using other known glucose meter configurations.
- this embodiment provides for a modular configuration between a receiver housing (152) and a single point glucose monitor (154), wherein the single point glucose monitor can be detached when a user prefers to carry a smaller, simpler, or lighter device (for example, during exercise).
- the glucose monitor (154) can be easily attached to the receiver (152) to form an integrated receiver (150) with its numerous associated advantages, hi one embodiment, electrical contacts (not shown) on the receiver housing (152) and the single point glucose monitor (154) allow an electrical connection to be established in its attached position.
- a wireless connection between the receiver housing (152) and the single point glucose monitor (154) can be provided, wherein the integration is advantageous for its convenient one-piece system (for example, fewer loose parts), its similar measurement technologies (for example, enzyme membrane-based electrochemical measurement), and its added versatility to function even when the modular device is detached.
- the single point glucose monitor (154) be dependent upon the integrated receiver (152) for at least a portion of its operation.
- the electronics and/or user interface for the single point glucose monitor (154) are located within the receiver (152).
- Numerous advantages associated with the integrated receiver (150), such as ensuring accurate time stamping of the single point glucose test at the receiver and other advantages described herein, can be provided by an integrated continuous glucose receiver and single point glucose monitor, such as described herein.
- the integrated receiver housing configurations of the preferred embodiments are advantageous in that they can be calibrated by the user and can be designed with a measurement technique consistent with that of the continuous glucose sensor.
- the single point glucose monitor comprises an integrated lancing and measurement device such as described in U.S. Patent 6,607,658 to Heller et al.
- the single point glucose monitor comprises a near infrared device such as described in U.S. Patent 5,068,536 to Rosenthal et al.
- the single point glucose monitor comprises an integrated lancer, blood-monitoring device, and medication delivery pen, such as described in U.S. Patent 6,192,891 to Gravel et al.
- the single point glucose monitor comprises a reflectance reading apparatus such as described in U.S.
- Fig. 8 is a block diagram that illustrates integrated receiver electronics in one embodiment. The described electronics are applicable to the preferred embodiments, including the integrated receiver (12) of Figs. 1, 4A, and 4B, the integrated receiver (92) of Figs. 5A to 5E, the integrated receiver (112) of Figs.
- a quartz crystal (160) is operably connected to an RF fransceiver (162), which together function to receive and synchronize data streams (164) via an antenna (166) (for example, transmission (46) from the RF transceiver (44) shown in Fig. 3).
- a microprocessor (168) processes the signals, such as described below.
- the microprocessor (168) is the central control unit that provides the processing, such as storing data, analyzing continuous glucose sensor data stream, analyzing single point glucose values, accuracy checking, checking clinical acceptability, calibrating sensor data, downloading data, and controlling the user interface by providing prompts, messages, warnings and alarms, or the like.
- the EEPROM (170) is operably connected to the microprocessor (168) and provides semi-permanent storage of data, storing data such as receiver ID and programming to process data streams (for example, programming for performing calibration and other algorithms described elsewhere herein).
- SRAM (172) is used for the system's cache memory and is helpful in data processing.
- the SRAM stores information from the continuous glucose sensor and the single point glucose monitor for later recall by the user or a doctor; a user or doctor can transcribe the stored information at a later time to determine compliance with the medical regimen or a comparison of glucose concenfration to medication administration (for example, this can be accomplished by downloading the information through the pc com port (174)).
- the SRAM (172) can also store updated program instructions and/or patient specific information.
- Figs. 9 and 10 describe more detail about programming that is preferably processed by the microprocessor (168).
- memory storage components comparable to EEPROM and SRAM can be used instead of or in addition to the preferred hardware, such as dynamic RAM, non-static RAM, rewritable ROMs, flash memory, or the like.
- a battery (176) is operably connected to the microprocessor (168) and provides power for the receiver, hi one embodiment, the battery is a standard AAA alkaline battery, however any appropriately sized and powered battery can be used.
- a plurality of batteries can be used to power the system.
- a power port (not shown) is provided permit recharging of rechargeable batteries.
- a quartz crystal (178) is operably connected to the microprocessor (168) and maintains system time for the computer system as a whole.
- a PC communication (com) port (174) can be provided to enable communication with systems, for example, a serial communications port, allows for communicating with another computer system (for example, PC, PDA, server, or the like).
- the receiver is able to download historical data to a physician's PC for retrospective analysis by the physician.
- the PC communication port (174) can also be used to interface with other medical devices, for example pacemakers, implanted analyte sensor patches, infusion devices, telemetry devices, or the like.
- Electronics associated with the single point glucose monitor (180) are operably connected to the microprocessor (168) and include a potentiostat (181) in one embodiment that measures a current flow produced at the working electrode when a biological sample is placed on the sensing membrane, such as described with reference to Figs. 4 to 7, for example.
- the current is then converted into an analog signal by a current to voltage converter, which can be inverted, level- shifted, and sent to the A/D converter (182).
- the microprocessor can set the analog gain via its control port (not shown).
- the A/D converter is preferably activated at one-second intervals.
- the microprocessor looks at the converter output with any number of pattern recognition algorithms known to those skilled in the art until a glucose peak is identified.
- a timer is then preferably activated for about 30 seconds at the end of which time the difference between the first and last electrode current values is calculated. This difference is then divided by the value stored in the memory during instrument calibration and is then multiplied by the calibration glucose concenfration. The glucose value in milligram per deciliter, millimoles per liter, or the like, is then stored in the microprocessor, displayed on the user interface, used to calibrate of the glucose sensor data stream, downloaded, etc.
- a user interface (184) comprises a keyboard (186), speaker (188), vibrator
- the components that comprise the user interface (184) provide controls to interact with the user.
- the keyboard (186) can allow, for example, input of user information about an individual, such as mealtime, exercise, insulin administration, and reference glucose values.
- the speaker (188) can provide, for example, audible signals or alerts for conditions such as present and/or predicted hyper- and hypoglycemic conditions.
- the vibrator (190) can provide, for example, tactile signals or alerts for reasons such as described with reference to the speaker, above.
- the backlight (192) can be provided, for example, to aid the user in reading the LCD in low light conditions.
- the LCD (194) can be provided, for example, to provide the user with visual data output.
- the LCD is a touch-activated screen.
- the buttons (196) can provide for toggle, menu selection, option selection, mode selection, and reset, for example.
- a microphone can be provided to allow for voice-activated control.
- the user interface (184) which is operably connected to the microprocessor (168) serves to provide data input and output for both the continuous glucose sensor (for example, Figs. 2 and 3) and for the integrated receiver including the single point glucose monitor (for example, Figs. 4 to 7).
- prompts or messages can be displayed on the user interface to guide the user through the initial calibration and sample measurement procedures for the single point glucose monitor.
- prompts can be displayed to inform the user about necessary maintenance procedures, such as "Replace Sensing Membrane” or "Replace Battery.” Even more, the glucose concenfration value measured from the single point glucose monitor can be individually displayed.
- prompts or messages can be displayed on the user interface to convey information to the user, such as malfunction, outlier values, missed data transmissions, or the like, for the continuous glucose sensor. Additionally, prompts can be displayed to guide the user through calibration of the continuous glucose sensor. Even more, calibrated sensor glucose data, which is described in more detail with reference to Figs. 9 and 10, can be displayed in numerical or graphical representations, or the like.
- Calibration of the glucose sensor (10) generally includes data processing that converts a sensor data stream into estimated glucose values that are meaningful to a user. Accordingly, a reference glucose value can be used to calibrate the data stream from the glucose sensor (10). The calibration can be performed on a real-time basis and/or backwards recalibrated (for example, retrospectively).
- a sensor data receiving module receives sensor data (for example, a data stream), including one or more time-spaced sensor data points, hereinafter referred to as "sensor data” or “sensor glucose data.”
- the integrated receiver receives the sensor data from a continuous glucose sensor, which can be in wired or wireless communication with the integrated receiver. Some or all of the sensor data point(s) can be smoothed or replaced by estimated signal values such as described with reference to co-pending U.S. Patent application entitled, "SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM,” filed August 22, 2003.
- a single point glucose module receives glucose data from the integrated single point glucose monitor, including one or more reference glucose data points, hereinafter referred as "reference data" or "reference glucose data.”
- reference data the single point glucose monitor, such as described in more detail with reference to Figs. 4 to 7, which is integral with the receiver, provides a reference glucose concenfration value, such as described above with respect to the single point glucose monitors of the preferred embodiments.
- the reference glucose concentration value from the single point glucose monitor is calibrated such as described above in more detail with reference to Fig 8.
- the microprocessor (168) monitors the continuous glucose sensor data stream to determine a preferable time for capturing glucose concenfration values using the single point glucose monitor electronics (180) for calibration of the continuous sensor data stream. For example, when sensor glucose data (for example, observed from the data stream) changes too rapidly, a single point glucose monitor reading may not be sufficiently reliable for calibration during unstable glucose changes in the host; in contrast, when sensor glucose data are relatively stable (for example, relatively low rate of change), a single point glucose monitor reading can be taken for a reliable calibration.
- the microprocessor can prompt the user via the user interface to obtain a single point glucose value for calibration at predetermined intervals.
- the user interface can prompt the user to obtain a single point glucose monitor value for calibration based upon certain events, such as meals, exercise, large excursions in glucose levels, faulty or interrupted data readings, or the like.
- certain acceptability parameters can be set for reference values received from the single point glucose monitor. For example, in one embodiment, the receiver only accepts reference glucose data between about 40 and about 400 mg/dL.
- a data matching module matches reference data (for example, one or more reference glucose data points) with substantially time corresponding sensor data (for example, one or more sensor data points) to provide one or more matched data pairs.
- reference data for example, one or more reference glucose data points
- sensor data for example, one or more sensor data points
- one reference data point is matched to one time corresponding sensor data point to form a matched data pair.
- a plurality of reference data points are averaged (for example, equally or non-equally weighted average, mean-value, median, or the like) and matched to one time corresponding sensor data point to form a matched data pair, hi another embodiment, one reference data point is matched to a plurality of time corresponding sensor data points averaged to form a matched data pair.
- time corresponding sensor data comprises one or more sensor data points that occur, for example, 15 ⁇ 5 min after the reference glucose data timestamp (for example, the time that the reference glucose data is obtained).
- the 15 minute time delay has been chosen to account for an approximately 10 minute delay introduced by the filter used in data smoothing and an approximately 5 minute physiological time-lag (for example, the time necessary for the glucose to diffusion through a membrane(s) of a glucose sensor),
- the time corresponding sensor value can be more or less than in the above-described embodiment, for example ⁇ 60 minutes.
- Variability in time correspondence of sensor and reference data can be attributed to, for example, a longer or shorter time delay introduced during signal estimation, or if the configuration of the glucose sensor (10) incurs a greater or lesser physiological time lag.
- One advantage of integrated receiver of the preferred embodiments can be seen in the time stamp of the reference glucose data. Namely, typical implementations of the continuous glucose sensor (10), wherein the single point glucose monitor is not integral with the receiver, the reference glucose data can be obtained at a time that is different from the time that the data is input into the receiver (30). Thus, the user may not accurately input the "time stamp" of the reference glucose (for example, the time at which the reference glucose value was actually obtained) at the time of reference data input into the receiver.
- the accuracy of the calibration is subject to human error (for example, due to inconsistencies in entering the actual time of the single point glucose test).
- the preferred embodiments of the integrated receiver advantageously do no suffer from this potential inaccuracy in that the time stamp is automatically and accurately obtained at the time of single point glucose test.
- the process of obtaining reference data is simplified and made convenient using the integrated receiver because of fewer loose parts (for example, cables, test strips, or the like) and less required data entry (for example, time of testing).
- tests are used to evaluate the best-matched pair using a reference data point against individual sensor values over a predetermined time period (for example, about 30 minutes), hi one such embodiment, the reference data point is matched with sensor data points at 5 -minute intervals and each matched pair is evaluated.
- the matched pair with the best correlation can be selected as the matched pair for data processing, i some alternative embodiments, matching a reference data point with an average of a plurality of sensor data points over a predetermined time period can be used to form a matched pair.
- a calibration set module forms an initial calibration set from a set of one or more matched data pairs, which are used to determine the relationship between the reference glucose data and the sensor glucose data, such as described in more detail with reference to block (208), below.
- the matched data pairs, which make up the initial calibration set can be selected according to predetermined criteria.
- the number (n) of data pair(s) selected for the initial calibration set is one.
- n data pairs are selected for the initial calibration set wherein n is a function of the frequency of the received reference glucose data points, hi one exemplary embodiment, six data pairs make up the initial calibration set.
- the calibration set includes only one data pair.
- the data pairs are selected only within a certain glucose value threshold, for example wherein the reference glucose value is between about 40 and about 400 mg/dL.
- the data pairs that form the initial calibration set are selected according to their time stamp.
- a conversion function module creates a conversion function using the calibration set.
- the conversion function substantially defines the relationship between the reference glucose data and the sensor glucose data.
- a variety of known methods can be used with the preferred embodiments to create the conversion function from the calibration set.
- a linear least squares regression is performed on the initial calibration set such as described in more detail with reference to Fig. 10.
- a sensor data transformation module uses the conversion function to transform sensor data into substantially real-time glucose value estimates, also referred to as calibrated data, as sensor data is continuously (or intermittently) received from the sensor.
- the sensor and/or reference glucose data are stored in a database for retrospective analysis.
- an output module provides output to the user via the user interface.
- the output is representative of the estimated glucose value, which is determined by converting the sensor data into a meaningful glucose value such as described in more detail with reference to block (210), above.
- User output can be in the form of a numeric estimated glucose value, an indication of directional trend of glucose concentration, and/or a graphical representation of the estimated glucose data over a period of time, for example. Other representations of the estimated glucose values are also possible, for example audio and tactile.
- the estimated glucose value is represented by a numeric value.
- the user interface graphically represents the estimated glucose data trend over a predetermined time period (for example, one, three, and nine hours, respectively). In alternative embodiments, other time periods can be represented.
- pictures, animation, charts, graphs, and numeric data can be selectively displayed.
- real-time continuous glucose information can be displayed on the user interface so that the user can regularly and proactively care for his/her diabetic condition within the bounds set by his/her physician.
- Both the calibrated reference glucose data from the single point glucose monitor and the sensor glucose data from the continuous glucose sensor can be displayed to the user, hi an embodiment wherein the continuous glucose sensor functions as an adjunctive device to the single point glucose monitor, the user interface can display numeric reference glucose data, while showing the sensor glucose data only in a graphical representation so that the user can see the historical and present sensor trend information as well as the most recent reference glucose data value.
- the user interface can display the reference glucose data and/or the sensor glucose data.
- the user can toggle through menus and screens using the buttons in order to view alternate data and/or screen formats, for example.
- the conversion function is used to predict glucose values at future points in time. These predicted values can be used to alert the user of upcoming hypoglycemic or hyperglycemic events. Additionally, predicted values can be used to compensate for the time lag (for example, 15 minute time lag such as described elsewhere herein), so that an estimated glucose value displayed to the user represents the instant time, rather than a time delayed estimated value.
- the substantially real-time estimated glucose value, a predicted future estimated glucose value, a rate of change, and/or a directional trend of the glucose concentration is used to control the administration of a constituent to the user, including an appropriate amount and time, in order to control an aspect of the user's biological system.
- a closed loop glucose sensor and insulin pump wherein the glucose data (for example, estimated glucose value, rate of change, and/or directional trend) from the glucose sensor is used to determine the amount of insulin, and time of administration, that can be given to a diabetic user to evade hyper- and hypoglycemic conditions.
- FIG. 10 is a graph that illustrates one embodiment of a regression performed on a calibration set to create a conversion function such as described with reference to Fig 9, block (208), above, hi this embodiment, a linear least squares regression is performed on the initial calibration set.
- the x-axis represents reference glucose data; the y-axis represents sensor data.
- the graph pictorially illustrates regression of matched pairs (214) in the calibration set.
- the conversion function can comprise two or more different optimal conversions because an optimal conversion at any time is dependent on one or more parameters, such as time of day, calories consumed, exercise, or glucose concentration above or below a set threshold, for example.
- the conversion function is adapted for the estimated glucose concentration (for example, high vs. low).
- the cells surrounding the implant will consume at least a small amount of glucose as it diffuses toward the glucose sensor. Assuming the cells consume substantially the same amount of glucose whether the glucose concenfration is low or high, this phenomenon will have a greater effect on the concentration of glucose during low blood sugar episodes than the effect on the concentration of glucose during relatively higher blood sugar episodes. Accordingly, the conversion function can be adapted to compensate for the sensitivity differences in blood sugar level.
- the conversion function comprises two different regression lines, wherein a first regression line is applied when the estimated glucose concenfration is at or below a certain threshold (for example, 150 mg/dL) and a second regression line is applied when the estimated glucose concentration is at or above a certain threshold (for example, 150 mg/dL).
- a predetermined pivot of the regression line that forms the conversion function can be applied when the estimated blood is above or below a set threshold (for example, 150 mg/dL), wherein the pivot and threshold are determined from a retrospective analysis of the performance of a conversion function and its performance at a range of glucose concentrations.
- the regression line that forms the conversion function is pivoted about a point in order to comply with clinical acceptability standards (for example, Clarke Error Grid, Consensus Grid, mean absolute relative difference, or other clinical cost function) and/or physiological parameters.
- clinical acceptability standards for example, Clarke Error Grid, Consensus Grid, mean absolute relative difference, or other clinical cost function
- the conversion function is adaptively applied based on one or more parameters that can affect the sensitivity of the sensor data over time.
- the preferred embodiments described a continuous glucose sensor and integrated receiver with single point glucose calibration that is more cost effective than conventional reference glucose monitors (for example, more cost effective than test strips).
Abstract
Description
Claims
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52384003P | 2003-11-19 | 2003-11-19 | |
US60/523,840 | 2003-11-19 | ||
US58778704P | 2004-07-13 | 2004-07-13 | |
US60/587,787 | 2004-07-13 | ||
US61468304P | 2004-09-30 | 2004-09-30 | |
US60/614,683 | 2004-09-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005051170A2 true WO2005051170A2 (en) | 2005-06-09 |
WO2005051170A3 WO2005051170A3 (en) | 2009-04-02 |
Family
ID=34637171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/038724 WO2005051170A2 (en) | 2003-11-19 | 2004-11-17 | Integrated receiver for continuous analyte sensor |
Country Status (2)
Country | Link |
---|---|
US (9) | US7519408B2 (en) |
WO (1) | WO2005051170A2 (en) |
Cited By (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009018058A1 (en) | 2007-07-31 | 2009-02-05 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in a medical communication system |
WO2009049252A1 (en) * | 2007-10-10 | 2009-04-16 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
WO2009144507A1 (en) * | 2008-05-31 | 2009-12-03 | Spd Swiss Precision Diagnostics Gmbh | Assay device |
CN101910832A (en) * | 2007-11-02 | 2010-12-08 | 爱德华兹生命科学公司 | Analyte monitoring system with the standby power supply that is used for system's transfer or main power supply disappearance |
ITMI20100258A1 (en) * | 2010-02-19 | 2011-08-20 | Antonio Americo Cannata | GLYCEMIC CONTROL DEVICE |
CN103472010A (en) * | 2013-09-17 | 2013-12-25 | 苏州凯恩医药科技有限公司 | Diabetes detection device |
CN103533884A (en) * | 2011-03-15 | 2014-01-22 | 传感技术股份有限公司 | Integrated catalytic protection of oxidation sensitive materials |
CN104287744A (en) * | 2009-02-03 | 2015-01-21 | 雅培糖尿病护理公司 | Compact on-body physiological monitoring devices and methods thereof |
US9302045B2 (en) | 2008-09-12 | 2016-04-05 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
US9963556B2 (en) | 2013-09-18 | 2018-05-08 | Senseonics, Incorporated | Critical point drying of hydrogels in analyte sensors |
US10136816B2 (en) | 2009-08-31 | 2018-11-27 | Abbott Diabetes Care Inc. | Medical devices and methods |
CN110353698A (en) * | 2019-08-01 | 2019-10-22 | 武汉优斯特传感器科技有限公司 | A kind of detector of the sustainable internal glucose content of measurement |
WO2021023160A1 (en) * | 2019-08-02 | 2021-02-11 | Bionime Corporation | Physiological signal monitoring system for fast assembly |
US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
US11386996B2 (en) | 2014-01-30 | 2022-07-12 | Insulet Netherlands B.V. | Therapeutic product delivery system and method of pairing |
US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
US11565043B2 (en) | 2018-05-04 | 2023-01-31 | Insulet Corporation | Safety constraints for a control algorithm based drug delivery system |
US11565039B2 (en) | 2018-10-11 | 2023-01-31 | Insulet Corporation | Event detection for drug delivery system |
US11596740B2 (en) | 2015-02-18 | 2023-03-07 | Insulet Corporation | Fluid delivery and infusion devices, and methods of use thereof |
US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
US11628251B2 (en) | 2018-09-28 | 2023-04-18 | Insulet Corporation | Activity mode for artificial pancreas system |
US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
US11724027B2 (en) | 2016-09-23 | 2023-08-15 | Insulet Corporation | Fluid delivery device with sensor |
US11738144B2 (en) | 2021-09-27 | 2023-08-29 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
US11857763B2 (en) | 2016-01-14 | 2024-01-02 | Insulet Corporation | Adjusting insulin delivery rates |
US11865299B2 (en) | 2008-08-20 | 2024-01-09 | Insulet Corporation | Infusion pump systems and methods |
US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
US11929158B2 (en) | 2016-01-13 | 2024-03-12 | Insulet Corporation | User interface for diabetes management system |
US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
USD1020794S1 (en) | 2018-04-02 | 2024-04-02 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
US11957875B2 (en) | 2019-12-06 | 2024-04-16 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
USD1024090S1 (en) | 2021-05-19 | 2024-04-23 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
Families Citing this family (522)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593852A (en) | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
SE9700384D0 (en) * | 1997-02-04 | 1997-02-04 | Biacore Ab | Analytical method and apparatus |
US9155496B2 (en) | 1997-03-04 | 2015-10-13 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US7899511B2 (en) | 2004-07-13 | 2011-03-01 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US7657297B2 (en) | 2004-05-03 | 2010-02-02 | Dexcom, Inc. | Implantable analyte sensor |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
WO2002078512A2 (en) | 2001-04-02 | 2002-10-10 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
US9282925B2 (en) | 2002-02-12 | 2016-03-15 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US7226978B2 (en) | 2002-05-22 | 2007-06-05 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US7727181B2 (en) | 2002-10-09 | 2010-06-01 | Abbott Diabetes Care Inc. | Fluid delivery device with autocalibration |
US7993108B2 (en) | 2002-10-09 | 2011-08-09 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
EP2386758A1 (en) | 2002-10-09 | 2011-11-16 | Abbott Diabetes Care Inc. | A method of pumping a predetermined dose of a medical fluid |
US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US7587287B2 (en) | 2003-04-04 | 2009-09-08 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
US7679407B2 (en) | 2003-04-28 | 2010-03-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing peak detection circuitry for data communication systems |
US8460243B2 (en) | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US8071028B2 (en) | 2003-06-12 | 2011-12-06 | Abbott Diabetes Care Inc. | Method and apparatus for providing power management in data communication systems |
US7722536B2 (en) * | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
US7761130B2 (en) | 2003-07-25 | 2010-07-20 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8423113B2 (en) | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9763609B2 (en) | 2003-07-25 | 2017-09-19 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
US6931327B2 (en) | 2003-08-01 | 2005-08-16 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8626257B2 (en) | 2003-08-01 | 2014-01-07 | Dexcom, Inc. | Analyte sensor |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US7519408B2 (en) * | 2003-11-19 | 2009-04-14 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20080119703A1 (en) * | 2006-10-04 | 2008-05-22 | Mark Brister | Analyte sensor |
US7494465B2 (en) | 2004-07-13 | 2009-02-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8160669B2 (en) | 2003-08-01 | 2012-04-17 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20100168542A1 (en) | 2003-08-01 | 2010-07-01 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8845536B2 (en) | 2003-08-01 | 2014-09-30 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8761856B2 (en) | 2003-08-01 | 2014-06-24 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8369919B2 (en) | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8886273B2 (en) | 2003-08-01 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US7959569B2 (en) | 2003-08-01 | 2011-06-14 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US20140121989A1 (en) | 2003-08-22 | 2014-05-01 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US7299082B2 (en) | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
USD914881S1 (en) | 2003-11-05 | 2021-03-30 | Abbott Diabetes Care Inc. | Analyte sensor electronic mount |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8364230B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
WO2005057168A2 (en) | 2003-12-05 | 2005-06-23 | Dexcom, Inc. | Calibration techniques for a continuous analyte sensor |
US8425416B2 (en) | 2006-10-04 | 2013-04-23 | Dexcom, Inc. | Analyte sensor |
US8425417B2 (en) | 2003-12-05 | 2013-04-23 | Dexcom, Inc. | Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device |
US20080200788A1 (en) * | 2006-10-04 | 2008-08-21 | Dexcorn, Inc. | Analyte sensor |
WO2005057175A2 (en) | 2003-12-09 | 2005-06-23 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
WO2005089103A2 (en) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US7815569B2 (en) * | 2004-04-21 | 2010-10-19 | University Of Virginia Patent Foundation | Method, system and computer program product for evaluating the accuracy of blood glucose monitoring sensors/devices |
US8792955B2 (en) | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060010098A1 (en) * | 2004-06-04 | 2006-01-12 | Goodnow Timothy T | Diabetes care host-client architecture and data management system |
US8452368B2 (en) | 2004-07-13 | 2013-05-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
US20060270922A1 (en) | 2004-07-13 | 2006-11-30 | Brauker James H | Analyte sensor |
US8565848B2 (en) | 2004-07-13 | 2013-10-22 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060020192A1 (en) | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8886272B2 (en) | 2004-07-13 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
US20090082693A1 (en) * | 2004-12-29 | 2009-03-26 | Therasense, Inc. | Method and apparatus for providing temperature sensor module in a data communication system |
US7731657B2 (en) | 2005-08-30 | 2010-06-08 | Abbott Diabetes Care Inc. | Analyte sensor introducer and methods of use |
US20090105569A1 (en) | 2006-04-28 | 2009-04-23 | Abbott Diabetes Care, Inc. | Introducer Assembly and Methods of Use |
US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US9636450B2 (en) | 2007-02-19 | 2017-05-02 | Udo Hoss | Pump system modular components for delivering medication and analyte sensing at seperate insertion sites |
US7883464B2 (en) | 2005-09-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
US20110073475A1 (en) * | 2009-08-29 | 2011-03-31 | Abbott Diabetes Care Inc. | Analyte Sensor |
US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US20110190603A1 (en) * | 2009-09-29 | 2011-08-04 | Stafford Gary A | Sensor Inserter Having Introducer |
US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
US8613703B2 (en) | 2007-05-31 | 2013-12-24 | Abbott Diabetes Care Inc. | Insertion devices and methods |
US9572534B2 (en) | 2010-06-29 | 2017-02-21 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US9743862B2 (en) | 2011-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Systems and methods for transcutaneously implanting medical devices |
US8571624B2 (en) | 2004-12-29 | 2013-10-29 | Abbott Diabetes Care Inc. | Method and apparatus for mounting a data transmission device in a communication system |
US9351669B2 (en) | 2009-09-30 | 2016-05-31 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US20060166629A1 (en) * | 2005-01-24 | 2006-07-27 | Therasense, Inc. | Method and apparatus for providing EMC Class-B compliant RF transmitter for data monitoring an detection systems |
US8202245B2 (en) * | 2005-01-26 | 2012-06-19 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US7547281B2 (en) | 2005-02-01 | 2009-06-16 | Medtronic Minimed, Inc. | Algorithm sensor augmented bolus estimator for semi-closed loop infusion system |
US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
US20090076360A1 (en) | 2007-09-13 | 2009-03-19 | Dexcom, Inc. | Transcutaneous analyte sensor |
CN101180093B (en) | 2005-03-21 | 2012-07-18 | 雅培糖尿病护理公司 | Method and system for providing integrated medication infusion and analyte monitoring system |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
WO2006110193A2 (en) | 2005-04-08 | 2006-10-19 | Dexcom, Inc. | Cellulosic-based interference domain for an analyte sensor |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
US7620437B2 (en) * | 2005-06-03 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
US20070060869A1 (en) * | 2005-08-16 | 2007-03-15 | Tolle Mike C V | Controller device for an infusion pump |
US20090227855A1 (en) | 2005-08-16 | 2009-09-10 | Medtronic Minimed, Inc. | Controller device for an infusion pump |
US20070060870A1 (en) * | 2005-08-16 | 2007-03-15 | Tolle Mike Charles V | Controller device for an infusion pump |
US7737581B2 (en) * | 2005-08-16 | 2010-06-15 | Medtronic Minimed, Inc. | Method and apparatus for predicting end of battery life |
CN101365374B (en) | 2005-08-31 | 2011-11-16 | 弗吉尼亚大学专利基金委员会 | Improving accuracy of continuous glucose sensors |
US7756561B2 (en) | 2005-09-30 | 2010-07-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
US8880138B2 (en) | 2005-09-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Device for channeling fluid and methods of use |
US7583190B2 (en) | 2005-10-31 | 2009-09-01 | Abbott Diabetes Care Inc. | Method and apparatus for providing data communication in data monitoring and management systems |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
EP1968432A4 (en) | 2005-12-28 | 2009-10-21 | Abbott Diabetes Care Inc | Medical device insertion |
US9757061B2 (en) | 2006-01-17 | 2017-09-12 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
EP2004796B1 (en) * | 2006-01-18 | 2015-04-08 | DexCom, Inc. | Membranes for an analyte sensor |
US7736310B2 (en) | 2006-01-30 | 2010-06-15 | Abbott Diabetes Care Inc. | On-body medical device securement |
US8344966B2 (en) | 2006-01-31 | 2013-01-01 | Abbott Diabetes Care Inc. | Method and system for providing a fault tolerant display unit in an electronic device |
ES2871822T3 (en) | 2006-02-22 | 2021-11-02 | Dexcom Inc | Analyte sensor |
US7826879B2 (en) | 2006-02-28 | 2010-11-02 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US7981034B2 (en) | 2006-02-28 | 2011-07-19 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
EP4218548A1 (en) | 2006-03-09 | 2023-08-02 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
EP1991110B1 (en) | 2006-03-09 | 2018-11-07 | DexCom, Inc. | Systems and methods for processing analyte sensor data |
US8478557B2 (en) | 2009-07-31 | 2013-07-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
US8140312B2 (en) | 2007-05-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and system for determining analyte levels |
US8219173B2 (en) | 2008-09-30 | 2012-07-10 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US8224415B2 (en) | 2009-01-29 | 2012-07-17 | Abbott Diabetes Care Inc. | Method and device for providing offset model based calibration for analyte sensor |
US7801582B2 (en) | 2006-03-31 | 2010-09-21 | Abbott Diabetes Care Inc. | Analyte monitoring and management system and methods therefor |
US7653425B2 (en) | 2006-08-09 | 2010-01-26 | Abbott Diabetes Care Inc. | Method and system for providing calibration of an analyte sensor in an analyte monitoring system |
US9392969B2 (en) | 2008-08-31 | 2016-07-19 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US7630748B2 (en) | 2006-10-25 | 2009-12-08 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US8374668B1 (en) | 2007-10-23 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte sensor with lag compensation |
US9675290B2 (en) | 2012-10-30 | 2017-06-13 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US9326709B2 (en) | 2010-03-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
US8473022B2 (en) | 2008-01-31 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte sensor with time lag compensation |
US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US20070253021A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic Minimed, Inc. | Identification of devices in a medical device network and wireless data communication techniques utilizing device identifiers |
US20070255126A1 (en) * | 2006-04-28 | 2007-11-01 | Moberg Sheldon B | Data communication in networked fluid infusion systems |
US20070258395A1 (en) * | 2006-04-28 | 2007-11-08 | Medtronic Minimed, Inc. | Wireless data communication protocols for a medical device network |
US8073008B2 (en) | 2006-04-28 | 2011-12-06 | Medtronic Minimed, Inc. | Subnetwork synchronization and variable transmit synchronization techniques for a wireless medical device network |
US7942844B2 (en) | 2006-04-28 | 2011-05-17 | Medtronic Minimed, Inc. | Remote monitoring for networked fluid infusion systems |
US20080071158A1 (en) * | 2006-06-07 | 2008-03-20 | Abbott Diabetes Care, Inc. | Analyte monitoring system and method |
US20080004601A1 (en) * | 2006-06-28 | 2008-01-03 | Abbott Diabetes Care, Inc. | Analyte Monitoring and Therapy Management System and Methods Therefor |
US9119582B2 (en) | 2006-06-30 | 2015-09-01 | Abbott Diabetes Care, Inc. | Integrated analyte sensor and infusion device and methods therefor |
US8206296B2 (en) | 2006-08-07 | 2012-06-26 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
US8932216B2 (en) | 2006-08-07 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for providing data management in integrated analyte monitoring and infusion system |
US7771320B2 (en) | 2006-09-07 | 2010-08-10 | Nike, Inc. | Athletic performance sensing and/or tracking systems and methods |
US8449464B2 (en) | 2006-10-04 | 2013-05-28 | Dexcom, Inc. | Analyte sensor |
US8298142B2 (en) | 2006-10-04 | 2012-10-30 | Dexcom, Inc. | Analyte sensor |
US8275438B2 (en) | 2006-10-04 | 2012-09-25 | Dexcom, Inc. | Analyte sensor |
US8478377B2 (en) | 2006-10-04 | 2013-07-02 | Dexcom, Inc. | Analyte sensor |
US8447376B2 (en) * | 2006-10-04 | 2013-05-21 | Dexcom, Inc. | Analyte sensor |
US8562528B2 (en) | 2006-10-04 | 2013-10-22 | Dexcom, Inc. | Analyte sensor |
CN102772212A (en) | 2006-10-26 | 2012-11-14 | 雅培糖尿病护理公司 | Method, device and system for detection of sensitivity decline in analyte sensors |
US20080119710A1 (en) * | 2006-10-31 | 2008-05-22 | Abbott Diabetes Care, Inc. | Medical devices and methods of using the same |
US7740580B2 (en) * | 2006-10-31 | 2010-06-22 | Abbott Diabetes Care Inc. | Analyte monitoring |
US8158081B2 (en) * | 2006-10-31 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring devices |
US8579853B2 (en) | 2006-10-31 | 2013-11-12 | Abbott Diabetes Care Inc. | Infusion devices and methods |
US20090288964A1 (en) * | 2006-12-13 | 2009-11-26 | Sung-Kwon Jung | Biosensor with coded information and method for manufacturing the same |
WO2008082987A2 (en) * | 2006-12-26 | 2008-07-10 | Abbott Diabetes Care Inc | Analyte meter protectors and methods |
US20080161666A1 (en) * | 2006-12-29 | 2008-07-03 | Abbott Diabetes Care, Inc. | Analyte devices and methods |
DE102007003341B4 (en) * | 2007-01-17 | 2018-01-04 | Eyesense Ag | Eyepiece sensor and measuring system for detecting an analyte in an eye fluid |
US8121857B2 (en) | 2007-02-15 | 2012-02-21 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US20080199894A1 (en) * | 2007-02-15 | 2008-08-21 | Abbott Diabetes Care, Inc. | Device and method for automatic data acquisition and/or detection |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
EP1972267A1 (en) | 2007-03-20 | 2008-09-24 | Roche Diagnostics GmbH | System for in vivo measurement of an analyte concentration |
CA2681412A1 (en) | 2007-03-26 | 2008-10-02 | Dexcom, Inc. | Analyte sensor |
CA2683721C (en) | 2007-04-14 | 2017-05-23 | Abbott Diabetes Care Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
WO2008128210A1 (en) | 2007-04-14 | 2008-10-23 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
WO2009096992A1 (en) | 2007-04-14 | 2009-08-06 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
CA2683953C (en) | 2007-04-14 | 2016-08-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
CA2683962C (en) | 2007-04-14 | 2017-06-06 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
EP2146624B1 (en) | 2007-04-14 | 2020-03-25 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10002233B2 (en) | 2007-05-14 | 2018-06-19 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8444560B2 (en) | 2007-05-14 | 2013-05-21 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US9125548B2 (en) | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US7996158B2 (en) | 2007-05-14 | 2011-08-09 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8560038B2 (en) | 2007-05-14 | 2013-10-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8103471B2 (en) | 2007-05-14 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8600681B2 (en) | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US20080312845A1 (en) * | 2007-05-14 | 2008-12-18 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US20200037874A1 (en) | 2007-05-18 | 2020-02-06 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US20080306444A1 (en) | 2007-06-08 | 2008-12-11 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US20080319294A1 (en) * | 2007-06-21 | 2008-12-25 | Abbott Diabetes Care, Inc. | Health management devices and methods |
CN101686804B (en) * | 2007-06-21 | 2013-05-08 | 雅培糖尿病护理公司 | Health monitor |
AU2008265541B2 (en) | 2007-06-21 | 2014-07-17 | Abbott Diabetes Care, Inc. | Health management devices and methods |
US8641618B2 (en) | 2007-06-27 | 2014-02-04 | Abbott Diabetes Care Inc. | Method and structure for securing a monitoring device element |
US8085151B2 (en) | 2007-06-28 | 2011-12-27 | Abbott Diabetes Care Inc. | Signal converting cradle for medical condition monitoring and management system |
US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US7768386B2 (en) | 2007-07-31 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8834366B2 (en) | 2007-07-31 | 2014-09-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor calibration |
US20090036760A1 (en) * | 2007-07-31 | 2009-02-05 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in a medical communication system |
WO2009020690A1 (en) * | 2007-08-06 | 2009-02-12 | Bayer Healthcare Llc | System and method for automatic calibration |
ES2692209T3 (en) * | 2007-08-29 | 2018-11-30 | Lifescan Scotland Limited | Data management system and method |
US7717903B2 (en) | 2007-09-06 | 2010-05-18 | M2 Group Holdings, Inc. | Operating an infusion pump system |
EP2227132B1 (en) | 2007-10-09 | 2023-03-08 | DexCom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US8216138B1 (en) | 2007-10-23 | 2012-07-10 | Abbott Diabetes Care Inc. | Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration |
US8409093B2 (en) | 2007-10-23 | 2013-04-02 | Abbott Diabetes Care Inc. | Assessing measures of glycemic variability |
US8377031B2 (en) | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
AU2008316630A1 (en) | 2007-10-25 | 2009-04-30 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8241488B2 (en) * | 2007-11-06 | 2012-08-14 | Bayer Healthcare Llc | Auto-calibrating test sensors |
US7809512B2 (en) * | 2007-11-11 | 2010-10-05 | Bayer Healthcare Llc | Biosensor coding system |
US8116838B2 (en) * | 2007-11-27 | 2012-02-14 | Carnegie Mellon University | Medical device for diagnosing pressure ulcers |
US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
US20090164190A1 (en) * | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Physiological condition simulation device and method |
US20090164239A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
US8313467B2 (en) | 2007-12-27 | 2012-11-20 | Medtronic Minimed, Inc. | Reservoir pressure equalization systems and methods |
US20090205399A1 (en) * | 2008-02-15 | 2009-08-20 | Bayer Healthcare, Llc | Auto-calibrating test sensors |
CA2715628A1 (en) | 2008-02-21 | 2009-08-27 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
US20090223287A1 (en) * | 2008-03-04 | 2009-09-10 | Visgeneer, Inc. | Bio-Monitoring System and Methods of Use Thereof |
USD612275S1 (en) | 2008-03-21 | 2010-03-23 | Lifescan Scotland, Ltd. | Analyte test meter |
USD611853S1 (en) | 2008-03-21 | 2010-03-16 | Lifescan Scotland Limited | Analyte test meter |
USD615431S1 (en) | 2008-03-21 | 2010-05-11 | Lifescan Scotland Limited | Analyte test meter |
US8396528B2 (en) | 2008-03-25 | 2013-03-12 | Dexcom, Inc. | Analyte sensor |
EP3387993A3 (en) | 2008-03-28 | 2018-11-14 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8682408B2 (en) | 2008-03-28 | 2014-03-25 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US11730407B2 (en) | 2008-03-28 | 2023-08-22 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8583204B2 (en) | 2008-03-28 | 2013-11-12 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US20090259118A1 (en) * | 2008-03-31 | 2009-10-15 | Abbott Diabetes Care Inc. | Shallow Implantable Analyte Sensor with Rapid Physiological Response |
EP2106784B1 (en) * | 2008-04-03 | 2015-04-22 | Rohm and Haas Company | Hair styling composition |
EP3659628A1 (en) | 2008-04-10 | 2020-06-03 | Abbott Diabetes Care, Inc. | Method and system for sterilizing an analyte sensor |
CN102014986B (en) | 2008-04-24 | 2013-09-25 | 爱科来株式会社 | Blood sugar level control system |
US8591410B2 (en) | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US20090300616A1 (en) * | 2008-05-30 | 2009-12-03 | Abbott Diabetes Care, Inc. | Automated task execution for an analyte monitoring system |
US7826382B2 (en) | 2008-05-30 | 2010-11-02 | Abbott Diabetes Care Inc. | Close proximity communication device and methods |
US8924159B2 (en) | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8620398B2 (en) * | 2008-06-02 | 2013-12-31 | Abbott Diabetes Care Inc. | Reference electrodes having an extended lifetime for use in long term amperometric sensors |
US8876755B2 (en) | 2008-07-14 | 2014-11-04 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
US8475732B2 (en) | 2010-10-26 | 2013-07-02 | Abbott Diabetes Care Inc. | Analyte measurement devices and systems, and components and methods related thereto |
US7896703B2 (en) * | 2008-07-17 | 2011-03-01 | Abbott Diabetes Care Inc. | Strip connectors for measurement devices |
WO2010011851A1 (en) * | 2008-07-23 | 2010-01-28 | Cleveland State University | An electrode, an electrochemical device and method thereof |
USD611489S1 (en) | 2008-07-25 | 2010-03-09 | Lifescan, Inc. | User interface display for a glucose meter |
US8622988B2 (en) | 2008-08-31 | 2014-01-07 | Abbott Diabetes Care Inc. | Variable rate closed loop control and methods |
US9943644B2 (en) | 2008-08-31 | 2018-04-17 | Abbott Diabetes Care Inc. | Closed loop control with reference measurement and methods thereof |
US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
US20100057040A1 (en) | 2008-08-31 | 2010-03-04 | Abbott Diabetes Care, Inc. | Robust Closed Loop Control And Methods |
US8560039B2 (en) | 2008-09-19 | 2013-10-15 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
USD611372S1 (en) * | 2008-09-19 | 2010-03-09 | Lifescan Scotland Limited | Analyte test meter |
US20100082364A1 (en) * | 2008-09-30 | 2010-04-01 | Abbott Diabetes Care, Inc. | Medical Information Management |
US8986208B2 (en) | 2008-09-30 | 2015-03-24 | Abbott Diabetes Care Inc. | Analyte sensor sensitivity attenuation mitigation |
US8424763B2 (en) * | 2008-10-07 | 2013-04-23 | Bayer Healthcare Llc | Method of forming an auto-calibration circuit or label |
US8203929B2 (en) | 2008-10-09 | 2012-06-19 | Sony Corporation | Frame and data pattern structure for multi-carrier systems |
US9326707B2 (en) | 2008-11-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US8560082B2 (en) | 2009-01-30 | 2013-10-15 | Abbott Diabetes Care Inc. | Computerized determination of insulin pump therapy parameters using real time and retrospective data processing |
US20100198196A1 (en) * | 2009-01-30 | 2010-08-05 | Abbott Diabetes Care, Inc. | Therapy Delivery Device Programming Tool |
DK3912551T3 (en) * | 2009-02-26 | 2023-10-30 | Abbott Diabetes Care Inc | Procedure for calibrating an analyte sensor |
WO2010111660A1 (en) | 2009-03-27 | 2010-09-30 | Dexcom, Inc. | Methods and systems for promoting glucose management |
WO2010114942A1 (en) * | 2009-03-31 | 2010-10-07 | Abbott Diabetes Care Inc. | Precise fluid dispensing method and device |
US8497777B2 (en) | 2009-04-15 | 2013-07-30 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
EP2419015A4 (en) | 2009-04-16 | 2014-08-20 | Abbott Diabetes Care Inc | Analyte sensor calibration management |
US20100274515A1 (en) * | 2009-04-28 | 2010-10-28 | Abbott Diabetes Care Inc. | Dynamic Analyte Sensor Calibration Based On Sensor Stability Profile |
WO2010127050A1 (en) | 2009-04-28 | 2010-11-04 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
US8467972B2 (en) | 2009-04-28 | 2013-06-18 | Abbott Diabetes Care Inc. | Closed loop blood glucose control algorithm analysis |
EP2425209A4 (en) | 2009-04-29 | 2013-01-09 | Abbott Diabetes Care Inc | Method and system for providing real time analyte sensor calibration with retrospective backfill |
WO2010127187A1 (en) | 2009-04-29 | 2010-11-04 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8613892B2 (en) | 2009-06-30 | 2013-12-24 | Abbott Diabetes Care Inc. | Analyte meter with a moveable head and methods of using the same |
US9351677B2 (en) | 2009-07-02 | 2016-05-31 | Dexcom, Inc. | Analyte sensor with increased reference capacity |
WO2011003035A2 (en) * | 2009-07-02 | 2011-01-06 | Dexcom, Inc. | Analyte sensor |
US8408900B2 (en) * | 2009-07-08 | 2013-04-02 | Triune Ip Llc | Electrochemical dispensing apparatus and method |
US8344847B2 (en) | 2009-07-09 | 2013-01-01 | Medtronic Minimed, Inc. | Coordination of control commands in a medical device system having at least one therapy delivery device and at least one wireless controller device |
WO2011011739A2 (en) | 2009-07-23 | 2011-01-27 | Abbott Diabetes Care Inc. | Real time management of data relating to physiological control of glucose levels |
LT3689237T (en) | 2009-07-23 | 2021-09-27 | Abbott Diabetes Care, Inc. | Method of manufacturing and system for continuous analyte measurement |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
DK3988470T3 (en) | 2009-08-31 | 2023-08-28 | Abbott Diabetes Care Inc | Display devices for a medical device |
EP2473099A4 (en) | 2009-08-31 | 2015-01-14 | Abbott Diabetes Care Inc | Analyte monitoring system and methods for managing power and noise |
US20110106126A1 (en) * | 2009-08-31 | 2011-05-05 | Michael Love | Inserter device including rotor subassembly |
US8487758B2 (en) | 2009-09-02 | 2013-07-16 | Medtronic Minimed, Inc. | Medical device having an intelligent alerting scheme, and related operating methods |
US8631679B2 (en) * | 2009-09-04 | 2014-01-21 | Isense Corporation | Additional calibration for analyte monitor |
WO2011041469A1 (en) | 2009-09-29 | 2011-04-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
WO2011044386A1 (en) * | 2009-10-07 | 2011-04-14 | Abbott Diabetes Care Inc. | Sensor inserter assembly having rotatable trigger |
US8185181B2 (en) | 2009-10-30 | 2012-05-22 | Abbott Diabetes Care Inc. | Method and apparatus for detecting false hypoglycemic conditions |
US8386042B2 (en) | 2009-11-03 | 2013-02-26 | Medtronic Minimed, Inc. | Omnidirectional accelerometer device and medical device incorporating same |
EP2335565A1 (en) * | 2009-12-18 | 2011-06-22 | Roche Diagnostics GmbH | Protective container for holding reusable diagnostic components |
US8574201B2 (en) | 2009-12-22 | 2013-11-05 | Medtronic Minimed, Inc. | Syringe piston with check valve seal |
US8755269B2 (en) | 2009-12-23 | 2014-06-17 | Medtronic Minimed, Inc. | Ranking and switching of wireless channels in a body area network of medical devices |
US20110184258A1 (en) * | 2010-01-28 | 2011-07-28 | Abbott Diabetes Care Inc. | Balloon Catheter Analyte Measurement Sensors and Methods for Using the Same |
USD924406S1 (en) | 2010-02-01 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
KR101100987B1 (en) * | 2010-03-23 | 2011-12-30 | 삼성모바일디스플레이주식회사 | Touch Screen Panel |
JP5904500B2 (en) | 2010-03-24 | 2016-04-13 | アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. | Apparatus and system for inserting sharp member under skin surface |
CN102255696B (en) | 2010-04-07 | 2016-03-30 | 华为技术有限公司 | A kind of method of transmitting uplink control information, subscriber equipment and base station |
US9351654B2 (en) | 2010-06-08 | 2016-05-31 | Alivecor, Inc. | Two electrode apparatus and methods for twelve lead ECG |
US8509882B2 (en) | 2010-06-08 | 2013-08-13 | Alivecor, Inc. | Heart monitoring system usable with a smartphone or computer |
US8635046B2 (en) | 2010-06-23 | 2014-01-21 | Abbott Diabetes Care Inc. | Method and system for evaluating analyte sensor response characteristics |
WO2011163519A2 (en) | 2010-06-25 | 2011-12-29 | Dexcom, Inc. | Systems and methods for communicating sensor data between communication devices |
US10092229B2 (en) | 2010-06-29 | 2018-10-09 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
US11064921B2 (en) | 2010-06-29 | 2021-07-20 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
EP3632308B1 (en) | 2010-09-29 | 2023-12-06 | Dexcom, Inc. | Advanced continuous analyte monitoring system |
JP2012075707A (en) * | 2010-10-01 | 2012-04-19 | Koden Kk | Blood component analyzer |
US11213226B2 (en) | 2010-10-07 | 2022-01-04 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods |
US8603032B2 (en) | 2010-10-15 | 2013-12-10 | Medtronic Minimed, Inc. | Medical device with membrane keypad sealing element, and related manufacturing method |
US8562565B2 (en) | 2010-10-15 | 2013-10-22 | Medtronic Minimed, Inc. | Battery shock absorber for a portable medical device |
US8603033B2 (en) | 2010-10-15 | 2013-12-10 | Medtronic Minimed, Inc. | Medical device and related assembly having an offset element for a piezoelectric speaker |
US8474332B2 (en) | 2010-10-20 | 2013-07-02 | Medtronic Minimed, Inc. | Sensor assembly and medical device incorporating same |
US8479595B2 (en) | 2010-10-20 | 2013-07-09 | Medtronic Minimed, Inc. | Sensor assembly and medical device incorporating same |
US8495918B2 (en) | 2010-10-20 | 2013-07-30 | Medtronic Minimed, Inc. | Sensor assembly and medical device incorporating same |
US9241631B2 (en) | 2010-10-27 | 2016-01-26 | Dexcom, Inc. | Continuous analyte monitor data recording device operable in a blinded mode |
US9713440B2 (en) | 2010-12-08 | 2017-07-25 | Abbott Diabetes Care Inc. | Modular analyte measurement systems, modular components thereof and related methods |
US8628510B2 (en) | 2010-12-22 | 2014-01-14 | Medtronic Minimed, Inc. | Monitoring the operating health of a force sensor in a fluid infusion device |
US8690855B2 (en) * | 2010-12-22 | 2014-04-08 | Medtronic Minimed, Inc. | Fluid reservoir seating procedure for a fluid infusion device |
US8469942B2 (en) | 2010-12-22 | 2013-06-25 | Medtronic Minimed, Inc. | Occlusion detection for a fluid infusion device |
US8197444B1 (en) | 2010-12-22 | 2012-06-12 | Medtronic Minimed, Inc. | Monitoring the seating status of a fluid reservoir in a fluid infusion device |
US9393399B2 (en) | 2011-02-22 | 2016-07-19 | Medtronic Minimed, Inc. | Sealing assembly for a fluid reservoir of a fluid infusion device |
US9283318B2 (en) | 2011-02-22 | 2016-03-15 | Medtronic Minimed, Inc. | Flanged sealing element and needle guide pin assembly for a fluid infusion device having a needled fluid reservoir |
US9463309B2 (en) | 2011-02-22 | 2016-10-11 | Medtronic Minimed, Inc. | Sealing assembly and structure for a fluid infusion device having a needled fluid reservoir |
US20120211946A1 (en) | 2011-02-22 | 2012-08-23 | Medtronic Minimed, Inc. | Sealing element for a hollow needle of a fluid infusion device |
US8614596B2 (en) | 2011-02-28 | 2013-12-24 | Medtronic Minimed, Inc. | Systems and methods for initializing a voltage bus and medical devices incorporating same |
EP2680754B1 (en) | 2011-02-28 | 2019-04-24 | Abbott Diabetes Care, Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US9101305B2 (en) | 2011-03-09 | 2015-08-11 | Medtronic Minimed, Inc. | Glucose sensor product and related manufacturing and packaging methods |
US9018893B2 (en) | 2011-03-18 | 2015-04-28 | Medtronic Minimed, Inc. | Power control techniques for an electronic device |
US8564447B2 (en) | 2011-03-18 | 2013-10-22 | Medtronic Minimed, Inc. | Battery life indication techniques for an electronic device |
US9028410B2 (en) | 2011-04-08 | 2015-05-12 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
DK3575796T3 (en) | 2011-04-15 | 2021-01-18 | Dexcom Inc | ADVANCED ANALYZE SENSOR CALIBRATION AND ERROR DETECTION |
WO2013016573A1 (en) * | 2011-07-26 | 2013-01-31 | Glysens Incorporated | Tissue implantable sensor with hermetically sealed housing |
WO2013022775A1 (en) | 2011-08-05 | 2013-02-14 | Dexcom, Inc. | Systems and methods for detecting glucose level data patterns |
EP3505064B8 (en) | 2011-09-23 | 2020-08-12 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
USD680454S1 (en) | 2011-10-25 | 2013-04-23 | Abbott Diabetes Care Inc. | Analyte meter and strip port |
US9069536B2 (en) | 2011-10-31 | 2015-06-30 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
US9622691B2 (en) | 2011-10-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
WO2013070794A2 (en) | 2011-11-07 | 2013-05-16 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US8710993B2 (en) | 2011-11-23 | 2014-04-29 | Abbott Diabetes Care Inc. | Mitigating single point failure of devices in an analyte monitoring system and methods thereof |
US9317656B2 (en) | 2011-11-23 | 2016-04-19 | Abbott Diabetes Care Inc. | Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof |
WO2013078426A2 (en) | 2011-11-25 | 2013-05-30 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
US20140311227A1 (en) * | 2011-12-01 | 2014-10-23 | Modz Oy | Portable device for measuring blood samples |
US9402570B2 (en) | 2011-12-11 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
US9610401B2 (en) | 2012-01-13 | 2017-04-04 | Medtronic Minimed, Inc. | Infusion set component with modular fluid channel element |
WO2013138369A1 (en) | 2012-03-16 | 2013-09-19 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US8603026B2 (en) | 2012-03-20 | 2013-12-10 | Medtronic Minimed, Inc. | Dynamic pulse-width modulation motor control and medical device incorporating same |
US8523803B1 (en) | 2012-03-20 | 2013-09-03 | Medtronic Minimed, Inc. | Motor health monitoring and medical device incorporating same |
US8603027B2 (en) | 2012-03-20 | 2013-12-10 | Medtronic Minimed, Inc. | Occlusion detection using pulse-width modulation and medical device incorporating same |
US20130267812A1 (en) | 2012-04-04 | 2013-10-10 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US20130325352A1 (en) | 2012-06-05 | 2013-12-05 | Dexcom, Inc. | Calculation engine based on histograms |
US20130338630A1 (en) | 2012-06-07 | 2013-12-19 | Medtronic Minimed, Inc. | Diabetes therapy management system for recommending adjustments to an insulin infusion device |
US9333292B2 (en) | 2012-06-26 | 2016-05-10 | Medtronic Minimed, Inc. | Mechanically actuated fluid infusion device |
US10881339B2 (en) | 2012-06-29 | 2021-01-05 | Dexcom, Inc. | Use of sensor redundancy to detect sensor failures |
US10598627B2 (en) | 2012-06-29 | 2020-03-24 | Dexcom, Inc. | Devices, systems, and methods to compensate for effects of temperature on implantable sensors |
US20140012511A1 (en) | 2012-07-09 | 2014-01-09 | Dexcom, Inc. | Systems and methods for leveraging smartphone features in continuous glucose monitoring |
US10561353B2 (en) | 2016-06-01 | 2020-02-18 | Glysens Incorporated | Biocompatible implantable sensor apparatus and methods |
US10660550B2 (en) | 2015-12-29 | 2020-05-26 | Glysens Incorporated | Implantable sensor apparatus and methods |
US8808269B2 (en) | 2012-08-21 | 2014-08-19 | Medtronic Minimed, Inc. | Reservoir plunger position monitoring and medical device incorporating same |
US9662445B2 (en) | 2012-08-30 | 2017-05-30 | Medtronic Minimed, Inc. | Regulating entry into a closed-loop operating mode of an insulin infusion system |
US9623179B2 (en) | 2012-08-30 | 2017-04-18 | Medtronic Minimed, Inc. | Safeguarding techniques for a closed-loop insulin infusion system |
US9878096B2 (en) | 2012-08-30 | 2018-01-30 | Medtronic Minimed, Inc. | Generation of target glucose values for a closed-loop operating mode of an insulin infusion system |
EP2890297B1 (en) | 2012-08-30 | 2018-04-11 | Abbott Diabetes Care, Inc. | Dropout detection in continuous analyte monitoring data during data excursions |
US10496797B2 (en) | 2012-08-30 | 2019-12-03 | Medtronic Minimed, Inc. | Blood glucose validation for a closed-loop operating mode of an insulin infusion system |
US20140066884A1 (en) | 2012-08-30 | 2014-03-06 | Medtronic Minimed, Inc. | Sensor model supervisor for a closed-loop insulin infusion system |
US9849239B2 (en) | 2012-08-30 | 2017-12-26 | Medtronic Minimed, Inc. | Generation and application of an insulin limit for a closed-loop operating mode of an insulin infusion system |
US10130767B2 (en) | 2012-08-30 | 2018-11-20 | Medtronic Minimed, Inc. | Sensor model supervisor for a closed-loop insulin infusion system |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
EP2901153A4 (en) | 2012-09-26 | 2016-04-27 | Abbott Diabetes Care Inc | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
US9788765B2 (en) | 2012-09-28 | 2017-10-17 | Dexcom, Inc. | Zwitterion surface modifications for continuous sensors |
US20140129151A1 (en) | 2012-11-07 | 2014-05-08 | Dexcom, Inc. | Systems and methods for managing glycemic variability |
WO2014074913A1 (en) | 2012-11-08 | 2014-05-15 | Alivecor, Inc. | Electrocardiogram signal detection |
US8870818B2 (en) | 2012-11-15 | 2014-10-28 | Medtronic Minimed, Inc. | Systems and methods for alignment and detection of a consumable component |
US9730621B2 (en) | 2012-12-31 | 2017-08-15 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US9801541B2 (en) | 2012-12-31 | 2017-10-31 | Dexcom, Inc. | Remote monitoring of analyte measurements |
WO2014107700A1 (en) | 2013-01-07 | 2014-07-10 | Alivecor, Inc. | Methods and systems for electrode placement |
US9107994B2 (en) | 2013-01-18 | 2015-08-18 | Medtronic Minimed, Inc. | Systems for fluid reservoir retention |
US9522223B2 (en) | 2013-01-18 | 2016-12-20 | Medtronic Minimed, Inc. | Systems for fluid reservoir retention |
US9033924B2 (en) | 2013-01-18 | 2015-05-19 | Medtronic Minimed, Inc. | Systems for fluid reservoir retention |
US9308321B2 (en) | 2013-02-18 | 2016-04-12 | Medtronic Minimed, Inc. | Infusion device having gear assembly initialization |
US8895316B2 (en) | 2013-03-12 | 2014-11-25 | Roche Diagnostics Operations, Inc. | Transferring blood glucose measures seamlessly from a handheld glucose meter |
WO2014158405A2 (en) | 2013-03-14 | 2014-10-02 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
US9445445B2 (en) | 2013-03-14 | 2016-09-13 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
CA2904031A1 (en) | 2013-03-14 | 2014-10-02 | Profusa, Inc. | Method and device for correcting optical signals |
US10335075B2 (en) | 2013-03-14 | 2019-07-02 | Dexcom, Inc. | Advanced calibration for analyte sensors |
US9254092B2 (en) | 2013-03-15 | 2016-02-09 | Alivecor, Inc. | Systems and methods for processing and analyzing medical data |
US10433773B1 (en) | 2013-03-15 | 2019-10-08 | Abbott Diabetes Care Inc. | Noise rejection methods and apparatus for sparsely sampled analyte sensor data |
US9474475B1 (en) | 2013-03-15 | 2016-10-25 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
US10076285B2 (en) | 2013-03-15 | 2018-09-18 | Abbott Diabetes Care Inc. | Sensor fault detection using analyte sensor data pattern comparison |
US8920381B2 (en) | 2013-04-12 | 2014-12-30 | Medtronic Minimed, Inc. | Infusion set with improved bore configuration |
CN105307559B (en) | 2013-06-06 | 2020-06-05 | 普罗菲尤萨股份有限公司 | Apparatus and method for detecting optical signals from implanted sensors |
US9247911B2 (en) | 2013-07-10 | 2016-02-02 | Alivecor, Inc. | Devices and methods for real-time denoising of electrocardiograms |
AU2014290745A1 (en) | 2013-07-19 | 2015-12-17 | Dexcom, Inc. | Time averaged basal rate optimizer |
US9433731B2 (en) | 2013-07-19 | 2016-09-06 | Medtronic Minimed, Inc. | Detecting unintentional motor motion and infusion device incorporating same |
US9402949B2 (en) | 2013-08-13 | 2016-08-02 | Medtronic Minimed, Inc. | Detecting conditions associated with medical device operations using matched filters |
US9880528B2 (en) | 2013-08-21 | 2018-01-30 | Medtronic Minimed, Inc. | Medical devices and related updating methods and systems |
US9889257B2 (en) | 2013-08-21 | 2018-02-13 | Medtronic Minimed, Inc. | Systems and methods for updating medical devices |
US9259528B2 (en) | 2013-08-22 | 2016-02-16 | Medtronic Minimed, Inc. | Fluid infusion device with safety coupling |
US9974469B2 (en) | 2013-11-07 | 2018-05-22 | Dexcom, Inc. | Systems and methods for a continuous monitoring of analyte values |
US9750877B2 (en) | 2013-12-11 | 2017-09-05 | Medtronic Minimed, Inc. | Predicted time to assess and/or control a glycemic state |
US9750878B2 (en) | 2013-12-11 | 2017-09-05 | Medtronic Minimed, Inc. | Closed-loop control of glucose according to a predicted blood glucose trajectory |
US9420956B2 (en) | 2013-12-12 | 2016-08-23 | Alivecor, Inc. | Methods and systems for arrhythmia tracking and scoring |
US10105488B2 (en) | 2013-12-12 | 2018-10-23 | Medtronic Minimed, Inc. | Predictive infusion device operations and related methods and systems |
US9849240B2 (en) | 2013-12-12 | 2017-12-26 | Medtronic Minimed, Inc. | Data modification for predictive operations and devices incorporating same |
CN105705078B (en) | 2013-12-16 | 2022-03-15 | 德克斯康公司 | Systems and methods for monitoring and managing the life of a battery in an analyte sensor system worn by a user |
US9694132B2 (en) | 2013-12-19 | 2017-07-04 | Medtronic Minimed, Inc. | Insertion device for insertion set |
US11229382B2 (en) | 2013-12-31 | 2022-01-25 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
US9861748B2 (en) | 2014-02-06 | 2018-01-09 | Medtronic Minimed, Inc. | User-configurable closed-loop notifications and infusion systems incorporating same |
US9399096B2 (en) | 2014-02-06 | 2016-07-26 | Medtronic Minimed, Inc. | Automatic closed-loop control adjustments and infusion systems incorporating same |
US9987422B2 (en) | 2014-03-24 | 2018-06-05 | Medtronic Minimed, Inc. | Fluid infusion patch pump device with automatic startup feature |
EP3865063A1 (en) | 2014-03-30 | 2021-08-18 | Abbott Diabetes Care, Inc. | Method and apparatus for determining meal start and peak events in analyte monitoring systems |
WO2015156966A1 (en) | 2014-04-10 | 2015-10-15 | Dexcom, Inc. | Sensors for continuous analyte monitoring, and related methods |
US10001450B2 (en) | 2014-04-18 | 2018-06-19 | Medtronic Minimed, Inc. | Nonlinear mapping technique for a physiological characteristic sensor |
US10232113B2 (en) | 2014-04-24 | 2019-03-19 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for regulating insulin on board |
US9681828B2 (en) | 2014-05-01 | 2017-06-20 | Medtronic Minimed, Inc. | Physiological characteristic sensors and methods for forming such sensors |
US10275572B2 (en) | 2014-05-01 | 2019-04-30 | Medtronic Minimed, Inc. | Detecting blockage of a reservoir cavity during a seating operation of a fluid infusion device |
US10152049B2 (en) | 2014-05-19 | 2018-12-11 | Medtronic Minimed, Inc. | Glucose sensor health monitoring and related methods and systems |
US10274349B2 (en) | 2014-05-19 | 2019-04-30 | Medtronic Minimed, Inc. | Calibration factor adjustments for infusion devices and related methods and systems |
US10007765B2 (en) | 2014-05-19 | 2018-06-26 | Medtronic Minimed, Inc. | Adaptive signal processing for infusion devices and related methods and systems |
US9833563B2 (en) | 2014-09-26 | 2017-12-05 | Medtronic Minimed, Inc. | Systems for managing reservoir chamber pressure |
US9839753B2 (en) | 2014-09-26 | 2017-12-12 | Medtronic Minimed, Inc. | Systems for managing reservoir chamber pressure |
US10279126B2 (en) | 2014-10-07 | 2019-05-07 | Medtronic Minimed, Inc. | Fluid conduit assembly with gas trapping filter in the fluid flow path |
US9833564B2 (en) | 2014-11-25 | 2017-12-05 | Medtronic Minimed, Inc. | Fluid conduit assembly with air venting features |
US9987420B2 (en) | 2014-11-26 | 2018-06-05 | Medtronic Minimed, Inc. | Systems and methods for fluid infusion device with automatic reservoir fill |
US10195341B2 (en) | 2014-11-26 | 2019-02-05 | Medtronic Minimed, Inc. | Systems and methods for fluid infusion device with automatic reservoir fill |
US9636453B2 (en) | 2014-12-04 | 2017-05-02 | Medtronic Minimed, Inc. | Advance diagnosis of infusion device operating mode viability |
US9943645B2 (en) | 2014-12-04 | 2018-04-17 | Medtronic Minimed, Inc. | Methods for operating mode transitions and related infusion devices and systems |
US9937292B2 (en) | 2014-12-09 | 2018-04-10 | Medtronic Minimed, Inc. | Systems for filling a fluid infusion device reservoir |
US10307535B2 (en) | 2014-12-19 | 2019-06-04 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for preemptive alerting |
US10265031B2 (en) | 2014-12-19 | 2019-04-23 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for automatic alert clearing |
US10307528B2 (en) | 2015-03-09 | 2019-06-04 | Medtronic Minimed, Inc. | Extensible infusion devices and related methods |
US10449298B2 (en) | 2015-03-26 | 2019-10-22 | Medtronic Minimed, Inc. | Fluid injection devices and related methods |
DE102015107563A1 (en) * | 2015-05-13 | 2016-11-17 | Endress+Hauser Conducta Gmbh+Co. Kg | Method for commissioning a sensor, computer program product, computer-readable data carrier and sensor |
EP3282933B1 (en) | 2015-05-13 | 2020-07-08 | Alivecor, Inc. | Discordance monitoring |
US10674944B2 (en) | 2015-05-14 | 2020-06-09 | Abbott Diabetes Care Inc. | Compact medical device inserters and related systems and methods |
US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
US9999721B2 (en) | 2015-05-26 | 2018-06-19 | Medtronic Minimed, Inc. | Error handling in infusion devices with distributed motor control and related operating methods |
US10137243B2 (en) | 2015-05-26 | 2018-11-27 | Medtronic Minimed, Inc. | Infusion devices with distributed motor control and related operating methods |
US10575767B2 (en) | 2015-05-29 | 2020-03-03 | Medtronic Minimed, Inc. | Method for monitoring an analyte, analyte sensor and analyte monitoring apparatus |
US10010668B2 (en) | 2015-06-22 | 2018-07-03 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and a force sensor |
US9878095B2 (en) | 2015-06-22 | 2018-01-30 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and multiple sensor contact elements |
US9993594B2 (en) | 2015-06-22 | 2018-06-12 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and rotor position sensors |
US9879668B2 (en) | 2015-06-22 | 2018-01-30 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and an optical sensor |
US9987425B2 (en) | 2015-06-22 | 2018-06-05 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and sensor contact elements |
CN113349766A (en) | 2015-07-10 | 2021-09-07 | 雅培糖尿病护理公司 | System, device and method for dynamic glucose curve response to physiological parameters |
US10293108B2 (en) | 2015-08-21 | 2019-05-21 | Medtronic Minimed, Inc. | Infusion devices and related patient ratio adjustment methods |
US10463297B2 (en) | 2015-08-21 | 2019-11-05 | Medtronic Minimed, Inc. | Personalized event detection methods and related devices and systems |
US10201657B2 (en) | 2015-08-21 | 2019-02-12 | Medtronic Minimed, Inc. | Methods for providing sensor site rotation feedback and related infusion devices and systems |
US10543314B2 (en) | 2015-08-21 | 2020-01-28 | Medtronic Minimed, Inc. | Personalized parameter modeling with signal calibration based on historical data |
US20170053552A1 (en) | 2015-08-21 | 2017-02-23 | Medtronic Minimed, Inc. | Management and prioritization of the delivery of glycemic insight messages |
US10117992B2 (en) | 2015-09-29 | 2018-11-06 | Medtronic Minimed, Inc. | Infusion devices and related rescue detection methods |
US11666702B2 (en) | 2015-10-19 | 2023-06-06 | Medtronic Minimed, Inc. | Medical devices and related event pattern treatment recommendation methods |
US11501867B2 (en) | 2015-10-19 | 2022-11-15 | Medtronic Minimed, Inc. | Medical devices and related event pattern presentation methods |
US20170112534A1 (en) | 2015-10-21 | 2017-04-27 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US10146911B2 (en) | 2015-10-23 | 2018-12-04 | Medtronic Minimed, Inc. | Medical devices and related methods and systems for data transfer |
US10037722B2 (en) | 2015-11-03 | 2018-07-31 | Medtronic Minimed, Inc. | Detecting breakage in a display element |
US10449306B2 (en) | 2015-11-25 | 2019-10-22 | Medtronics Minimed, Inc. | Systems for fluid delivery with wicking membrane |
US10231655B2 (en) | 2015-12-21 | 2019-03-19 | Dexcom, Inc. | Continuous analyte monitoring system power conservation |
AU2016380858B2 (en) | 2015-12-28 | 2019-08-08 | Dexcom, Inc. | Systems and methods for remote and host monitoring communications |
EP3397141B1 (en) | 2015-12-28 | 2022-01-26 | Dexcom, Inc. | Intelligent wireless communications for continuous analyte monitoring |
WO2017117472A1 (en) | 2015-12-30 | 2017-07-06 | Dexcom, Inc. | Biointerface layer for analyte sensors |
US11375932B2 (en) | 2015-12-30 | 2022-07-05 | Dexcom, Inc. | Transcutaneous analyte sensor systems and methods |
AU2017240490B2 (en) | 2016-03-30 | 2019-12-05 | Dexcom, Inc. | Systems, devices and methods for analyte monitoring system |
US10596318B2 (en) | 2016-03-31 | 2020-03-24 | Dexcom, Inc. | Systems and methods for inter-app communications |
ES2837390T3 (en) | 2016-03-31 | 2021-06-30 | Dexcom Inc | Analyte monitoring system |
US10589038B2 (en) | 2016-04-27 | 2020-03-17 | Medtronic Minimed, Inc. | Set connector systems for venting a fluid reservoir |
US10638962B2 (en) * | 2016-06-29 | 2020-05-05 | Glysens Incorporated | Bio-adaptable implantable sensor apparatus and methods |
WO2018017484A1 (en) | 2016-07-20 | 2018-01-25 | Dexcom, Inc. | System and method for wireless communication of glucose data |
WO2018031803A1 (en) | 2016-08-12 | 2018-02-15 | Dexcom, Inc. | Systems and methods for health data visualization and user support tools for continuous glucose monitoring |
US11222724B2 (en) | 2016-09-09 | 2022-01-11 | Dexcom, Inc. | Systems and methods for CGM-based bolus calculator for display and for provision to medicament delivery devices |
US11032855B2 (en) | 2016-10-18 | 2021-06-08 | Dexcom, Inc. | System and method for communication of analyte data |
EP3528705B1 (en) | 2016-10-18 | 2021-05-26 | Dexcom, Inc. | A method for wireless communication of glucose data |
US11097051B2 (en) | 2016-11-04 | 2021-08-24 | Medtronic Minimed, Inc. | Methods and apparatus for detecting and reacting to insufficient hypoglycemia response |
WO2018089375A1 (en) | 2016-11-09 | 2018-05-17 | Dexcom, Inc. | Systems and methods for technical support of continuous analyte monitoring and sensor systems |
WO2023034934A1 (en) | 2021-09-03 | 2023-03-09 | Dexcom, Inc. | Systems and methods for technical support of continuous analyte monitoring and sensor systems |
US10238030B2 (en) | 2016-12-06 | 2019-03-26 | Medtronic Minimed, Inc. | Wireless medical device with a complementary split ring resonator arrangement for suppression of electromagnetic interference |
US10272201B2 (en) | 2016-12-22 | 2019-04-30 | Medtronic Minimed, Inc. | Insertion site monitoring methods and related infusion devices and systems |
EP3563224B1 (en) | 2016-12-27 | 2023-12-20 | Dexcom, Inc. | Systems and methods for patient monitoring using an hcp - specific device |
US11071478B2 (en) | 2017-01-23 | 2021-07-27 | Abbott Diabetes Care Inc. | Systems, devices and methods for analyte sensor insertion |
US10532165B2 (en) | 2017-01-30 | 2020-01-14 | Medtronic Minimed, Inc. | Fluid reservoir and systems for filling a fluid reservoir of a fluid infusion device |
US10500135B2 (en) | 2017-01-30 | 2019-12-10 | Medtronic Minimed, Inc. | Fluid reservoir and systems for filling a fluid reservoir of a fluid infusion device |
US10552580B2 (en) | 2017-02-07 | 2020-02-04 | Medtronic Minimed, Inc. | Infusion system consumables and related calibration methods |
US10363365B2 (en) | 2017-02-07 | 2019-07-30 | Medtronic Minimed, Inc. | Infusion devices and related consumable calibration methods |
US10646649B2 (en) | 2017-02-21 | 2020-05-12 | Medtronic Minimed, Inc. | Infusion devices and fluid identification apparatuses and methods |
US11207463B2 (en) | 2017-02-21 | 2021-12-28 | Medtronic Minimed, Inc. | Apparatuses, systems, and methods for identifying an infusate in a reservoir of an infusion device |
EP3600014A4 (en) | 2017-03-21 | 2020-10-21 | Abbott Diabetes Care Inc. | Methods, devices and system for providing diabetic condition diagnosis and therapy |
JP2020524035A (en) | 2017-06-19 | 2020-08-13 | デックスコム・インコーポレーテッド | Applicator for applying a transdermal analyte sensor, and related manufacturing method |
EP4154800A1 (en) | 2017-06-23 | 2023-03-29 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US10638979B2 (en) | 2017-07-10 | 2020-05-05 | Glysens Incorporated | Analyte sensor data evaluation and error reduction apparatus and methods |
US20190094233A1 (en) | 2017-09-26 | 2019-03-28 | Senseonics, Incorporated | Methods and systems for weighting calibration points and updating lag parameters |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
AU2018354120A1 (en) | 2017-10-24 | 2020-04-23 | Dexcom, Inc. | Pre-connected analyte sensors |
DE202018006860U1 (en) | 2017-10-30 | 2023-11-20 | Dexcom, Inc. | Diabetes management partner interface for wireless transmission of analyte data |
US11278668B2 (en) | 2017-12-22 | 2022-03-22 | Glysens Incorporated | Analyte sensor and medicant delivery data evaluation and error reduction apparatus and methods |
US11255839B2 (en) | 2018-01-04 | 2022-02-22 | Glysens Incorporated | Apparatus and methods for analyte sensor mismatch correction |
GB201805263D0 (en) * | 2018-03-29 | 2018-05-16 | Nicoventures Trading Ltd | Apparatus for generating aerosol from an aerosolisable medium, an article of aerosolisable medium and a method of operating an aerosol generating apparatus |
CN112020327A (en) | 2018-05-03 | 2020-12-01 | 德克斯康公司 | System and method for activating analyte sensor electronics |
US11457843B2 (en) | 2018-08-03 | 2022-10-04 | Dexcom, Inc. | Systems and methods for communication with analyte sensor electronics |
CA3142233A1 (en) | 2019-05-29 | 2020-12-03 | Dexcom, Inc. | System and method for wireless communication of analyte data |
USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
US11449577B2 (en) | 2019-11-20 | 2022-09-20 | Micron Technology, Inc. | Methods and apparatus for performing video processing matrix operations within a memory array |
US11853385B2 (en) | 2019-12-05 | 2023-12-26 | Micron Technology, Inc. | Methods and apparatus for performing diversity matrix operations within a memory array |
USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
CN117015340A (en) | 2021-02-11 | 2023-11-07 | 德克斯康公司 | Network physical layer configuration for mobile physiological parameter monitoring and therapeutic intervention systems |
AU2022258973A1 (en) | 2021-04-15 | 2023-11-09 | Dexcom, Inc. | Global configuration service |
US11319810B1 (en) | 2021-06-23 | 2022-05-03 | China University Of Geosciences (Wuhan) | Monitoring device for deformation of locked patch crack of rock slope and arrangement method |
WO2023044293A1 (en) | 2021-09-14 | 2023-03-23 | Dexcom, Inc. | Machine learning techniques for optimized communication with users of a software application |
US20230126810A1 (en) | 2021-10-22 | 2023-04-27 | Dexcom, Inc. | Proximity-based data access authentication and authorization in an analyte monitoring system |
WO2023081588A1 (en) | 2021-11-04 | 2023-05-11 | Dexcom, Inc. | Wireless setup and security of a continuous analyte sensor system deployed in healthcare infrastructure |
WO2023147389A1 (en) | 2022-01-27 | 2023-08-03 | Dexcom, Inc. | System and method for activating an analyte monitoring system |
US20230263434A1 (en) | 2022-02-23 | 2023-08-24 | Dexcom, Inc. | Sensing systems and methods for providing decision support around kidney health and/or diabetes |
WO2023178218A1 (en) | 2022-03-16 | 2023-09-21 | Dexcom, Inc. | Proximity pairing and security of a continuous analyte sensor system |
US20230390466A1 (en) | 2022-06-01 | 2023-12-07 | Dexcom, Inc. | Systems and methods for optimizing treatment using physiological profiles |
US20230397858A1 (en) | 2022-06-10 | 2023-12-14 | Dexcom, Inc. | Apparatuses, systems, and methods of controlling sensor deployment |
US20240022636A1 (en) | 2022-07-15 | 2024-01-18 | Dexcom, Inc. | Systems and methods for enhanced wireless communications between analyte sensor systems and display devices |
US20240074682A1 (en) | 2022-09-02 | 2024-03-07 | Dexcom, Inc. | Devices and methods for measuring a concentration of a target analyte in a biological fluid in vivo |
US20240090802A1 (en) | 2022-09-02 | 2024-03-21 | Dexcom, Inc. | Continuous analyte sensor devices and methods |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6424847B1 (en) * | 1999-02-25 | 2002-07-23 | Medtronic Minimed, Inc. | Glucose monitor calibration methods |
US6633772B2 (en) * | 2000-08-18 | 2003-10-14 | Cygnus, Inc. | Formulation and manipulation of databases of analyte and associated values |
Family Cites Families (655)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19852258A1 (en) | 1998-11-11 | 2000-05-18 | Agfa Gevaert Ag | Radiation-sensitive recording material for the production of waterless offset printing plates |
US2719797A (en) | 1950-05-23 | 1955-10-04 | Baker & Co Inc | Platinizing tantalum |
US3210578A (en) | 1962-01-12 | 1965-10-05 | Westinghouse Electric Corp | Multispeed motor connector |
BE629985A (en) | 1962-11-29 | |||
US3381371A (en) | 1965-09-27 | 1968-05-07 | Sanders Associates Inc | Method of constructing lightweight antenna |
US3553241A (en) * | 1968-10-09 | 1971-01-05 | Colgate Palmolive Co | Azacycloalkylferrocene |
USRE31916E (en) | 1970-11-10 | 1985-06-18 | Becton Dickinson & Company | Electrochemical detection cell |
GB1412983A (en) | 1971-11-30 | 1975-11-05 | Debell & Richardson | Method of producing porous plastic materials |
US3943918A (en) | 1971-12-02 | 1976-03-16 | Tel-Pac, Inc. | Disposable physiological telemetric device |
US3837339A (en) | 1972-02-03 | 1974-09-24 | Whittaker Corp | Blood glucose level monitoring-alarm system and method therefor |
US3775182A (en) | 1972-02-25 | 1973-11-27 | Du Pont | Tubular electrochemical cell with coiled electrodes and compressed central spindle |
US3780727A (en) | 1972-02-25 | 1973-12-25 | Hoffmann La Roche | Cardiac pacer monitoring means with rate and pulse discrimination |
GB1442303A (en) | 1972-09-08 | 1976-07-14 | Radiometer As | Cell for electro-chemical analysis |
CS164231B2 (en) | 1972-09-28 | 1975-11-07 | ||
US3929971A (en) | 1973-03-30 | 1975-12-30 | Research Corp | Porous biomaterials and method of making same |
US3826244A (en) | 1973-07-20 | 1974-07-30 | Us Health Education & Welfare | Thumbtack microelectrode and method of making same |
US3898984A (en) | 1974-02-04 | 1975-08-12 | Us Navy | Ambulatory patient monitoring system |
US3957613A (en) | 1974-11-01 | 1976-05-18 | General Electric Company | Miniature probe having multifunctional electrodes for sensing ions and gases |
US4245634A (en) * | 1975-01-22 | 1981-01-20 | Hospital For Sick Children | Artificial beta cell |
US4052754A (en) | 1975-08-14 | 1977-10-11 | Homsy Charles A | Implantable structure |
US3979274A (en) * | 1975-09-24 | 1976-09-07 | The Yellow Springs Instrument Company, Inc. | Membrane for enzyme electrodes |
CH591237A5 (en) | 1975-11-06 | 1977-09-15 | Bbc Brown Boveri & Cie | |
US4040908A (en) | 1976-03-12 | 1977-08-09 | Children's Hospital Medical Center | Polarographic analysis of cholesterol and other macromolecular substances |
US4024312A (en) | 1976-06-23 | 1977-05-17 | Johnson & Johnson | Pressure-sensitive adhesive tape having extensible and elastic backing composed of a block copolymer |
JPS5921500B2 (en) | 1978-01-28 | 1984-05-21 | 東洋紡績株式会社 | Enzyme membrane for oxygen electrode |
US4172770A (en) | 1978-03-27 | 1979-10-30 | Technicon Instruments Corporation | Flow-through electrochemical system analytical method |
US4259540A (en) | 1978-05-30 | 1981-03-31 | Bell Telephone Laboratories, Incorporated | Filled cables |
US4215703A (en) | 1978-08-29 | 1980-08-05 | Willson James K V | Variable stiffness guide wire |
US4240438A (en) | 1978-10-02 | 1980-12-23 | Wisconsin Alumni Research Foundation | Method for monitoring blood glucose levels and elements |
US4255500A (en) | 1979-03-29 | 1981-03-10 | General Electric Company | Vibration resistant electrochemical cell having deformed casing and method of making same |
US4253469A (en) | 1979-04-20 | 1981-03-03 | The Narda Microwave Corporation | Implantable temperature probe |
USRE32361E (en) | 1979-05-14 | 1987-02-24 | Medtronic, Inc. | Implantable telemetry transmission system for analog and digital data |
JPS5627643A (en) | 1979-08-14 | 1981-03-18 | Toshiba Corp | Electrochemical measuring device |
US4403984A (en) | 1979-12-28 | 1983-09-13 | Biotek, Inc. | System for demand-based adminstration of insulin |
SE419903B (en) * | 1980-03-05 | 1981-08-31 | Enfors Sven Olof | enzyme electrode |
JPS625174Y2 (en) | 1980-09-02 | 1987-02-05 | ||
US4436094A (en) | 1981-03-09 | 1984-03-13 | Evreka, Inc. | Monitor for continuous in vivo measurement of glucose concentration |
US4442841A (en) | 1981-04-30 | 1984-04-17 | Mitsubishi Rayon Company Limited | Electrode for living bodies |
US4431004A (en) | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
US4415666A (en) | 1981-11-05 | 1983-11-15 | Miles Laboratories, Inc. | Enzyme electrode membrane |
NL193256C (en) | 1981-11-10 | 1999-04-02 | Cordis Europ | Sensor system. |
US4454295A (en) | 1981-11-16 | 1984-06-12 | Uco Optics, Inc. | Cured cellulose ester, method of curing same, and use thereof |
US4494950A (en) | 1982-01-19 | 1985-01-22 | The Johns Hopkins University | Plural module medication delivery system |
EP0098592A3 (en) | 1982-07-06 | 1985-08-21 | Fujisawa Pharmaceutical Co., Ltd. | Portable artificial pancreas |
DE3228551A1 (en) | 1982-07-30 | 1984-02-02 | Siemens AG, 1000 Berlin und 8000 München | METHOD FOR DETERMINING SUGAR CONCENTRATION |
EP0107634B1 (en) | 1982-10-25 | 1989-04-12 | Lars Gustav Inge Hellgren | Enzyme composition for cleaning, the use thereof and preparation of the composition |
US5059654A (en) | 1983-02-14 | 1991-10-22 | Cuno Inc. | Affinity matrices of modified polysaccharide supports |
US4506680A (en) | 1983-03-17 | 1985-03-26 | Medtronic, Inc. | Drug dispensing body implantable lead |
US5682884A (en) | 1983-05-05 | 1997-11-04 | Medisense, Inc. | Strip electrode with screen printing |
CA1226036A (en) | 1983-05-05 | 1987-08-25 | Irving J. Higgins | Analytical equipment and sensor electrodes therefor |
WO1985000463A1 (en) | 1983-07-05 | 1985-01-31 | Matsushita Electric Industrial Co., Ltd. | Aluminum electrolytic capacitor and method of manufacture thereof |
US4535786A (en) | 1983-07-25 | 1985-08-20 | Kater John A R | Measurement of body fluid chemistry |
US4655880A (en) | 1983-08-01 | 1987-04-07 | Case Western Reserve University | Apparatus and method for sensing species, substances and substrates using oxidase |
US4554927A (en) | 1983-08-30 | 1985-11-26 | Thermometrics Inc. | Pressure and temperature sensor |
GB2149918A (en) | 1983-11-03 | 1985-06-19 | John Anderson | Sudden infant death syndrome monitor |
US4753652A (en) | 1984-05-04 | 1988-06-28 | Children's Medical Center Corporation | Biomaterial implants which resist calcification |
US4883057A (en) | 1984-05-09 | 1989-11-28 | Research Foundation, The City University Of New York | Cathodic electrochemical current arrangement with telemetric application |
US4583976A (en) | 1984-05-31 | 1986-04-22 | E. R. Squibb & Sons, Inc. | Catheter support |
US5030333A (en) | 1984-09-13 | 1991-07-09 | Children's Hospital Medical Center | Polarographic method for measuring both analyte and oxygen with the same detecting electrode of an electroenzymatic sensor |
US5235003A (en) | 1985-01-04 | 1993-08-10 | Thoratec Laboratories Corporation | Polysiloxane-polylactone block copolymers |
US4577642A (en) | 1985-02-27 | 1986-03-25 | Medtronic, Inc. | Drug dispensing body implantable lead employing molecular sieves and methods of fabrication |
US5279294A (en) * | 1985-04-08 | 1994-01-18 | Cascade Medical, Inc. | Medical diagnostic system |
US4787398A (en) | 1985-04-08 | 1988-11-29 | Garid, Inc. | Glucose medical monitoring system |
US4781798A (en) | 1985-04-19 | 1988-11-01 | The Regents Of The University Of California | Transparent multi-oxygen sensor array and method of using same |
US4671288A (en) | 1985-06-13 | 1987-06-09 | The Regents Of The University Of California | Electrochemical cell sensor for continuous short-term use in tissues and blood |
US4805624A (en) * | 1985-09-09 | 1989-02-21 | The Montefiore Hospital Association Of Western Pa | Low-potential electrochemical redox sensors |
US4680268A (en) | 1985-09-18 | 1987-07-14 | Children's Hospital Medical Center | Implantable gas-containing biosensor and method for measuring an analyte such as glucose |
US4890620A (en) | 1985-09-20 | 1990-01-02 | The Regents Of The University Of California | Two-dimensional diffusion glucose substrate sensing electrode |
JPS6283849A (en) | 1985-10-04 | 1987-04-17 | Reiji Yoshinaka | Method of purifying collagen |
JPS6283649A (en) | 1985-10-08 | 1987-04-17 | Matsushita Electric Ind Co Ltd | Blood-sugar measuring device |
US4757022A (en) * | 1986-04-15 | 1988-07-12 | Markwell Medical Institute, Inc. | Biological fluid measuring device |
US4994167A (en) * | 1986-04-15 | 1991-02-19 | Markwell Medical Institute, Inc. | Biological fluid measuring device |
WO1987006706A1 (en) | 1986-04-30 | 1987-11-05 | Igen, Inc. | Electrochemiluminescent assays |
US4703756A (en) | 1986-05-06 | 1987-11-03 | The Regents Of The University Of California | Complete glucose monitoring system with an implantable, telemetered sensor module |
US4731726A (en) | 1986-05-19 | 1988-03-15 | Healthware Corporation | Patient-operated glucose monitor and diabetes management system |
DE3772450D1 (en) | 1986-05-22 | 1991-10-02 | Siemens Ag | MEASURING DEVICE FOR INTRA-CARDIAL DETECTION OF BLOOD OXYGEN SATURATION. |
US4750496A (en) * | 1987-01-28 | 1988-06-14 | Xienta, Inc. | Method and apparatus for measuring blood glucose concentration |
JPS636451A (en) * | 1986-06-27 | 1988-01-12 | Terumo Corp | Enzyme sensor |
US4935346A (en) * | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
US5002572A (en) | 1986-09-11 | 1991-03-26 | Picha George J | Biological implant with textured surface |
US5007929B1 (en) | 1986-11-04 | 1994-08-30 | Medical Products Dev | Open-cell silicone-elastomer medical implant |
AU617667B2 (en) | 1986-11-04 | 1991-12-05 | Allergan, Inc. | Open-cell, silicone-elastomer medical implant and method for making |
FR2607696B1 (en) * | 1986-12-03 | 1995-08-11 | Gosserez Olivier | IMPLANTABLE BREAST PROSTHESIS CONTRARY TO THE FORMATION OF A RETRACTILE SHELL |
DE3774680D1 (en) | 1986-12-22 | 1992-01-02 | Siemens Ag | ARRANGEMENT FOR EXAMINING A LIQUID MEDIUM AND METHOD FOR OPERATING THE ARRANGEMENT. |
DE3700119A1 (en) | 1987-01-03 | 1988-07-14 | Inst Diabetestechnologie Gemei | IMPLANTABLE ELECTROCHEMICAL SENSOR |
AT391063B (en) * | 1987-01-08 | 1990-08-10 | Blum Gmbh Julius | CONNECTING FITTING FOR FASTENING THE RAILING OF A DRAWER |
AT391998B (en) * | 1987-02-02 | 1990-12-27 | Falko Dr Skrabal | Device for determining the concentration of at least one medicinal substance in living organisms |
US4759828A (en) | 1987-04-09 | 1988-07-26 | Nova Biomedical Corporation | Glucose electrode and method of determining glucose |
US4832034A (en) | 1987-04-09 | 1989-05-23 | Pizziconi Vincent B | Method and apparatus for withdrawing, collecting and biosensing chemical constituents from complex fluids |
EP0288793A3 (en) | 1987-04-22 | 1990-04-25 | Abbott Laboratories | Cartridge and methods for performing a solid-phase immunoassay |
US5540828A (en) | 1987-06-08 | 1996-07-30 | Yacynych; Alexander | Method for making electrochemical sensors and biosensors having a polymer modified surface |
US4810470A (en) | 1987-06-19 | 1989-03-07 | Miles Inc. | Volume independent diagnostic device |
JPH07122624B2 (en) | 1987-07-06 | 1995-12-25 | ダイキン工業株式会社 | Biosensor |
US4805625A (en) * | 1987-07-08 | 1989-02-21 | Ad-Tech Medical Instrument Corporation | Sphenoidal electrode and insertion method |
US4974929A (en) | 1987-09-22 | 1990-12-04 | Baxter International, Inc. | Fiber optical probe connector for physiologic measurement devices |
NL8702370A (en) | 1987-10-05 | 1989-05-01 | Groningen Science Park | METHOD AND SYSTEM FOR GLUCOSE DETERMINATION AND USEABLE MEASURING CELL ASSEMBLY. |
US4831070A (en) | 1987-11-02 | 1989-05-16 | Dow Corning Corporation | Moldable elastomeric pressure sensitive adhesives |
GB8725936D0 (en) | 1987-11-05 | 1987-12-09 | Genetics Int Inc | Sensing system |
US4852573A (en) | 1987-12-04 | 1989-08-01 | Kennedy Philip R | Implantable neural electrode |
ES2050697T3 (en) | 1987-12-21 | 1994-06-01 | Abbott Lab | METHODS AND DEVICES FOR CHROMATOGRAPHIC FIXATION TEST. |
US4890621A (en) | 1988-01-19 | 1990-01-02 | Northstar Research Institute, Ltd. | Continuous glucose monitoring and a system utilized therefor |
US5244630A (en) | 1988-04-22 | 1993-09-14 | Abbott Laboratories | Device for performing solid-phase diagnostic assay |
US5034112A (en) * | 1988-05-19 | 1991-07-23 | Nissan Motor Company, Ltd. | Device for measuring concentration of nitrogen oxide in combustion gas |
US4849458A (en) | 1988-06-17 | 1989-07-18 | Matrix Medica, Inc. | Segmented polyether polyurethane |
CA1299653C (en) | 1988-07-07 | 1992-04-28 | Markwell Medical Institute, Inc. | Biological fluid measuring device |
US5208147A (en) * | 1988-07-21 | 1993-05-04 | Radiometer A/S | Means for measuring a characteristic in a sample fluid |
EP0352631A3 (en) | 1988-07-25 | 1991-07-10 | Abbott Laboratories | Optical fiber distribution system for an optical fiber sensor |
US4907857A (en) | 1988-07-25 | 1990-03-13 | Abbott Laboratories | Optical fiber distribution system for an optical fiber sensor |
US4925268A (en) | 1988-07-25 | 1990-05-15 | Abbott Laboratories | Fiber-optic physiological probes |
GB8817997D0 (en) | 1988-07-28 | 1988-09-01 | Cambridge Life Sciences | Enzyme electrodes & improvements in manufacture thereof |
EP0353328A1 (en) | 1988-08-03 | 1990-02-07 | Dräger Nederland B.V. | A polarographic-amperometric three-electrode sensor |
NL8802481A (en) | 1988-10-10 | 1990-05-01 | Texas Instruments Holland | TRANSPONDER AND METHOD FOR MAKING THE SAME |
US4974592A (en) | 1988-11-14 | 1990-12-04 | American Sensor Systems Corporation | Continuous on-line blood monitoring system |
US5068536A (en) | 1989-01-19 | 1991-11-26 | Futrex, Inc. | Method for providing custom calibration for near infrared instruments for measurement of blood glucose |
US5077476A (en) | 1990-06-27 | 1991-12-31 | Futrex, Inc. | Instrument for non-invasive measurement of blood glucose |
DK115989D0 (en) | 1989-03-09 | 1989-03-09 | Nordisk Gentofte | METHOD AND METHOD FOR MEASURING A LIQUID COMPONENT |
US5269891A (en) | 1989-03-09 | 1993-12-14 | Novo Nordisk A/S | Method and apparatus for determination of a constituent in a fluid |
JPH02298855A (en) | 1989-03-20 | 1990-12-11 | Assoc Univ Inc | Electrochemical biosensor using immobilized enzyme and redox polymer |
US4986671A (en) | 1989-04-12 | 1991-01-22 | Luxtron Corporation | Three-parameter optical fiber sensor and system |
US4953552A (en) * | 1989-04-21 | 1990-09-04 | Demarzo Arthur P | Blood glucose monitoring system |
US4975636A (en) | 1989-05-01 | 1990-12-04 | Hewlett-Packard Company | Method and apparatus for selecting and displaying a high resolution window from a main display |
EP0396788A1 (en) | 1989-05-08 | 1990-11-14 | Dräger Nederland B.V. | Process and sensor for measuring the glucose content of glucosecontaining fluids |
US4988341A (en) | 1989-06-05 | 1991-01-29 | Eastman Kodak Company | Sterilizing dressing device and method for skin puncture |
US4927407A (en) | 1989-06-19 | 1990-05-22 | Regents Of The University Of Minnesota | Cardiac assist pump with steady rate supply of fluid lubricant |
CH677149A5 (en) | 1989-07-07 | 1991-04-15 | Disetronic Ag | |
CA1341592C (en) | 1989-07-07 | 2009-04-14 | Abbott Laboratories | Ion capture reagents and methods for performing binding assays |
US5431160A (en) | 1989-07-19 | 1995-07-11 | University Of New Mexico | Miniature implantable refillable glucose sensor and material therefor |
US5264104A (en) | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
US4944299A (en) | 1989-08-08 | 1990-07-31 | Siemens-Pacesetter, Inc. | High speed digital telemetry system for implantable device |
US5190041A (en) * | 1989-08-11 | 1993-03-02 | Palti Yoram Prof | System for monitoring and controlling blood glucose |
US5101814A (en) | 1989-08-11 | 1992-04-07 | Palti Yoram Prof | System for monitoring and controlling blood glucose |
US5050612A (en) | 1989-09-12 | 1991-09-24 | Matsumura Kenneth N | Device for computer-assisted monitoring of the body |
FR2652736A1 (en) * | 1989-10-06 | 1991-04-12 | Neftel Frederic | IMPLANTABLE DEVICE FOR EVALUATING THE RATE OF GLUCOSE. |
JPH03133440A (en) | 1989-10-18 | 1991-06-06 | Nishitomo:Kk | Clinical thermometer for ladies |
US5067491A (en) | 1989-12-08 | 1991-11-26 | Becton, Dickinson And Company | Barrier coating on blood contacting devices |
US5140985A (en) | 1989-12-11 | 1992-08-25 | Schroeder Jon M | Noninvasive blood glucose measuring device |
FR2656423A1 (en) | 1989-12-22 | 1991-06-28 | Rhone Poulenc Chimie | Electrochemical biosensor |
EP0440044A1 (en) | 1990-01-31 | 1991-08-07 | Abbott Laboratories | Avoidance of human anti-mouse antibody interference in in vitro diagnostic testing |
ES2106737T3 (en) | 1990-02-07 | 1997-11-16 | Abbott Lab | ALKALINE PHOSPHATASE ENZYMES WITH IMPROVED SPECIFIC ACTIVITY FOR USE IN INDICATOR REAGENTS. |
CA2034285A1 (en) | 1990-02-09 | 1991-08-10 | Masao Yafuso | Method and system for monitoring of blood constituents in vivo |
US5108819A (en) | 1990-02-14 | 1992-04-28 | Eli Lilly And Company | Thin film electrical component |
US5031618A (en) | 1990-03-07 | 1991-07-16 | Medtronic, Inc. | Position-responsive neuro stimulator |
US5316008A (en) | 1990-04-06 | 1994-05-31 | Casio Computer Co., Ltd. | Measurement of electrocardiographic wave and sphygmus |
US5165407A (en) | 1990-04-19 | 1992-11-24 | The University Of Kansas | Implantable glucose sensor |
US5331555A (en) | 1990-05-11 | 1994-07-19 | Sharp Kabushiki Kaisha | Electronic apparatus |
IT1248934B (en) | 1990-06-01 | 1995-02-11 | Fidia Spa | BIOCOMPATIBLE PERFORATED MEMBRANES, PROCESSES FOR THEIR PREPARATION, THEIR USE AS A SUPPORT FOR THE IN VITRO GROWTH OF EPITHELIAL CELLS, ARTIFICIAL LEATHER THUS OBTAINED AND THEIR USE IN LEATHER TRANSPLANTS |
EP0467078B1 (en) | 1990-07-18 | 1996-05-08 | Abbott Laboratories | An analyte-subtitute reagent for use in specific binding assay methods, devices and kits |
JPH0820412B2 (en) | 1990-07-20 | 1996-03-04 | 松下電器産業株式会社 | Quantitative analysis method and device using disposable sensor |
ES2081490T3 (en) * | 1990-08-28 | 1996-03-16 | Meadox Medicals Inc | VASCULAR GRAFT SELF-SUPPORTING FABRIC. |
US5380536A (en) * | 1990-10-15 | 1995-01-10 | The Board Of Regents, The University Of Texas System | Biocompatible microcapsules |
US5344454A (en) | 1991-07-24 | 1994-09-06 | Baxter International Inc. | Closed porous chambers for implanting tissue in a host |
US5314471A (en) * | 1991-07-24 | 1994-05-24 | Baxter International Inc. | Tissue inplant systems and methods for sustaining viable high cell densities within a host |
EP0507933B1 (en) | 1990-10-31 | 1996-05-22 | Baxter International Inc. | Close vascularization implant material |
TW279133B (en) | 1990-12-13 | 1996-06-21 | Elan Med Tech | |
US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
US5243983A (en) | 1990-12-14 | 1993-09-14 | Georgia Tech Research Corporation | Non-invasive blood glucose measurement system and method using stimulated raman spectroscopy |
US5354449A (en) | 1991-01-10 | 1994-10-11 | Band David M | pH electrode |
AU1356792A (en) | 1991-01-25 | 1992-08-27 | Markwell Medical Institute, Inc. | Implantable biological fluid measuring device |
US5348788A (en) | 1991-01-30 | 1994-09-20 | Interpore Orthopaedics, Inc. | Mesh sheet with microscopic projections and holes |
CA2050057A1 (en) | 1991-03-04 | 1992-09-05 | Adam Heller | Interferant eliminating biosensors |
US5593852A (en) | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
US5262305A (en) | 1991-03-04 | 1993-11-16 | E. Heller & Company | Interferant eliminating biosensors |
US5632272A (en) | 1991-03-07 | 1997-05-27 | Masimo Corporation | Signal processing apparatus |
US5397848A (en) | 1991-04-25 | 1995-03-14 | Allergan, Inc. | Enhancing the hydrophilicity of silicone polymers |
AU666118B2 (en) | 1991-04-25 | 1996-02-01 | Brown University Research Foundation | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
US5271736A (en) | 1991-05-13 | 1993-12-21 | Applied Medical Research | Collagen disruptive morphology for implants |
JP3118015B2 (en) | 1991-05-17 | 2000-12-18 | アークレイ株式会社 | Biosensor and separation and quantification method using the same |
FI88223C (en) * | 1991-05-22 | 1993-04-13 | Polar Electro Oy | Telemetric transmitter unit |
US5284570A (en) * | 1991-06-26 | 1994-02-08 | Ppg Industries, Inc. | Fluid sample analyte collector and calibration assembly |
JP2816262B2 (en) | 1991-07-09 | 1998-10-27 | 工業技術院長 | Carbon microsensor electrode and method of manufacturing the same |
US5453278A (en) | 1991-07-24 | 1995-09-26 | Baxter International Inc. | Laminated barriers for tissue implants |
US5198771A (en) | 1991-09-03 | 1993-03-30 | Transducer Research, Inc. | Potentiostatic apparatus and methods |
US5312361A (en) * | 1991-09-13 | 1994-05-17 | Zadini Filiberto P | Automatic cannulation device |
ATE137912T1 (en) | 1991-09-13 | 1996-06-15 | Rodney Arthur Stafford | ELECTRONIC ANIMAL IDENTIFICATION SYSTEM |
DE4130742A1 (en) | 1991-09-16 | 1993-03-18 | Inst Diabetestechnologie Gemei | METHOD AND ARRANGEMENT FOR DETERMINING THE CONCENTRATION OF INGREDIENTS IN BODY LIQUIDS |
US5322063A (en) | 1991-10-04 | 1994-06-21 | Eli Lilly And Company | Hydrophilic polyurethane membranes for electrochemical glucose sensors |
US5605162A (en) | 1991-10-15 | 1997-02-25 | Advanced Cardiovascular Systems, Inc. | Method for using a variable stiffness guidewire |
US5249576A (en) | 1991-10-24 | 1993-10-05 | Boc Health Care, Inc. | Universal pulse oximeter probe |
US5310469A (en) | 1991-12-31 | 1994-05-10 | Abbott Laboratories | Biosensor with a membrane containing biologically active material |
DE69215204T2 (en) * | 1992-01-29 | 1997-03-13 | Hewlett Packard Gmbh | Process and system for monitoring vital functions |
JPH07508183A (en) | 1992-02-01 | 1995-09-14 | ザ ヴィクトリア ユニヴァーシティ オヴ マンチェスター | Improvements regarding monitoring system |
NL9200207A (en) | 1992-02-05 | 1993-09-01 | Nedap Nv | IMPLANTABLE BIOMEDICAL SENSOR DEVICE, IN PARTICULAR FOR MEASUREMENT OF THE GLUCOSE CONCENTRATION. |
US5284140A (en) * | 1992-02-11 | 1994-02-08 | Eli Lilly And Company | Acrylic copolymer membranes for biosensors |
US5284478A (en) * | 1992-06-08 | 1994-02-08 | Nobles Anthony A | Detachable tip optical valvulotome |
DE69319771T2 (en) | 1992-03-31 | 1999-04-22 | Dainippon Printing Co Ltd | Immobilized enzyme electrode, composition for its production and electrically conductive enzymes |
US5324322A (en) | 1992-04-20 | 1994-06-28 | Case Western Reserve University | Thin film implantable electrode and method of manufacture |
US5287753A (en) | 1992-05-02 | 1994-02-22 | Advanced Technology Laboratories, Inc. | Continuous display of peak and mean blood flow velocities |
GB9211402D0 (en) | 1992-05-29 | 1992-07-15 | Univ Manchester | Sensor devices |
US5330521A (en) | 1992-06-29 | 1994-07-19 | Cohen Donald M | Low resistance implantable electrical leads |
US5434412A (en) | 1992-07-15 | 1995-07-18 | Myron J. Block | Non-spectrophotometric measurement of analyte concentrations and optical properties of objects |
JPH0634596A (en) | 1992-07-20 | 1994-02-08 | Fujitsu Ltd | Oxygen electrode, biosensor and manufacture thereof |
JP2541081B2 (en) * | 1992-08-28 | 1996-10-09 | 日本電気株式会社 | Biosensor and method of manufacturing and using biosensor |
US5330634A (en) | 1992-08-28 | 1994-07-19 | Via Medical Corporation | Calibration solutions useful for analyses of biological fluids and methods employing same |
US5376070A (en) | 1992-09-29 | 1994-12-27 | Minimed Inc. | Data transfer system for an infusion pump |
GB9221099D0 (en) | 1992-10-07 | 1992-11-18 | Ecossensors Ltd | Improvements in and relating to gas permeable membranes for amperometric gas electrodes |
US5750029A (en) | 1992-10-16 | 1998-05-12 | Suprex Corporation | Method and apparatus for determination of analyte concentration |
US5387327A (en) | 1992-10-19 | 1995-02-07 | Duquesne University Of The Holy Ghost | Implantable non-enzymatic electrochemical glucose sensor |
US5368224A (en) | 1992-10-23 | 1994-11-29 | Nellcor Incorporated | Method for reducing ambient noise effects in electronic monitoring instruments |
US5307263A (en) | 1992-11-17 | 1994-04-26 | Raya Systems, Inc. | Modular microprocessor-based health monitoring system |
US5899855A (en) | 1992-11-17 | 1999-05-04 | Health Hero Network, Inc. | Modular microprocessor-based health monitoring system |
US20010011224A1 (en) | 1995-06-07 | 2001-08-02 | Stephen James Brown | Modular microprocessor-based health monitoring system |
US7624028B1 (en) | 1992-11-17 | 2009-11-24 | Health Hero Network, Inc. | Remote health monitoring and maintenance system |
US5933136A (en) | 1996-12-23 | 1999-08-03 | Health Hero Network, Inc. | Network media access control system for encouraging patient compliance with a treatment plan |
US5956501A (en) | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
ZA938555B (en) * | 1992-11-23 | 1994-08-02 | Lilly Co Eli | Technique to improve the performance of electrochemical sensors |
US6256522B1 (en) | 1992-11-23 | 2001-07-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Sensors for continuous monitoring of biochemicals and related method |
US5285513A (en) | 1992-11-30 | 1994-02-08 | At&T Bell Laboratories | Optical fiber cable provided with stabilized waterblocking material |
US5448992A (en) | 1992-12-10 | 1995-09-12 | Sunshine Medical Instruments, Inc. | Method and apparatus for non-invasive phase sensitive measurement of blood glucose concentration |
US5299571A (en) | 1993-01-22 | 1994-04-05 | Eli Lilly And Company | Apparatus and method for implantation of sensors |
US5411866A (en) | 1993-03-30 | 1995-05-02 | National Research Council Of Canada | Method and system for determining bioactive substances |
WO1994022367A1 (en) | 1993-03-30 | 1994-10-13 | Pfizer Inc. | Radiotelemetry impedance plethysmography device |
US5387329A (en) | 1993-04-09 | 1995-02-07 | Ciba Corning Diagnostics Corp. | Extended use planar sensors |
US5352351A (en) | 1993-06-08 | 1994-10-04 | Boehringer Mannheim Corporation | Biosensing meter with fail/safe procedures to prevent erroneous indications |
AU666821B2 (en) | 1993-08-05 | 1996-02-22 | Bayer Corporation | Analyte detection device and process |
US5508203A (en) | 1993-08-06 | 1996-04-16 | Fuller; Milton E. | Apparatus and method for radio frequency spectroscopy using spectral analysis |
DE4329898A1 (en) | 1993-09-04 | 1995-04-06 | Marcus Dr Besson | Wireless medical diagnostic and monitoring device |
AU7607494A (en) | 1993-09-10 | 1995-03-27 | Ottawa Heart Institute Research Corporation | Electrohydraulic ventricular assist device |
JP3102613B2 (en) | 1993-09-16 | 2000-10-23 | 松下電器産業株式会社 | Biosensor |
FR2710413B1 (en) | 1993-09-21 | 1995-11-03 | Asulab Sa | Measuring device for removable sensors. |
US5582184A (en) | 1993-10-13 | 1996-12-10 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
US5781455A (en) | 1993-11-02 | 1998-07-14 | Kyoto Daiichi Kagaku Co., Ltd. | Article of manufacture comprising computer usable medium for a portable blood sugar value measuring apparatus |
US5545220A (en) | 1993-11-04 | 1996-08-13 | Lipomatrix Incorporated | Implantable prosthesis with open cell textured surface and method for forming same |
US5814599A (en) * | 1995-08-04 | 1998-09-29 | Massachusetts Insitiute Of Technology | Transdermal delivery of encapsulated drugs |
US5885211A (en) | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
US5997501A (en) | 1993-11-18 | 1999-12-07 | Elan Corporation, Plc | Intradermal drug delivery device |
US5791344A (en) * | 1993-11-19 | 1998-08-11 | Alfred E. Mann Foundation For Scientific Research | Patient monitoring system |
US5497772A (en) * | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
US5553616A (en) | 1993-11-30 | 1996-09-10 | Florida Institute Of Technology | Determination of concentrations of biological substances using raman spectroscopy and artificial neural network discriminator |
US5421923A (en) | 1993-12-03 | 1995-06-06 | Baxter International, Inc. | Ultrasonic welding horn with sonics dampening insert |
US5443080A (en) | 1993-12-22 | 1995-08-22 | Americate Transtech, Inc. | Integrated system for biological fluid constituent analysis |
US6127154A (en) | 1994-02-10 | 2000-10-03 | Mosbach; Klaus | Methods for direct synthesis of compounds having complementary structure to a desired molecular entity and use thereof |
US5531679A (en) | 1994-03-14 | 1996-07-02 | Schulman; Joseph H. | Fluidic infusion system for catheter or probe |
US5391250A (en) | 1994-03-15 | 1995-02-21 | Minimed Inc. | Method of fabricating thin film sensors |
US5390671A (en) | 1994-03-15 | 1995-02-21 | Minimed Inc. | Transcutaneous sensor insertion set |
AUPM506894A0 (en) * | 1994-04-14 | 1994-05-05 | Memtec Limited | Novel electrochemical cells |
US5569186A (en) | 1994-04-25 | 1996-10-29 | Minimed Inc. | Closed loop infusion pump system with removable glucose sensor |
US5584876A (en) | 1994-04-29 | 1996-12-17 | W. L. Gore & Associates, Inc. | Cell excluding sheath for vascular grafts |
US5466356A (en) | 1994-04-29 | 1995-11-14 | Mine Safety Appliances Company | Potentiostat circuit for electrochemical cells |
DE4415896A1 (en) * | 1994-05-05 | 1995-11-09 | Boehringer Mannheim Gmbh | Analysis system for monitoring the concentration of an analyte in the blood of a patient |
US5484404A (en) * | 1994-05-06 | 1996-01-16 | Alfred E. Mann Foundation For Scientific Research | Replaceable catheter system for physiological sensors, tissue stimulating electrodes and/or implantable fluid delivery systems |
US5482473A (en) * | 1994-05-09 | 1996-01-09 | Minimed Inc. | Flex circuit connector |
EP0685735B1 (en) | 1994-06-03 | 2002-01-16 | Metrohm Ag | Voltammetric apparaus, indicating electrode arrangement for such apparatus, especially as a part of a tape cassette, and voltammetric method for serial analysis |
US5771890A (en) * | 1994-06-24 | 1998-06-30 | Cygnus, Inc. | Device and method for sampling of substances using alternating polarity |
US5494562A (en) | 1994-06-27 | 1996-02-27 | Ciba Corning Diagnostics Corp. | Electrochemical sensors |
US5429735A (en) | 1994-06-27 | 1995-07-04 | Miles Inc. | Method of making and amperometric electrodes |
US5474552A (en) | 1994-06-27 | 1995-12-12 | Cb-Carmel Biotechnology Ltd. | Implantable drug delivery pump |
US5513636A (en) | 1994-08-12 | 1996-05-07 | Cb-Carmel Biotechnology Ltd. | Implantable sensor chip |
US5462051A (en) | 1994-08-31 | 1995-10-31 | Colin Corporation | Medical communication system |
AT402452B (en) | 1994-09-14 | 1997-05-26 | Avl Verbrennungskraft Messtech | PLANAR SENSOR FOR DETECTING A CHEMICAL PARAMETER OF A SAMPLE |
US5807406A (en) | 1994-10-07 | 1998-09-15 | Baxter International Inc. | Porous microfabricated polymer membrane structures |
CA2159052C (en) | 1994-10-28 | 2007-03-06 | Rainer Alex | Injection device |
IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
US5590651A (en) * | 1995-01-17 | 1997-01-07 | Temple University - Of The Commonwealth System Of Higher Education | Breathable liquid elimination analysis |
US5697366A (en) | 1995-01-27 | 1997-12-16 | Optical Sensors Incorporated | In situ calibration system for sensors located in a physiologic line |
US5676820A (en) | 1995-02-03 | 1997-10-14 | New Mexico State University Technology Transfer Corp. | Remote electrochemical sensor |
US5586553A (en) | 1995-02-16 | 1996-12-24 | Minimed Inc. | Transcutaneous sensor insertion set |
US5568806A (en) | 1995-02-16 | 1996-10-29 | Minimed Inc. | Transcutaneous sensor insertion set |
US5640470A (en) | 1995-03-27 | 1997-06-17 | Abbott Laboratories | Fiber-optic detectors with terpolymeric analyte-permeable matrix coating |
US5882494A (en) | 1995-03-27 | 1999-03-16 | Minimed, Inc. | Polyurethane/polyurea compositions containing silicone for biosensor membranes |
FR2733104B1 (en) | 1995-04-12 | 1997-06-06 | Droz Francois | SMALL-DIMENSIONAL ANSWERING MACHINE AND METHOD FOR MANUFACTURING SUCH ANSWERING MACHINES |
US5620579A (en) | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
US5665065A (en) | 1995-05-26 | 1997-09-09 | Minimed Inc. | Medication infusion device with blood glucose data input |
US5806517A (en) | 1995-05-26 | 1998-09-15 | The Regents Of The University Of Colorado | In vivo electrochemistry computer system and method |
WO1996039993A1 (en) | 1995-06-07 | 1996-12-19 | Gore Hybrid Technologies, Inc. | An implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein |
US5626561A (en) | 1995-06-07 | 1997-05-06 | Gore Hybrid Technologies, Inc. | Implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein |
US5584813A (en) | 1995-06-07 | 1996-12-17 | Minimed Inc. | Subcutaneous injection set |
US5743262A (en) | 1995-06-07 | 1998-04-28 | Masimo Corporation | Blood glucose monitoring system |
US5840148A (en) | 1995-06-30 | 1998-11-24 | Bio Medic Data Systems, Inc. | Method of assembly of implantable transponder |
US5995860A (en) | 1995-07-06 | 1999-11-30 | Thomas Jefferson University | Implantable sensor and system for measurement and control of blood constituent levels |
US5611900A (en) * | 1995-07-20 | 1997-03-18 | Michigan State University | Microbiosensor used in-situ |
US6212424B1 (en) | 1998-10-29 | 2001-04-03 | Rio Grande Medical Technologies, Inc. | Apparatus and method for determination of the adequacy of dialysis by non-invasive near-infrared spectroscopy |
US7016713B2 (en) | 1995-08-09 | 2006-03-21 | Inlight Solutions, Inc. | Non-invasive determination of direction and rate of change of an analyte |
US6001471A (en) | 1995-08-11 | 1999-12-14 | 3M Innovative Properties Company | Removable adhesive tape with controlled sequential release |
AUPN487495A0 (en) | 1995-08-18 | 1995-09-14 | Cardiac Crc Nominees Pty Limited | A multipolar transmural probe |
US5628890A (en) * | 1995-09-27 | 1997-05-13 | Medisense, Inc. | Electrochemical sensor |
JP3592416B2 (en) | 1995-10-31 | 2004-11-24 | 晃敏 吉田 | Measuring device for intraocular substances |
AU1058297A (en) * | 1995-11-22 | 1997-06-11 | Minimed, Inc. | Detection of biological molecules using chemical amplification and optical sensors |
US5711861A (en) | 1995-11-22 | 1998-01-27 | Ward; W. Kenneth | Device for monitoring changes in analyte concentration |
US6063637A (en) | 1995-12-13 | 2000-05-16 | California Institute Of Technology | Sensors for sugars and other metal binding analytes |
US5730654A (en) | 1995-12-18 | 1998-03-24 | Raya Systems, Inc. | Multi-player video game for health education |
WO1997024059A1 (en) | 1995-12-28 | 1997-07-10 | Cygnus, Inc. | Continuous monitoring of physiological analyte |
FI118509B (en) | 1996-02-12 | 2007-12-14 | Nokia Oyj | A method and apparatus for predicting blood glucose levels in a patient |
EP0923335B1 (en) * | 1996-07-08 | 2006-08-23 | Animas Corporation | Implantable sensor and system for in vivo measurement and control of fluid constituent levels |
JP2943700B2 (en) | 1996-07-10 | 1999-08-30 | 日本電気株式会社 | Biosensor |
US5696314A (en) | 1996-07-12 | 1997-12-09 | Chiron Diagnostics Corporation | Multilayer enzyme electrode membranes and methods of making same |
US6325978B1 (en) | 1998-08-04 | 2001-12-04 | Ntc Technology Inc. | Oxygen monitoring and apparatus |
US6054142A (en) | 1996-08-01 | 2000-04-25 | Cyto Therapeutics, Inc. | Biocompatible devices with foam scaffolds |
US6544193B2 (en) | 1996-09-04 | 2003-04-08 | Marcio Marc Abreu | Noninvasive measurement of chemical substances |
US5836887A (en) | 1996-09-19 | 1998-11-17 | Colin Corporation | Physical information monitor system having means for determining reference range for abnormality determination, based on moving average of previously obtained values |
US5714123A (en) * | 1996-09-30 | 1998-02-03 | Lifescan, Inc. | Protective shield for a blood glucose strip |
US6168568B1 (en) * | 1996-10-04 | 2001-01-02 | Karmel Medical Acoustic Technologies Ltd. | Phonopneumograph system |
US5963132A (en) | 1996-10-11 | 1999-10-05 | Avid Indentification Systems, Inc. | Encapsulated implantable transponder |
US6001068A (en) | 1996-10-22 | 1999-12-14 | Terumo Kabushiki Kaisha | Guide wire having tubular connector with helical slits |
WO1998024358A2 (en) | 1996-12-04 | 1998-06-11 | Enact Health Management Systems | System for downloading and reporting medical information |
US6027459A (en) * | 1996-12-06 | 2000-02-22 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US5811487A (en) | 1996-12-16 | 1998-09-22 | Dow Corning Corporation | Thickening silicones with elastomeric silicone polyethers |
US5964993A (en) | 1996-12-19 | 1999-10-12 | Implanted Biosystems Inc. | Glucose sensor |
US5836989A (en) | 1996-12-26 | 1998-11-17 | Medtronic, Inc. | Method and apparatus for controlling an implanted medical device in a time-dependent manner |
US5914026A (en) | 1997-01-06 | 1999-06-22 | Implanted Biosystems Inc. | Implantable sensor employing an auxiliary electrode |
DE69807042T2 (en) | 1997-01-17 | 2003-02-06 | Metracor Technologies Inc | METHOD FOR CALIBRATING SENSORS IN DIAGNOSTIC TEST METHODS |
US5928155A (en) | 1997-01-24 | 1999-07-27 | Cardiox Corporation | Cardiac output measurement with metabolizable analyte containing fluid |
US6607509B2 (en) | 1997-12-31 | 2003-08-19 | Medtronic Minimed, Inc. | Insertion device for an insertion set and method of using the same |
US5851197A (en) | 1997-02-05 | 1998-12-22 | Minimed Inc. | Injector for a subcutaneous infusion set |
US6093172A (en) | 1997-02-05 | 2000-07-25 | Minimed Inc. | Injector for a subcutaneous insertion set |
JP3394262B2 (en) * | 1997-02-06 | 2003-04-07 | セラセンス、インク. | Small volume in vitro analyte sensor |
US6891317B2 (en) | 2001-05-22 | 2005-05-10 | Sri International | Rolled electroactive polymers |
US5749907A (en) * | 1997-02-18 | 1998-05-12 | Pacesetter, Inc. | System and method for identifying and displaying medical data which violate programmable alarm conditions |
US6208894B1 (en) * | 1997-02-26 | 2001-03-27 | Alfred E. Mann Foundation For Scientific Research And Advanced Bionics | System of implantable devices for monitoring and/or affecting body parameters |
EP1011426A1 (en) | 1997-02-26 | 2000-06-28 | Diasense, Inc. | Individual calibration of blood glucose for supporting noninvasive self-monitoring blood glucose |
US7657297B2 (en) | 2004-05-03 | 2010-02-02 | Dexcom, Inc. | Implantable analyte sensor |
US6558321B1 (en) * | 1997-03-04 | 2003-05-06 | Dexcom, Inc. | Systems and methods for remote monitoring and modulation of medical devices |
US7192450B2 (en) * | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
US6741877B1 (en) | 1997-03-04 | 2004-05-25 | Dexcom, Inc. | Device and method for determining analyte levels |
US20050033132A1 (en) * | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
US6001067A (en) | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
US6862465B2 (en) * | 1997-03-04 | 2005-03-01 | Dexcom, Inc. | Device and method for determining analyte levels |
US7899511B2 (en) | 2004-07-13 | 2011-03-01 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
FR2760962B1 (en) | 1997-03-20 | 1999-05-14 | Sillonville Francis Klefstad | REMOTE MEDICAL ASSISTANCE AND SURVEILLANCE SYSTEM |
US6270455B1 (en) | 1997-03-28 | 2001-08-07 | Health Hero Network, Inc. | Networked system for interactive communications and remote monitoring of drug delivery |
US5961451A (en) | 1997-04-07 | 1999-10-05 | Motorola, Inc. | Noninvasive apparatus having a retaining member to retain a removable biosensor |
US6059946A (en) | 1997-04-14 | 2000-05-09 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
US5944661A (en) | 1997-04-16 | 1999-08-31 | Giner, Inc. | Potential and diffusion controlled solid electrolyte sensor for continuous measurement of very low levels of transdermal alcohol |
AT404992B (en) | 1997-04-17 | 1999-04-26 | Avl List Gmbh | SENSOR FOR DETERMINING AN ENZYME SUBSTRATE |
US6115634A (en) | 1997-04-30 | 2000-09-05 | Medtronic, Inc. | Implantable medical device and method of manufacture |
TW357517B (en) | 1997-05-29 | 1999-05-01 | Koji Akai | Monitoring system |
US5954643A (en) | 1997-06-09 | 1999-09-21 | Minimid Inc. | Insertion set for a transcutaneous sensor |
US7267665B2 (en) * | 1999-06-03 | 2007-09-11 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
US6558351B1 (en) | 1999-06-03 | 2003-05-06 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
US6093167A (en) | 1997-06-16 | 2000-07-25 | Medtronic, Inc. | System for pancreatic stimulation and glucose measurement |
CA2294610A1 (en) * | 1997-06-16 | 1998-12-23 | George Moshe Katz | Methods of calibrating and testing a sensor for in vivo measurement of an analyte and devices for use in such methods |
US6013711A (en) | 1997-06-18 | 2000-01-11 | Ck Witco Corporation | Hydrophilic polysiloxane compositions |
SE9702739D0 (en) | 1997-07-17 | 1997-07-17 | Siemens Elema Ab | Method for rinsing and calibrating sensors included in a body fluid analysis system |
US5861019A (en) | 1997-07-25 | 1999-01-19 | Medtronic Inc. | Implantable medical device microstrip telemetry antenna |
US5871514A (en) | 1997-08-01 | 1999-02-16 | Medtronic, Inc. | Attachment apparatus for an implantable medical device employing ultrasonic energy |
US6731976B2 (en) * | 1997-09-03 | 2004-05-04 | Medtronic, Inc. | Device and method to measure and communicate body parameters |
US5917346A (en) | 1997-09-12 | 1999-06-29 | Alfred E. Mann Foundation | Low power current to frequency converter circuit for use in implantable sensors |
US5999848A (en) | 1997-09-12 | 1999-12-07 | Alfred E. Mann Foundation | Daisy chainable sensors and stimulators for implantation in living tissue |
US6259937B1 (en) | 1997-09-12 | 2001-07-10 | Alfred E. Mann Foundation | Implantable substrate sensor |
US6117290A (en) * | 1997-09-26 | 2000-09-12 | Pepex Biomedical, Llc | System and method for measuring a bioanalyte such as lactate |
US6585763B1 (en) | 1997-10-14 | 2003-07-01 | Vascusense, Inc. | Implantable therapeutic device and method |
EP0910023A2 (en) * | 1997-10-17 | 1999-04-21 | Siemens Aktiengesellschaft | Method and device for the neuronal modelling of a dynamic system with non-linear stochastic behavior |
US6081736A (en) * | 1997-10-20 | 2000-06-27 | Alfred E. Mann Foundation | Implantable enzyme-based monitoring systems adapted for long term use |
US6104280A (en) | 1997-10-20 | 2000-08-15 | Micron Technology, Inc. | Method of manufacturing and testing an electronic device, and an electronic device |
US6119028A (en) | 1997-10-20 | 2000-09-12 | Alfred E. Mann Foundation | Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces |
US6088608A (en) * | 1997-10-20 | 2000-07-11 | Alfred E. Mann Foundation | Electrochemical sensor and integrity tests therefor |
US6117643A (en) * | 1997-11-25 | 2000-09-12 | Ut Battelle, Llc | Bioluminescent bioreporter integrated circuit |
DE19824036A1 (en) * | 1997-11-28 | 1999-06-02 | Roche Diagnostics Gmbh | Analytical measuring device with lancing device |
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6579690B1 (en) * | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
US6893552B1 (en) * | 1997-12-29 | 2005-05-17 | Arrowhead Center, Inc. | Microsensors for glucose and insulin monitoring |
US6306347B1 (en) | 1998-01-21 | 2001-10-23 | Bayer Corporation | Optical sensor and method of operation |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6103033A (en) | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
US6299583B1 (en) | 1998-03-17 | 2001-10-09 | Cardiox Corporation | Monitoring total circulating blood volume and cardiac output |
US5904708A (en) * | 1998-03-19 | 1999-05-18 | Medtronic, Inc. | System and method for deriving relative physiologic signals |
GB9805896D0 (en) | 1998-03-20 | 1998-05-13 | Eglise David | Remote analysis system |
US6091975A (en) | 1998-04-01 | 2000-07-18 | Alza Corporation | Minimally invasive detecting device |
WO1999051974A1 (en) | 1998-04-02 | 1999-10-14 | Matsushita Electric Industrial Co., Ltd. | Substrate determining method |
US6537318B1 (en) | 1998-04-06 | 2003-03-25 | Konjac Technologies, Llc | Use of glucomannan hydrocolloid as filler material in prostheses |
JPH11296598A (en) | 1998-04-07 | 1999-10-29 | Seizaburo Arita | System and method for predicting blood-sugar level and record medium where same method is recorded |
US6534711B1 (en) | 1998-04-14 | 2003-03-18 | The Goodyear Tire & Rubber Company | Encapsulation package and method of packaging an electronic circuit module |
US6241863B1 (en) | 1998-04-27 | 2001-06-05 | Harold G. Monbouquette | Amperometric biosensors based on redox enzymes |
US7647237B2 (en) | 1998-04-29 | 2010-01-12 | Minimed, Inc. | Communication station and software for interfacing with an infusion pump, analyte monitor, analyte meter, or the like |
US6175752B1 (en) * | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
JP2002514452A (en) * | 1998-05-13 | 2002-05-21 | シグナス, インコーポレイテッド | Signal processing for measurement of physiological analytes |
PT1077634E (en) | 1998-05-13 | 2003-12-31 | Cygnus Therapeutic Systems | MONITORING OF PHYSIOLOGICAL SUBSTANCES TO BE ANALYZED |
US6272364B1 (en) | 1998-05-13 | 2001-08-07 | Cygnus, Inc. | Method and device for predicting physiological values |
US6526298B1 (en) | 1998-05-18 | 2003-02-25 | Abbott Laboratories | Method for the non-invasive determination of analytes in a selected volume of tissue |
US6129757A (en) | 1998-05-18 | 2000-10-10 | Scimed Life Systems | Implantable members for receiving therapeutically useful compositions |
US6302855B1 (en) | 1998-05-20 | 2001-10-16 | Novo Nordisk A/S | Medical apparatus for use by a patient for medical self treatment of diabetes |
US7540875B2 (en) | 1998-06-01 | 2009-06-02 | Avatar Design & Development, Inc. | Surgical cutting tool with automatically retractable blade assembly |
US6702972B1 (en) | 1998-06-09 | 2004-03-09 | Diametrics Medical Limited | Method of making a kink-resistant catheter |
US6187062B1 (en) | 1998-06-16 | 2001-02-13 | Alcatel | Current collection through thermally sprayed tabs at the ends of a spirally wound electrochemical cell |
EP0967788A2 (en) | 1998-06-26 | 1999-12-29 | Hewlett-Packard Company | Dynamic generation of multi-resolution and tile-based images from flat compressed images |
US6554798B1 (en) * | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
US6558320B1 (en) | 2000-01-20 | 2003-05-06 | Medtronic Minimed, Inc. | Handheld personal data assistant (PDA) with a medical device and method of using the same |
US6248067B1 (en) * | 1999-02-05 | 2001-06-19 | Minimed Inc. | Analyte sensor and holter-type monitor system and method of using the same |
US6107083A (en) | 1998-08-21 | 2000-08-22 | Bayer Corporation | Optical oxidative enzyme-based sensors |
AU770909B2 (en) | 1998-08-26 | 2004-03-04 | Sensors For Medicine And Science, Inc. | Optical-based sensing devices |
US6233080B1 (en) | 1998-08-26 | 2001-05-15 | Ciena Corporation | Crosstalk-free signal source for dense wavelength division multiplexed systems |
US6087182A (en) | 1998-08-27 | 2000-07-11 | Abbott Laboratories | Reagentless analysis of biological samples |
US6403349B1 (en) | 1998-09-02 | 2002-06-11 | Abbott Laboratories | Elongase gene and uses thereof |
US6740518B1 (en) | 1998-09-17 | 2004-05-25 | Clinical Micro Sensors, Inc. | Signal detection techniques for the detection of analytes |
JP3537136B2 (en) | 1998-09-30 | 2004-06-14 | シグナス, インコーポレイテッド | Method and apparatus for predicting physiological values |
US6180416B1 (en) | 1998-09-30 | 2001-01-30 | Cygnus, Inc. | Method and device for predicting physiological values |
US6201980B1 (en) | 1998-10-05 | 2001-03-13 | The Regents Of The University Of California | Implantable medical sensor system |
US6591125B1 (en) | 2000-06-27 | 2003-07-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
DK1413245T3 (en) | 1998-10-08 | 2011-10-10 | Medtronic Minimed Inc | Installations for monitoring a characteristic of remote sensing |
US6338790B1 (en) | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
DE69815108T2 (en) | 1998-10-23 | 2004-02-05 | Pierre Beuret | Heat treatment plant for a batch of metallic workpieces |
US6016448A (en) | 1998-10-27 | 2000-01-18 | Medtronic, Inc. | Multilevel ERI for implantable medical devices |
US6156013A (en) | 1998-11-04 | 2000-12-05 | Mahurkar; Sakharam D. | Safety syringe |
JP2002529204A (en) * | 1998-11-13 | 2002-09-10 | エラン・フアルマ・インターナシヨナル・リミテツド | System and method for delivering chemicals |
EP1131114B1 (en) | 1998-11-20 | 2004-06-16 | The University of Connecticut | Apparatus and method for control of tissue/implant interactions |
EP1135677A1 (en) | 1998-12-02 | 2001-09-26 | UT-Battelle, LLC | In vivo biosensor apparatus and method of use |
US6201993B1 (en) | 1998-12-09 | 2001-03-13 | Medtronic, Inc. | Medical device telemetry receiver having improved noise discrimination |
US6329929B1 (en) | 1998-12-21 | 2001-12-11 | Medtronic Inc. | Telemetry system with phase-locking noise suppressing receiver |
US6447448B1 (en) | 1998-12-31 | 2002-09-10 | Ball Semiconductor, Inc. | Miniature implanted orthopedic sensors |
ATE408372T1 (en) | 1999-01-04 | 2008-10-15 | Terumo Corp | LANDZET ARRANGEMENT FOR COLLECTION AND DETECTION OF BODY FLUID |
US6169155B1 (en) * | 1999-01-14 | 2001-01-02 | Dow Corning Corporation | Silicone gel composition and silicone gel produced therefrom |
US6561978B1 (en) * | 1999-02-12 | 2003-05-13 | Cygnus, Inc. | Devices and methods for frequent measurement of an analyte present in a biological system |
US6360888B1 (en) * | 1999-02-25 | 2002-03-26 | Minimed Inc. | Glucose sensor package system |
US6416651B1 (en) | 1999-02-26 | 2002-07-09 | Honeywell Measurex | Multi-electrode composition measuring device and method |
US6230059B1 (en) | 1999-03-17 | 2001-05-08 | Medtronic, Inc. | Implantable monitor |
JP2002541441A (en) | 1999-04-07 | 2002-12-03 | スペクトルクス,インコーポレイティド | Analytical device for continuous measurement of fluid properties |
US6189536B1 (en) | 1999-04-15 | 2001-02-20 | Medtronic Inc. | Method for protecting implantable devices |
US6223083B1 (en) | 1999-04-16 | 2001-04-24 | Medtronic, Inc. | Receiver employing digital filtering for use with an implantable medical device |
US6192891B1 (en) * | 1999-04-26 | 2001-02-27 | Becton Dickinson And Company | Integrated system including medication delivery pen, blood monitoring device, and lancer |
US7371400B2 (en) | 2001-01-02 | 2008-05-13 | The General Hospital Corporation | Multilayer device for tissue engineering |
US6475750B1 (en) | 1999-05-11 | 2002-11-05 | M-Biotech, Inc. | Glucose biosensor |
US6300002B1 (en) | 1999-05-13 | 2001-10-09 | Moltech Power Systems, Inc. | Notched electrode and method of making same |
US6546268B1 (en) | 1999-06-02 | 2003-04-08 | Ball Semiconductor, Inc. | Glucose sensor |
CA2388689A1 (en) | 1999-06-17 | 2000-12-28 | Medtronic Minimed, Inc. | Characteristic monitor system for use with analyte sensor |
EP2322645A1 (en) | 1999-06-18 | 2011-05-18 | Abbott Diabetes Care Inc. | Mass transport limited in vivo analyte sensor |
US7247138B2 (en) | 1999-07-01 | 2007-07-24 | Medtronic Minimed, Inc. | Reusable analyte sensor site and method of using the same |
US6413393B1 (en) | 1999-07-07 | 2002-07-02 | Minimed, Inc. | Sensor including UV-absorbing polymer and method of manufacture |
JP2001041238A (en) | 1999-07-28 | 2001-02-13 | Seiko Seiki Co Ltd | Composite type electromagnet and radial magnetic bearing |
US6471689B1 (en) | 1999-08-16 | 2002-10-29 | Thomas Jefferson University | Implantable drug delivery catheter system with capillary interface |
US6673022B1 (en) | 1999-08-20 | 2004-01-06 | Innerspace Medical, Inc. | Gas column pressure monitoring catheters |
US6346583B1 (en) | 1999-08-25 | 2002-02-12 | General Electric Company | Polar solvent compatible polyethersiloxane elastomers |
WO2001016579A1 (en) | 1999-08-31 | 2001-03-08 | Cme Telemetrix Inc. | Method of calibrating a spectroscopic device |
US6312469B1 (en) | 1999-09-13 | 2001-11-06 | Medtronic Inc. | Lamina prosthesis for delivery of medical treatment |
US6343225B1 (en) | 1999-09-14 | 2002-01-29 | Implanted Biosystems, Inc. | Implantable glucose sensor |
WO2001020334A1 (en) | 1999-09-15 | 2001-03-22 | The Regents Of The University Of California | Glucose sensing molecules having selected fluorescent properties |
US6464849B1 (en) | 1999-10-07 | 2002-10-15 | Pepex Biomedical, L.L.C. | Sensor for measuring a bioanalyte such as lactate |
US6406426B1 (en) | 1999-11-03 | 2002-06-18 | Criticare Systems | Medical monitoring and alert system for use with therapeutic devices |
US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
US6527729B1 (en) | 1999-11-10 | 2003-03-04 | Pacesetter, Inc. | Method for monitoring patient using acoustic sensor |
SE9904087D0 (en) | 1999-11-11 | 1999-11-11 | Pacesetter Ab | Recommended replacement time of an implantable medical device |
JP3426549B2 (en) | 1999-11-12 | 2003-07-14 | 本田技研工業株式会社 | Exhaust pipe connection structure |
WO2001036660A2 (en) * | 1999-11-15 | 2001-05-25 | Therasense, Inc. | Transition metal complexes attached to a polymer via a flexible chain |
US8268143B2 (en) | 1999-11-15 | 2012-09-18 | Abbott Diabetes Care Inc. | Oxygen-effect free analyte sensor |
US6925393B1 (en) | 1999-11-18 | 2005-08-02 | Roche Diagnostics Gmbh | System for the extrapolation of glucose concentration |
DE19956822B4 (en) * | 1999-11-25 | 2004-01-29 | Siemens Ag | Method for determining the NOx concentration |
US6612984B1 (en) | 1999-12-03 | 2003-09-02 | Kerr, Ii Robert A. | System and method for collecting and transmitting medical data |
US6520997B1 (en) * | 1999-12-08 | 2003-02-18 | Baxter International Inc. | Porous three dimensional structure |
US6873268B2 (en) * | 2000-01-21 | 2005-03-29 | Medtronic Minimed, Inc. | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
US20020016535A1 (en) | 2000-01-28 | 2002-02-07 | Martin W. Blake | Subcutaneous glucose measurement device |
EP1130393A3 (en) | 2000-02-03 | 2001-11-28 | Nihon Kohden Corporation | Gas sensor and gas sensor system |
US6687521B2 (en) * | 2000-02-03 | 2004-02-03 | Hamamatsu Photonics K.K. | Noninvasion biological optical measuring instrument, measured portion holding device, and method for manufacturing the same |
CA2395868C (en) | 2000-02-10 | 2009-07-14 | Medtronic Minimed, Inc. | Improved analyte sensor and method of making the same |
US20030060765A1 (en) | 2000-02-16 | 2003-03-27 | Arthur Campbell | Infusion device menu structure and method of using the same |
US7890295B2 (en) * | 2000-02-23 | 2011-02-15 | Medtronic Minimed, Inc. | Real time self-adjusting calibration algorithm |
US6895263B2 (en) | 2000-02-23 | 2005-05-17 | Medtronic Minimed, Inc. | Real time self-adjusting calibration algorithm |
US6551496B1 (en) | 2000-03-03 | 2003-04-22 | Ysi Incorporated | Microstructured bilateral sensor |
US6365670B1 (en) | 2000-03-10 | 2002-04-02 | Wacker Silicones Corporation | Organopolysiloxane gels for use in cosmetics |
CA2406814A1 (en) | 2000-03-17 | 2001-09-20 | F. Hoffmann-La Roche Ag | Implantable analyte sensor |
US6405066B1 (en) | 2000-03-17 | 2002-06-11 | The Regents Of The University Of California | Implantable analyte sensor |
WO2001072208A2 (en) | 2000-03-29 | 2001-10-04 | University Of Virginia Patent Foundation | Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data |
US6599281B1 (en) * | 2000-05-03 | 2003-07-29 | Aspect Medical Systems, Inc. | System and method for adaptive drug delivery |
IT1314759B1 (en) | 2000-05-08 | 2003-01-03 | Menarini Farma Ind | INSTRUMENTATION FOR MEASUREMENT AND CONTROL OF THE CONTENT OF GLUCOSIOLACTATE OR OTHER METABOLITES IN BIOLOGICAL FLUIDS |
WO2001088524A1 (en) | 2000-05-12 | 2001-11-22 | Therasense, Inc. | Electrodes with multilayer membranes and methods of using and making the electrodes |
WO2001088534A2 (en) | 2000-05-16 | 2001-11-22 | Cygnus, Inc. | Methods for improving performance and reliability of biosensors |
WO2001090733A1 (en) | 2000-05-23 | 2001-11-29 | Radiometer Medical A/S | A sensor membrane, a method for the preparation thereof, a sensor and a layered membrane structure for such sensor |
US7395158B2 (en) | 2000-05-30 | 2008-07-01 | Sensys Medical, Inc. | Method of screening for disorders of glucose metabolism |
US6991652B2 (en) * | 2000-06-13 | 2006-01-31 | Burg Karen J L | Tissue engineering composite |
WO2002100266A1 (en) | 2000-06-13 | 2002-12-19 | Edward Henry Mathews | A dietary system: 'blood sugar predicting system' |
US7261690B2 (en) | 2000-06-16 | 2007-08-28 | Bodymedia, Inc. | Apparatus for monitoring health, wellness and fitness |
US6494830B1 (en) | 2000-06-22 | 2002-12-17 | Guidance Interactive Technologies, Inc. | Handheld controller for monitoring/using medical parameters |
US6773565B2 (en) * | 2000-06-22 | 2004-08-10 | Kabushiki Kaisha Riken | NOx sensor |
US6699188B2 (en) | 2000-06-22 | 2004-03-02 | Guidance Interactive Technologies | Interactive reward devices and methods |
AU2001272249A1 (en) | 2000-07-05 | 2002-01-14 | Andrew J. E. Seely | Method and apparatus for multiple patient parameter variability analysis and display |
US6569521B1 (en) | 2000-07-06 | 2003-05-27 | 3M Innovative Properties Company | Stretch releasing pressure sensitive adhesive tape and articles |
US6477392B1 (en) | 2000-07-14 | 2002-11-05 | Futrex Inc. | Calibration of near infrared quantitative measurement device using optical measurement cross-products |
WO2002005702A2 (en) | 2000-07-18 | 2002-01-24 | Healthetech, Inc. | Closed loop glycemic index system |
US6795068B1 (en) | 2000-07-21 | 2004-09-21 | Sony Computer Entertainment Inc. | Prop input device and method for mapping an object from a two-dimensional camera image to a three-dimensional space for controlling action in a game program |
US6589229B1 (en) * | 2000-07-31 | 2003-07-08 | Becton, Dickinson And Company | Wearable, self-contained drug infusion device |
US6683535B1 (en) * | 2000-08-09 | 2004-01-27 | Alderon Industries, Llc | Water detection system and method |
WO2002015778A1 (en) * | 2000-08-18 | 2002-02-28 | Cygnus, Inc. | Analyte monitoring device alarm augmentation system |
US20020026111A1 (en) * | 2000-08-28 | 2002-02-28 | Neil Ackerman | Methods of monitoring glucose levels in a subject and uses thereof |
US6553241B2 (en) | 2000-08-31 | 2003-04-22 | Mallinckrodt Inc. | Oximeter sensor with digital memory encoding sensor expiration data |
US6572545B2 (en) * | 2000-09-22 | 2003-06-03 | Knobbe, Lim & Buckingham | Method and apparatus for real-time control of physiological parameters |
FR2815199B1 (en) | 2000-10-10 | 2003-01-17 | Canon Kk | CIRCULAR TURBOCODING METHODS OF LARGE MINIMUM DISTANCE, AND SYSTEMS FOR IMPLEMENTING THE SAME |
DE60126325T2 (en) | 2000-11-09 | 2007-11-08 | Insulet Corp., Beverly | DEVICE FOR THE TRANSCUTANEOUS DISPOSAL OF MEDICAMENTS |
US6695860B1 (en) | 2000-11-13 | 2004-02-24 | Isense Corp. | Transcutaneous sensor insertion device |
US6742635B2 (en) | 2000-12-20 | 2004-06-01 | Jr286 Inc. | Sports bag including an attached mat |
JP2002189015A (en) | 2000-12-20 | 2002-07-05 | Sankyo Co Ltd | Reaction-current measuring method by enzyme electrode |
IL156245A0 (en) | 2000-12-22 | 2004-01-04 | Dca Design Int Ltd | Drive mechanism for an injection device |
US6642015B2 (en) | 2000-12-29 | 2003-11-04 | Minimed Inc. | Hydrophilic polymeric material for coating biosensors |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6510329B2 (en) * | 2001-01-24 | 2003-01-21 | Datex-Ohmeda, Inc. | Detection of sensor off conditions in a pulse oximeter |
US6841389B2 (en) | 2001-02-05 | 2005-01-11 | Glucosens, Inc. | Method of determining concentration of glucose in blood |
US7014610B2 (en) | 2001-02-09 | 2006-03-21 | Medtronic, Inc. | Echogenic devices and methods of making and using such devices |
WO2002064027A2 (en) | 2001-02-15 | 2002-08-22 | The Regents Of The University Of California | Membrane and electrode structure for implantable sensor |
US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
FR2822383B1 (en) | 2001-03-23 | 2004-12-17 | Perouse Lab | PROSTHESIS FOR PLASTIC RECONSTRUCTION WITH IMPROVED HYDROPHILICITY PROPERTIES, AND METHOD FOR OBTAINING SAME |
WO2002078512A2 (en) | 2001-04-02 | 2002-10-10 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US6574490B2 (en) | 2001-04-11 | 2003-06-03 | Rio Grande Medical Technologies, Inc. | System for non-invasive measurement of glucose in humans |
US7167734B2 (en) | 2001-04-13 | 2007-01-23 | Abbott Laboratories | Method for optical measurements of tissue to determine disease state or concentration of an analyte |
US6613379B2 (en) | 2001-05-08 | 2003-09-02 | Isense Corp. | Implantable analyte sensor |
IL143374A0 (en) | 2001-05-24 | 2002-04-21 | Transscan Medical Ltd | Anomaly detection based on signal variations |
US6793632B2 (en) | 2001-06-12 | 2004-09-21 | Lifescan, Inc. | Percutaneous biological fluid constituent sampling and measurement devices and methods |
US6501976B1 (en) | 2001-06-12 | 2002-12-31 | Lifescan, Inc. | Percutaneous biological fluid sampling and analyte measurement devices and methods |
US7011630B2 (en) | 2001-06-22 | 2006-03-14 | Animas Technologies, Llc | Methods for computing rolling analyte measurement values, microprocessors comprising programming to control performance of the methods, and analyte monitoring devices employing the methods |
US7150737B2 (en) | 2001-07-13 | 2006-12-19 | Sci/Med Life Systems, Inc. | Methods and apparatuses for navigating the subarachnoid space |
US20030208113A1 (en) | 2001-07-18 | 2003-11-06 | Mault James R | Closed loop glycemic index system |
US6702857B2 (en) | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
US20030032874A1 (en) | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
US6544212B2 (en) * | 2001-07-31 | 2003-04-08 | Roche Diagnostics Corporation | Diabetes management system |
US8152789B2 (en) | 2001-10-23 | 2012-04-10 | Medtronic Minimed, Inc. | System and method for providing closed loop infusion formulation delivery |
US6827702B2 (en) * | 2001-09-07 | 2004-12-07 | Medtronic Minimed, Inc. | Safety limits for closed-loop infusion pump control |
US7025760B2 (en) | 2001-09-07 | 2006-04-11 | Medtronic Minimed, Inc. | Method and system for non-vascular sensor implantation |
US6650915B2 (en) | 2001-09-13 | 2003-11-18 | Fovioptics, Inc. | Non-invasive measurement of blood analytes using photodynamics |
US6830562B2 (en) | 2001-09-27 | 2004-12-14 | Unomedical A/S | Injector device for placing a subcutaneous infusion set |
US6802957B2 (en) | 2001-09-28 | 2004-10-12 | Marine Biological Laboratory | Self-referencing enzyme-based microsensor and method of use |
US6840904B2 (en) * | 2001-10-11 | 2005-01-11 | Jason Goldberg | Medical monitoring device and system |
US6809507B2 (en) | 2001-10-23 | 2004-10-26 | Medtronic Minimed, Inc. | Implantable sensor electrodes and electronic circuitry |
US6705833B2 (en) | 2001-11-15 | 2004-03-16 | Hewlett-Packard Development Company, L.P. | Airflow flapper valve |
US6755785B2 (en) | 2001-11-20 | 2004-06-29 | Matsushita Electric Industrial Co., Ltd. | Ultrasonic image generating apparatus and ultrasonic image generating method |
US20040030294A1 (en) | 2001-11-28 | 2004-02-12 | Mahurkar Sakharam D. | Retractable needle single use safety syringe |
US20050101841A9 (en) * | 2001-12-04 | 2005-05-12 | Kimberly-Clark Worldwide, Inc. | Healthcare networks with biosensors |
US7204823B2 (en) * | 2001-12-19 | 2007-04-17 | Medtronic Minimed, Inc. | Medication delivery system and monitor |
US6952604B2 (en) | 2001-12-21 | 2005-10-04 | Becton, Dickinson And Company | Minimally-invasive system and method for monitoring analyte levels |
US7399277B2 (en) | 2001-12-27 | 2008-07-15 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
US7022072B2 (en) | 2001-12-27 | 2006-04-04 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
US20080255438A1 (en) | 2001-12-27 | 2008-10-16 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
US20050027182A1 (en) | 2001-12-27 | 2005-02-03 | Uzair Siddiqui | System for monitoring physiological characteristics |
US7018336B2 (en) | 2001-12-27 | 2006-03-28 | Medtronic Minimed, Inc. | Implantable sensor flush sleeve |
CA2474359A1 (en) | 2002-01-29 | 2003-08-07 | Sicel Technologies, Inc. | Implantable sensor housing and fabrication methods |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US9247901B2 (en) * | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9282925B2 (en) | 2002-02-12 | 2016-03-15 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US6998247B2 (en) * | 2002-03-08 | 2006-02-14 | Sensys Medical, Inc. | Method and apparatus using alternative site glucose determinations to calibrate and maintain noninvasive and implantable analyzers |
DE60337038D1 (en) | 2002-03-22 | 2011-06-16 | Animas Technologies Llc | Performance improvement of an analyte monitoring device |
US6936006B2 (en) | 2002-03-22 | 2005-08-30 | Novo Nordisk, A/S | Atraumatic insertion of a subcutaneous device |
US7027848B2 (en) | 2002-04-04 | 2006-04-11 | Inlight Solutions, Inc. | Apparatus and method for non-invasive spectroscopic measurement of analytes in tissue using a matched reference analyte |
AU2003233468A1 (en) | 2002-04-05 | 2003-10-27 | Eyelab Group, Llc | Monitoring blood substances using self-sampled tears |
US20070227907A1 (en) | 2006-04-04 | 2007-10-04 | Rajiv Shah | Methods and materials for controlling the electrochemistry of analyte sensors |
US6743635B2 (en) | 2002-04-25 | 2004-06-01 | Home Diagnostics, Inc. | System and methods for blood glucose sensing |
EP1498067A1 (en) | 2002-04-25 | 2005-01-19 | Matsushita Electric Industrial Co., Ltd. | Dosage determination supporting device, injector, and health management supporting system |
US7060192B2 (en) * | 2002-05-09 | 2006-06-13 | Lifescan, Inc. | Methods of fabricating physiological sample collection devices |
US7343188B2 (en) * | 2002-05-09 | 2008-03-11 | Lifescan, Inc. | Devices and methods for accessing and analyzing physiological fluid |
JP2003347399A (en) * | 2002-05-23 | 2003-12-05 | Sharp Corp | Method of manufacturing semiconductor substrate |
AU2003240018A1 (en) | 2002-05-31 | 2003-12-19 | Dow Corning Toray Silicone Co., Ltd. | Cartridge for moisture-curable sealant |
JP2005531759A (en) | 2002-06-28 | 2005-10-20 | ノヴェンバー アクティエンゲゼルシャフト | Electrochemical detection apparatus and method |
US20040010207A1 (en) | 2002-07-15 | 2004-01-15 | Flaherty J. Christopher | Self-contained, automatic transcutaneous physiologic sensing system |
US7278983B2 (en) | 2002-07-24 | 2007-10-09 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
US20040068230A1 (en) * | 2002-07-24 | 2004-04-08 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
US6892093B2 (en) * | 2002-08-01 | 2005-05-10 | Ge Medical Systems Information Technologies Inc. | Method and apparatus for real time display of filtered electrocardiogram data |
EP1575656B1 (en) | 2002-10-11 | 2009-06-17 | Becton, Dickinson and Company | Insulin delivery system with sensor |
US20040074785A1 (en) * | 2002-10-18 | 2004-04-22 | Holker James D. | Analyte sensors and methods for making them |
WO2004042364A2 (en) * | 2002-11-05 | 2004-05-21 | Therasense, Inc. | Assay device, system and method |
US7228160B2 (en) | 2002-11-13 | 2007-06-05 | Sorenson Medical, Inc. | System, apparatus and method for inferring glucose levels within the peritoneum with implantable sensors |
US7229288B2 (en) | 2002-12-20 | 2007-06-12 | Medtronic Minimed, Inc. | Method, system, and program for using a virtual environment to provide information on using a product |
US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US6965791B1 (en) | 2003-03-26 | 2005-11-15 | Sorenson Medical, Inc. | Implantable biosensor system, apparatus and method |
WO2004087256A1 (en) | 2003-04-02 | 2004-10-14 | Neurostream Technologies Inc. | Implantable nerve signal sensing and stimulation device for treating foot drop and other neurological disorders |
US7587287B2 (en) | 2003-04-04 | 2009-09-08 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US7875293B2 (en) * | 2003-05-21 | 2011-01-25 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
US8460243B2 (en) | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
US20040254433A1 (en) | 2003-06-12 | 2004-12-16 | Bandis Steven D. | Sensor introducer system, apparatus and method |
US20050051427A1 (en) * | 2003-07-23 | 2005-03-10 | Brauker James H. | Rolled electrode array and its method for manufacture |
US8423113B2 (en) | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7460898B2 (en) | 2003-12-05 | 2008-12-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7108778B2 (en) * | 2003-07-25 | 2006-09-19 | Dexcom, Inc. | Electrochemical sensors including electrode systems with increased oxygen generation |
US7074307B2 (en) * | 2003-07-25 | 2006-07-11 | Dexcom, Inc. | Electrode systems for electrochemical sensors |
US7761130B2 (en) | 2003-07-25 | 2010-07-20 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
WO2005012871A2 (en) * | 2003-07-25 | 2005-02-10 | Dexcom, Inc. | Increasing bias for oxygen production in an electrode system |
EP1648298A4 (en) * | 2003-07-25 | 2010-01-13 | Dexcom Inc | Oxygen enhancing membrane systems for implantable devices |
US20070208245A1 (en) | 2003-08-01 | 2007-09-06 | Brauker James H | Transcutaneous analyte sensor |
US20080119703A1 (en) | 2006-10-04 | 2008-05-22 | Mark Brister | Analyte sensor |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US7519408B2 (en) | 2003-11-19 | 2009-04-14 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
US7959569B2 (en) | 2003-08-01 | 2011-06-14 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US6931327B2 (en) | 2003-08-01 | 2005-08-16 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20100168542A1 (en) | 2003-08-01 | 2010-07-01 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8845536B2 (en) | 2003-08-01 | 2014-09-30 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7494465B2 (en) | 2004-07-13 | 2009-02-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8160669B2 (en) | 2003-08-01 | 2012-04-17 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8369919B2 (en) | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7920906B2 (en) * | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US7632234B2 (en) | 2003-08-29 | 2009-12-15 | Medtronic, Inc. | Implantable biosensor devices for monitoring cardiac marker molecules |
US7723099B2 (en) | 2003-09-10 | 2010-05-25 | Abbott Point Of Care Inc. | Immunoassay device with immuno-reference electrode |
US7433727B2 (en) | 2003-09-24 | 2008-10-07 | Legacy Good Samaritan Hospital And Medical Center | Implantable biosensor |
EP1670595A4 (en) | 2003-10-06 | 2010-07-21 | Nicast Ltd | Method and apparatus for coating medical implants |
US20050090607A1 (en) * | 2003-10-28 | 2005-04-28 | Dexcom, Inc. | Silicone composition for biocompatible membrane |
EP1685393B1 (en) | 2003-10-31 | 2007-02-21 | Lifescan Scotland Ltd | Electrochemical test strip for reducing the effect of direct interference current |
US7299082B2 (en) * | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
WO2005057168A2 (en) | 2003-12-05 | 2005-06-23 | Dexcom, Inc. | Calibration techniques for a continuous analyte sensor |
EP1711802B1 (en) | 2003-12-08 | 2010-07-14 | DexCom, Inc. | Systems and methods for improving electrochemical analyte sensors |
WO2005057175A2 (en) | 2003-12-09 | 2005-06-23 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US8147426B2 (en) | 2003-12-31 | 2012-04-03 | Nipro Diagnostics, Inc. | Integrated diagnostic test system |
US7637868B2 (en) | 2004-01-12 | 2009-12-29 | Dexcom, Inc. | Composite material for implantable device |
US20050182451A1 (en) | 2004-01-12 | 2005-08-18 | Adam Griffin | Implantable device with improved radio frequency capabilities |
JP2007518499A (en) | 2004-01-26 | 2007-07-12 | ノボ・ノルデイスク・エー/エス | Impact syringe chamber |
US8165651B2 (en) | 2004-02-09 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte sensor, and associated system and method employing a catalytic agent |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US20050245799A1 (en) | 2004-05-03 | 2005-11-03 | Dexcom, Inc. | Implantable analyte sensor |
US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
JP2007536974A (en) | 2004-05-14 | 2007-12-20 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Optical fiber probe |
US7125382B2 (en) | 2004-05-20 | 2006-10-24 | Digital Angel Corporation | Embedded bio-sensor system |
US20060015020A1 (en) * | 2004-07-06 | 2006-01-19 | Dexcom, Inc. | Systems and methods for manufacture of an analyte-measuring device including a membrane system |
US20060020192A1 (en) | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8565848B2 (en) | 2004-07-13 | 2013-10-22 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
US8886272B2 (en) | 2004-07-13 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US20060017575A1 (en) | 2004-07-20 | 2006-01-26 | Medtronic, Inc. | Alert system and method for an implantable medical device |
US20060100588A1 (en) | 2004-07-23 | 2006-05-11 | Lennart Brunnberg | Needle handling device |
US7608042B2 (en) | 2004-09-29 | 2009-10-27 | Intellidx, Inc. | Blood monitoring system |
KR100659498B1 (en) | 2005-03-10 | 2006-12-20 | 애니젠 주식회사 | Potassium channel opener having benzofuroindole skeleton |
US20090076360A1 (en) | 2007-09-13 | 2009-03-19 | Dexcom, Inc. | Transcutaneous analyte sensor |
GB0505763D0 (en) | 2005-03-22 | 2005-04-27 | Enigma Diagnostics Ltd | Polymorphism detection method |
EP1869414A4 (en) | 2005-03-29 | 2010-07-28 | Arkal Medical Inc | Devices, systems, methods and tools for continuous glucose monitoring |
US7904158B2 (en) | 2005-04-28 | 2011-03-08 | Medtronic, Inc. | Measurement of coronary sinus parameters to optimize left ventricular performance |
WO2006130854A2 (en) * | 2005-06-02 | 2006-12-07 | Isense Corporation | Use of multiple data points and filtering in an analyte sensor |
US20060276771A1 (en) | 2005-06-06 | 2006-12-07 | Galley Paul J | System and method providing for user intervention in a diabetes control arrangement |
US20070031283A1 (en) | 2005-06-23 | 2007-02-08 | Davis Charles Q | Assay cartridges and methods for point of care instruments |
US7359723B2 (en) | 2005-08-02 | 2008-04-15 | Qualcomm Incorporated | Systems, devices and methods for providing a reward based upon use of a mobile communications device |
US7162290B1 (en) * | 2005-09-16 | 2007-01-09 | Palco Labs, Inc. | Method and apparatus for blood glucose testing from a reversible infusion line |
US7941200B2 (en) | 2005-12-08 | 2011-05-10 | Roche Diagnostics Operations, Inc. | System and method for determining drug administration information |
US7367942B2 (en) | 2006-02-02 | 2008-05-06 | Palco Labs, Inc. | Method and apparatus for testing blood glucose in a reversible infusion line |
ES2871822T3 (en) | 2006-02-22 | 2021-11-02 | Dexcom Inc | Analyte sensor |
EP1991110B1 (en) | 2006-03-09 | 2018-11-07 | DexCom, Inc. | Systems and methods for processing analyte sensor data |
US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
US7824333B2 (en) | 2006-03-31 | 2010-11-02 | Lifescan, Inc. | Diabetes management methods and systems |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US8478406B2 (en) | 2006-04-24 | 2013-07-02 | Medtronic, Inc. | Apparatus and methods of delivering an enhanced refractory period stimulation therapy |
US20080071158A1 (en) | 2006-06-07 | 2008-03-20 | Abbott Diabetes Care, Inc. | Analyte monitoring system and method |
ATE514755T1 (en) | 2006-07-25 | 2011-07-15 | Glumetrics Inc | FLUORESCENT DYES FOR USE IN GLUCOSE DETECTION |
WO2009008892A1 (en) | 2006-08-15 | 2009-01-15 | Optiscan Biomedical Corporation | Accurate and timely body fluid analysis |
ATE519423T1 (en) | 2006-09-27 | 2011-08-15 | Univ Connecticut | IMPLANTABLE BIOSENSOR AND METHOD OF USE |
US7740580B2 (en) * | 2006-10-31 | 2010-06-22 | Abbott Diabetes Care Inc. | Analyte monitoring |
WO2008076868A2 (en) | 2006-12-18 | 2008-06-26 | Abbott Laboratories | Methods and compositions related to modulation of receptor tyrosine kinase orphan receptor-1 (ror-1) |
EP2989975B1 (en) | 2007-02-06 | 2018-06-13 | Medtronic MiniMed, Inc. | Optical systems and methods for rationmetric measurement of blood glucose concentration |
US7751863B2 (en) | 2007-02-06 | 2010-07-06 | Glumetrics, Inc. | Optical determination of ph and glucose |
EP2122334B1 (en) | 2007-02-06 | 2018-01-24 | Medtronic Minimed, Inc. | Method for polymerizing a monomer solution within a cavity to generate a smooth polymer surface |
US8088097B2 (en) | 2007-11-21 | 2012-01-03 | Glumetrics, Inc. | Use of an equilibrium intravascular sensor to achieve tight glycemic control |
US7824918B2 (en) | 2007-08-06 | 2010-11-02 | Glumetrics, Inc. | HPTS-Mono and BIS Cys-Ma polymerizable fluorescent dyes for use in analyte sensors |
US20090018426A1 (en) | 2007-05-10 | 2009-01-15 | Glumetrics, Inc. | Device and methods for calibrating analyte sensors |
WO2008137604A1 (en) | 2007-05-01 | 2008-11-13 | Glumetrics, Inc. | Pyridinium boronic acid quenchers for use in analyte sensors |
WO2008141241A1 (en) | 2007-05-10 | 2008-11-20 | Glumetrics, Inc. | Equilibrium non-consuming fluorescence sensor for real time intravascular glucose measurement |
US20080306444A1 (en) | 2007-06-08 | 2008-12-11 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US10238532B2 (en) | 2007-06-11 | 2019-03-26 | Cesaroni Technology Incorporated | Body temperature controlling system |
WO2009009756A2 (en) | 2007-07-11 | 2009-01-15 | Glumetrics, Inc. | Polyviologen boronic acid quenchers for use in analyte sensors |
US20090062645A1 (en) * | 2007-09-03 | 2009-03-05 | Jens Fehre | Method for diagnosis and treatment of prostate cancer |
US7731659B2 (en) | 2007-10-18 | 2010-06-08 | Lifescan Scotland Limited | Method for predicting a user's future glycemic state |
US7695434B2 (en) | 2007-10-19 | 2010-04-13 | Lifescan Scotland, Ltd. | Medical device for predicting a user's future glycemic state |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
WO2009097450A1 (en) | 2008-01-30 | 2009-08-06 | Dexcom. Inc. | Continuous cardiac marker sensor system |
WO2009105337A2 (en) | 2008-02-20 | 2009-08-27 | Dexcom, Inc. | Continuous medicament sensor system for in vivo use |
CA2715628A1 (en) | 2008-02-21 | 2009-08-27 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
US20090242399A1 (en) | 2008-03-25 | 2009-10-01 | Dexcom, Inc. | Analyte sensor |
US8396528B2 (en) | 2008-03-25 | 2013-03-12 | Dexcom, Inc. | Analyte sensor |
WO2009129186A2 (en) | 2008-04-17 | 2009-10-22 | Glumetrics, Inc. | Sensor for percutaneous intravascular deployment without an indwelling cannula |
US8560039B2 (en) | 2008-09-19 | 2013-10-15 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
BRPI1008267B1 (en) | 2009-02-16 | 2021-06-22 | Basf Se | PROCESS FOR THE FERMENTAL PRODUCTION OF SUCCINIC ACID |
-
2004
- 2004-11-17 US US10/991,966 patent/US7519408B2/en active Active
- 2004-11-17 WO PCT/US2004/038724 patent/WO2005051170A2/en active Application Filing
-
2008
- 2008-07-29 US US12/182,073 patent/US20080287765A1/en not_active Abandoned
- 2008-07-29 US US12/182,083 patent/US7927274B2/en active Active
- 2008-07-29 US US12/182,008 patent/US8282550B2/en active Active
-
2009
- 2009-09-23 US US12/565,205 patent/US20100016698A1/en not_active Abandoned
-
2010
- 2010-03-25 US US12/731,965 patent/US9538946B2/en active Active
-
2011
- 2011-04-22 US US13/092,538 patent/US20110201910A1/en not_active Abandoned
-
2016
- 2016-11-09 US US15/347,687 patent/US11564602B2/en active Active
-
2023
- 2023-01-06 US US18/151,356 patent/US20230284945A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6424847B1 (en) * | 1999-02-25 | 2002-07-23 | Medtronic Minimed, Inc. | Glucose monitor calibration methods |
US6633772B2 (en) * | 2000-08-18 | 2003-10-14 | Cygnus, Inc. | Formulation and manipulation of databases of analyte and associated values |
Cited By (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2182838A1 (en) * | 2007-07-31 | 2010-05-12 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in a medical communication system |
WO2009018058A1 (en) | 2007-07-31 | 2009-02-05 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in a medical communication system |
EP2182838A4 (en) * | 2007-07-31 | 2014-02-12 | Abbott Diabetes Care Inc | Method and apparatus for providing data processing and control in a medical communication system |
WO2009049252A1 (en) * | 2007-10-10 | 2009-04-16 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
EP3868284A1 (en) * | 2007-10-10 | 2021-08-25 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
US9414782B2 (en) | 2007-10-10 | 2016-08-16 | Optiscan Biomedical Corporation | Fluid component analysis systems and methods for glucose monitoring and control |
CN101910832A (en) * | 2007-11-02 | 2010-12-08 | 爱德华兹生命科学公司 | Analyte monitoring system with the standby power supply that is used for system's transfer or main power supply disappearance |
WO2009144507A1 (en) * | 2008-05-31 | 2009-12-03 | Spd Swiss Precision Diagnostics Gmbh | Assay device |
CN102099678A (en) * | 2008-05-31 | 2011-06-15 | 瑞士斯保德精密诊断有限公司 | Assay device |
US8606528B2 (en) | 2008-05-31 | 2013-12-10 | Spd Swiss Precision Diagnostics Gmbh | Assay device |
US11865299B2 (en) | 2008-08-20 | 2024-01-09 | Insulet Corporation | Infusion pump systems and methods |
US9302045B2 (en) | 2008-09-12 | 2016-04-05 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
US11202591B2 (en) | 2009-02-03 | 2021-12-21 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006871B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
CN104287744B (en) * | 2009-02-03 | 2017-04-12 | 雅培糖尿病护理公司 | Compact on-body physiological monitoring devices and methods thereof |
CN104287744A (en) * | 2009-02-03 | 2015-01-21 | 雅培糖尿病护理公司 | Compact on-body physiological monitoring devices and methods thereof |
US11213229B2 (en) | 2009-02-03 | 2022-01-04 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11166656B2 (en) | 2009-02-03 | 2021-11-09 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006870B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006872B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11872370B2 (en) | 2009-05-29 | 2024-01-16 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
USD1010133S1 (en) | 2009-08-31 | 2024-01-02 | Abbott Diabetes Care Inc. | Analyte sensor assembly |
US10492685B2 (en) | 2009-08-31 | 2019-12-03 | Abbott Diabetes Care Inc. | Medical devices and methods |
US10136816B2 (en) | 2009-08-31 | 2018-11-27 | Abbott Diabetes Care Inc. | Medical devices and methods |
ITMI20100258A1 (en) * | 2010-02-19 | 2011-08-20 | Antonio Americo Cannata | GLYCEMIC CONTROL DEVICE |
US10674937B2 (en) | 2011-03-15 | 2020-06-09 | Senseonics, Incorporated | Integrated catalytic protection of oxidation sensitive materials |
CN103533884A (en) * | 2011-03-15 | 2014-01-22 | 传感技术股份有限公司 | Integrated catalytic protection of oxidation sensitive materials |
US9681824B2 (en) | 2011-03-15 | 2017-06-20 | Senseonics, Incorporated | Integrated catalytic protection of oxidation sensitive materials |
CN103472010A (en) * | 2013-09-17 | 2013-12-25 | 苏州凯恩医药科技有限公司 | Diabetes detection device |
US10435517B2 (en) | 2013-09-18 | 2019-10-08 | Senseonics, Incorporated | Critical point drying of hydrogels in analyte sensors |
US9963556B2 (en) | 2013-09-18 | 2018-05-08 | Senseonics, Incorporated | Critical point drying of hydrogels in analyte sensors |
US11386996B2 (en) | 2014-01-30 | 2022-07-12 | Insulet Netherlands B.V. | Therapeutic product delivery system and method of pairing |
US11596740B2 (en) | 2015-02-18 | 2023-03-07 | Insulet Corporation | Fluid delivery and infusion devices, and methods of use thereof |
US11929158B2 (en) | 2016-01-13 | 2024-03-12 | Insulet Corporation | User interface for diabetes management system |
US11857763B2 (en) | 2016-01-14 | 2024-01-02 | Insulet Corporation | Adjusting insulin delivery rates |
US11724027B2 (en) | 2016-09-23 | 2023-08-15 | Insulet Corporation | Fluid delivery device with sensor |
USD1020794S1 (en) | 2018-04-02 | 2024-04-02 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
US11565043B2 (en) | 2018-05-04 | 2023-01-31 | Insulet Corporation | Safety constraints for a control algorithm based drug delivery system |
US11628251B2 (en) | 2018-09-28 | 2023-04-18 | Insulet Corporation | Activity mode for artificial pancreas system |
US11565039B2 (en) | 2018-10-11 | 2023-01-31 | Insulet Corporation | Event detection for drug delivery system |
CN110353698A (en) * | 2019-08-01 | 2019-10-22 | 武汉优斯特传感器科技有限公司 | A kind of detector of the sustainable internal glucose content of measurement |
CN110353698B (en) * | 2019-08-01 | 2024-03-12 | 武汉优斯特传感器科技有限公司 | Detector for continuously measuring glucose content in body |
WO2021023160A1 (en) * | 2019-08-02 | 2021-02-11 | Bionime Corporation | Physiological signal monitoring system for fast assembly |
US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
US11957875B2 (en) | 2019-12-06 | 2024-04-16 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
USD1024090S1 (en) | 2021-05-19 | 2024-04-23 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
US11969579B2 (en) | 2021-06-11 | 2024-04-30 | Insulet Corporation | Insulin delivery methods, systems and devices |
US11738144B2 (en) | 2021-09-27 | 2023-08-29 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
Also Published As
Publication number | Publication date |
---|---|
US20080287766A1 (en) | 2008-11-20 |
US20080287764A1 (en) | 2008-11-20 |
US7519408B2 (en) | 2009-04-14 |
US7927274B2 (en) | 2011-04-19 |
US20050154271A1 (en) | 2005-07-14 |
US11564602B2 (en) | 2023-01-31 |
WO2005051170A3 (en) | 2009-04-02 |
US8282550B2 (en) | 2012-10-09 |
US20110201910A1 (en) | 2011-08-18 |
US20170055889A1 (en) | 2017-03-02 |
US20100016698A1 (en) | 2010-01-21 |
US20230284945A1 (en) | 2023-09-14 |
US20100179401A1 (en) | 2010-07-15 |
US20080287765A1 (en) | 2008-11-20 |
US9538946B2 (en) | 2017-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230284945A1 (en) | Integrated receiver for continuous analyte sensor | |
US20220203038A1 (en) | Integrated delivery device for continuous glucose sensor | |
EP2256493B1 (en) | Calibration techniques for a continuous analyte sensor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |